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 “Credo di poter affermare che nella 
ricerca scientifica né il grado di 
intelligenza né la capacità di eseguire 
e portare a termine il compito 
intrapreso siano fattori essenziali per 
la riuscita e per la soddisfazione 
personale. Nell'uno e nell'altro 
contano maggiormente la totale 
dedizione e il chiudere gli occhi 
davanti alle difficoltà: in tal modo 
possiamo affrontare i problemi che 
altri, più critici e più acuti, non 
affronterebbero”. 
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Asymmetric organocatalysis is a new rapidly growing field whose 
huge potential is becoming more and more evident. This PhD 
project has been conceived and developed in the context of non-
covalent organocatalysis. 
 The aim of this work has been to design, plan and develop new 
organocatalytic methodologies for the synthesis of optically active, 
densely functionalized, organic molecules whose functional groups 
are susceptible to further manipulation. The target molecules 
represent important motifs present in many biologically active 
natural and non-natural substances.  
 The catalysts used are small chiral organic molecules, in 
particular the attention has been focused on bifunctional 
organocatalysts. The main features of the catalysts are their non-
toxicity, stability to air and moisture and the ability to work under 
mild conditions that make them convenient tools in organic 
chemistry. These promoters are able to synergistically activate both 
the electrophile and the nucleophile through multiple hydrogen-
bonding interactions provided by their acid and basic groups with 
the reactive groups of the reagents. The best-performing chiral 
scaffold of the bifunctional organocatalysts, employed in the 
methodologies herein developed, has been selected screening the 
activity of previously reported promoters such as ureas, thioureas, 
squaramides, amino alcohols. However, the design and synthesis of 
new optically pure bifunctional organocatalysts, modifying the 
chiral backbone and by tuning their stereoelectronic features has 




stereoselective construction of a quaternary stereocentre, especially 
when it is an all-carbon quaternary stereocentre, is one of the most 
difficult goals in organic synthesis due to the steric congestion 
imposed by the four attached substituents. In this project, the 
synthesis of challenging molecules, bearing quaternary 
stereocentres in their structure, has been accomplished. 
 The methodologies developed aimed to the stereocontrolled 
construction of carbon-carbon and carbon-heteroatom bonds to give 
access to new and important cyclic compounds of different nature 
and size (such as epoxides, tetrahydrothiophenes, γ-butyrolactones) 
and non-cyclic compounds, such as α-hydroxy β-ketoamides.  
 In order to access the cyclic compounds, the one-pot tandem 
organocatalytic methodologies developed, such as 
Michael/Michael, aldol/lactonization, allowed us to obtain the 
densely functionalized molecules with a minimum number of 
synthetic operations. Unquestionably, these processes are becoming 
of considerable synthetic interest in terms of sustainability and 
advantageous in terms of time, costs saving issues and minimal 
manual operations. 
 In this doctoral work, the first stereoselective cascade sulfa-
Michael/Michael reaction for the synthesis of tetrahydrothiophenes 
from trans-α-carbonyl-β-substituted acrylonitriles has been 
developed, by using a novel readily available secondary amine 
thiourea. Highly functionalized tetrahydrothiophenes, bearing three 
contiguous stereocentres, one of them quaternary, were formed by 
means of a highly stereoselective cascade transformation. This 




outcome of an asymmetric synthesis of tetrahydrothiophenes has 
been controlled exclusively by a dinamic kinetic resolution process. 
 The first straighforward approach to enantioenriched β,β-
disubstituted γ-butyrolactones has been achieved through a cascade 
aldol/lactonization process. From simple starting materials and 
working under mild reaction conditions, highly challenging γ-
butyrolactones, bearing an all-carbon quaternary stereocentre at the 
remote β-position were obtained. Remarkably, this work represents 
the first example of an enantioselective hydroxymethylation 
reaction of 2-substituted-1,3-dicarbonyl compounds catalyzed by an 
organocatalyst. 
Moreover, we demonstrated that these products can be elaborated to 
prepare valuable hydroxy γ-butyrolactones, bearing contiguous 
tertiary and quaternary stereocentres, so far inaccessible via 
alternative methods. 
 Another important goal of this project concerned the 
development of a first approach to enantiomerically enriched 
aromatic α-nitroepoxides. An aminolytic kinetic resolution of 
racemic aromatic α-nitroepoxides with aniline, catalyzed by an 
easily accessible cinchona alkaloid-derived thiourea, was devised as 
a successful strategy. The first demonstration of synthetic utility of 
the chiral epoxides obtained has been reported: they have been 
transformed into highly valuable anti-1,2-amino alcohols through 
an one-pot stereoselective ring-opening reaction followed by 
reduction.  
 Finally, the first enantioselective α-hydroxylation reaction of α-




available HQN/TBHP system, has been realized in this PhD project. 
This protocol enables a facile access to functionalized tertiary 
alcohols bearing a quaternary stereocentre, substituted with both 
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1. INTRODUCTION: ASYMMETRIC 
ORGANOCATALYSIS 
 
1.1 Asymmetric Synthesis 
IUPAC defines Asymmetric Synthesis as: “a chemical reaction (or 
reaction sequence) in which one or more new elements of chirality 
are formed in a substrate molecule and which produces the 




 More enantiopure is a compound, more is “valuable”. In fact, it 
should be kept in mind that life is strictly connected with chirality. 
Many building blocks of the biological systems are chiral, such as 
sugars and amino acids, and the chirality is often the basis of the 
interactions receptor-substrate. Frequently, only one enantiomer is 
recognized by its receptor and the opposite is inactive, less active 
or, in some cases, it is even a poison. This concept is very important 
in the field of pharmaceutical industry. For example, an α-amino 
acid metabolite of penicillin, the D-penicillamine, sold under the 
trade names Cupreimine and Depen, is active in treatment of 
rheumatoid arthritis and used as chelating agent in the treatment of 
several diseases such as the Wilson’s desease. The enantiomer L-
penicillamine, on the contrary, is toxic because inhibits the action 
of the B vitamin pyridoxine. 
The opposite chirality of the enantiomers leads, in hundreds of 
known compounds, also to differences in flavor and in the aroma.
2
 
Is the case, for example, of cyclic terpene limonene, shown in 
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Figure 1.1: the (R)-limonene has a strong smell of oranges while the 
(S)-isomer of turpentine. 
 
Figure 1.1 (R)- and (S)-limonene. 
 
Other classical examples of enantiomers showing different odour 
and/or taste properties are amino-acids - L-amino acids usually are 
bitter while D-amino acids are sweet - carvone, menthol, β-
cintronellol and linalool. 
 The enantioselective synthesis is difficult to achieve because 
enantiomers have identical enthalpies and entropies. In achiral 
reactions they are produced in equal amounts, as racemic mixture, 
because transition states that lead to enantiomers are also 
enantiomeric, having equal energy. The only way to perform a 
reaction in a stereoselective manner is to use a chiral “component” 
that produces diastereomeric transition states with different energy 









Figure 1.2 Gibbs free energy plots of (a) an achiral and (b) a chiral 
reaction. 
 
An approach to asymmetric synthesis involves the use of molecules 
from the chiral pool: chiral non racemic starting materials are 
manipulated through successive reactions, often using achiral 
reagents, to obtain the desired enantiopure molecule. However, this 
approach is not cheap because a stoichiometric amount of a chiral 
reagent is required, the synthetic routs may be not very easy and, 
unfortunately, the range of enantiopure compounds provided by 
Nature is limited with respect to structure and stereochemistry. It is 
possible to use chiral auxiliaries, chiral solvents or chiral catalysts 
in order to make the activation energy needed to form an 
enantiomer lower than needed for the opposite enantiomer. 
In a reaction that occurs in solution, components are solvated, 
therefore, if the solvent is chiral, it is possible to have an 
asymmetric synthesis because transition states become 
diastereomeric. Nevertheless, chiral solvents are seldom utilized 
because the level of stereoselectivity is often low and not 
predictable and a large amount of chiral substance is required. 
Chiral auxiliaries, hooked to the prochiral substrate before the 
reaction, are used in stoichiometric amounts and this strategy 
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requires additional synthetic steps to append and remove the 
auxiliary. However, the reactions usually give predictable and 
reproducible results, the auxiliary can be recycled and purification 
is usually easy because the products are diastereomeric. In some 
cases, this is the only available stereoselective methodology to 
access enantiomerically pure products. 
An alternative approach to perform an asymmetric synthesis is the 
kinetic resolution: in the presence of an enantiomerically pure 
reagent or a catalyst, the two enantiomers of a racemate can have 
different reaction rates. If the rate difference is very large (the ideal 
cases are enzymes) one enantiomer is inert and the other one reacts 
quickly and the product can be separated from the unreacted 
enantiomer. 
 The asymmetric synthesis performed employing chiral catalysts 
provides the best “atom economy”, because the amount of chiral 
substance used in the transformation is minimized. 
Until recently, the catalytic enantioselective synthesis of chiral 
organic compounds such as agrochemicals, synthetic intermediates 
and pharmaceuticals was based on metal and enzymatic catalysis.
4
 
The organometallic catalysis is the field that received more 
emphasis in asymmetric synthesis over the years. The chiral 
organometallic catalysts can be modulated and tailored to many 
kinds of organic reactions. Several transformations in asymmetric 
catalysis are promoted by organometallic complexes and there are 
many well-established metal-based methodologies in this field.
5
 At 
the beginning of the new century, the field of biocatalysis has made 
great progress thanks to the discovery that is possible to prepare 
INTRODUCTION                                                        1.1 Asymmetric Synthesis 
 
 5 
useful enzymes from novel organisms and optimize the enzyme 
performance by evolutionary methods and selective mutation.
6
 
 Nevertheless, in the last ten years, this picture is changing: 
between these two pillars the organocatalysis has emerged.
7
 As 
metal complexes and enzymes, even small organic molecules may 
promote chemical reactions. Organic molecules, without metal 
element, used in a substoichiometric amount, are useful means to 
accelerate chemical transformations. 
Organocatalysis offers several advantages over transition metal- 
and bio-catalysis: reactions can be performed under an aerobic 
atmosphere, with not perfectly anhydrous solvents, indeed, in some 
cases, the presence of water has proven to be beneficial to the rate 
and selectivity of the reaction. Organocatalysts are usually readily 
available, less toxic and cheaper than metal complexes. They are 
more stable and robust than metal complexes and enzymes. The risk 
of metal leakage is avoided and no expensive waste treatment is 
required. Thanks to the sustainability of the catalysts, 
environmentally friendliness and green features, organocatalysis 
has found applications in several industrial asymmetric syntheses.
8
 
Moreover, these organic catalysts are particularly efficient in 
promoting tandem stereoselective multistep and multicomponent 
reactions, thus offering the opportunity to increase the structural 
complexity of the products.  
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1.2 Historical Background  
The organocatalysis has a very ancient story: there are evidences 
that such catalysis has played a key role in the beginning of life on 
Earth. It is thought that such catalysis has been responsible for the 
formation of probiotic key building-blocks such as sugars, leading 
to the birth of homochirality in living systems.
9
 Pizzarello and 
Weber demonstrated that L-isovaline, found in the Murchison 
meteorite, promotes the self- aldol reaction of glycolaldehyde in 
water, generating sugar aldol products such as L-threose and D-
erythrose with up to 10.7 ± 1.2% and 4.8 ± 0.9% ee, respectively.9 
This means that enantiomerically enriched amino acids such as L-
alanine and L-isovaline, which may be present in up to 15% ee in 
carbonaceous meteorites, probably were able to catalyze aldol 
reactions of glycolaldehyde and formaldehyde producing sugar 
derivatives. After the formation of sugars, more complex 
carbohydrates and complex molecules such as DNA and RNA were 
formed. Most likely, prebiotic RNA had a key role in basic 
biochemical transformations necessary for life, in which sugars 
were the chiral templates.
10
 For example, it is believed, that, as the 
first step of protein synthesis is the asymmetric aminoacylation, the 
homochirality of RNA determined homochirality of amino acids in 




 Accidentally, von Liebig, in the 1800s, discovered the first 
organocatalytic reaction, developed in an aqueous solution of 
acetaldehyde and dicyan leading to the oxalamide (Scheme 1.1). 




Scheme 1.1 von Liebig’s oxamide synthesis. 
 
Later, this reaction has been the basis of the industrial Degussa 
oxamide synthesis. 
The organocatalysis was born when chemists began to use little 
organic molecules in an attempt to understand and to mimic the 
catalytic activity and selectivity displayed by enzymes. 
In 1912, Bredig and Friske discovered that quinine and quinidine 
accelerate the addition of HCN to benzaldehyde giving chiral 
cyanohydrins of opposite chirality, albeit with low ee (≤ 10%).12 
Subsequently, Pracejus et al., in 1960, obtained the product of 
addition of methanol to phenylmethylketene in 74% ee using 1 mol 




Scheme 1.2 Pracejus’ reaction. 
 
Further milestones in the organocatalysis field were laid in the 
1970s and 1980s. In 1971, Hajos-Parrish-Eder-Sauer-Wiechert 
reported the synthesis of an important intermediate in steroid 
synthesis, the Wieland-Miescher ketone, exploiting a proline-
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Scheme 1.3 The L-proline catalyzed Robinson annulation. 
 
The real growth of organocatalysis has taken place, however, in the 
early 2000s when List, Barbas et al. disclosed that acetone can react 
with a number of aldehydes in the presence of L-proline, obtaining 
the corresponding aldols in high yield and excellent enantiomeric 
excess. For example, with iso-butyraldehyde the product was 




Scheme 1.4 Intermolecular aldol reaction catalyzed by L-proline. 
 
List and Barbas’ pioneering work has given rise to an intense study 
by several research groups on the catalytic activity of L-proline in 
many organic reactions such as Michael, Mannich, aldol and so on. 
 Another catalyst widely adopted in several reactions, after its 
discovery in the same year of List and Barbas’ work, was the 
phenylalanine-derived secondary amine 1 (Scheme 1.5). MacMillan 
demontrated that the Diels-Alder reaction of α,β-unsaturated 
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aldehydes is effectively catalyzed in terms of yield and 




Scheme 1.5 Diels-Alder reaction promoted by MacMillan’s catalyst. 
 
A massive research activity in the field of peptide-catalyzed 
reactions started after the Inoue’s work in 1981. The cyclic 
dipeptide 2 derived from L-histidine and L-phenylalanine catalyzes 
the reaction between HCN and benzaldehyde giving the product 




Scheme 1.6 The dipeptide catalyst by Inoue. 
 
In the same period, Juliá, Colonna et al. reported the highly 
enantioselective epoxidation of chalcones with hydrogen peroxide 
promoted by catalyst 3 (Scheme 1.7).
18
  




Scheme 1.7 Enantioselective Juliá-Colonna epoxidation. 
 
In summary, although the first catalytic reactions date back to the 
early 1900s, organocatalysis had a very slow growth until the early 
2000s, when an exponential growth of organocatalysis led off with 
the groundbreaking works of List, Barbas, MacMillan and others. 
Every year, new methodologies promoted by new organocatalysts 
are published and the studies are becoming more sophisticated, 
complex and in-depth thanks to the advancement of analytical 
techniques and the support of theoretical and computational 
chemistry. 
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1.3 Mechanistic Aspects 
Generally, the organocatalytic reactions can be grouped into two 
categories depending on whether the structure of the transition state 
between catalyst and substrate/s is “tight” or “loose”. The former 
category is defined covalent catalysis and includes reactions in 
which covalent bonds between the catalyst and reagent/s are formed 
with energies higher than 15 kcal mol
-1
. The latter set involves 
reactions in which complexes maintained by non-covalent bonds, 
between the catalyst and the substrate, are formed. These non-
covalent interactions are weaker – ion pairing, neutral host-guest 
interactions, acid-base associations, H-bonding – with energies that 
usually don’t exceed 4 kcal mol
-1
. 
The bonds formed in the transition state are determined by the 
activation strategy of the substrates by the catalyst and by its 
chemical nature. Most but not all organocatalysts can be grouped in 





1.3.1 Lewis base catalysis 
Unlike metal catalysts, which act as Lewis acids, organocatalysts 
form especially Lewis bases. The Lewis base can be centred on N-, 
C-, O-, P-, and S- but the N- and P-based catalysts are the most 
used and studied. The amine catalysts are more easily available than 
phosphorus ones and these latter catalysts have to be synthesized. 
Since the phosphorus atom is less basic than amine nitrogen, the 
phosphorus Lewis basic catalysts are chosen when it’s necessary to 
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avoid side reactions promoted by the base. 
There are various activation mechanisms depending on the Lewis 
base and several are the intermediates that are formed. The 
intermediates are nucleophiles or electrophiles, more reactive than 




Scheme 1.8 Intermediates formed in Lewis base organocatalysis. 
 
All the examples of Lewis base organocatalysis are examples of 




As we can see in the first two examples in the upper left in Scheme 
1.8, the amine catalysts may activate the substrates forming 
imminium ions and enamines as intermediates.
21
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By the formation of the iminium ion the carbonyl carbon is made 
more electrophilic and the α-position more acidic (Scheme 1.9). 
This facilitates reactions such as Knoevenagel-type condensations, 
cleavage of σ-bonds adjacent to the α-carbon and cyclo- and 
nucleophilic additions. The formation of the enamine increases the 
electron density on the α-carbon, thus becoming more nucleophilic 
(Scheme 1.9).
7
 Enamines react with different electrophiles giving 
aldol, Michael and Mannich reactions, α-functionalization of 
aldehydes and ketones or undergo pericyclic reactions. The 
enamine is generated by deprotonation of an ion iminium and the 
equilibrium between the two species (acid and basic form) is a 
protonation-deprotonation equilibrium which makes more active 
the reagents and also makes more kinetically labile the chiral 
catalyst.  
 
Scheme 1.9  
 
In the reaction mixture both species are formed and are in 
equilibrium with each other, so the same centre can behave both as 
a Lewis base and acid. The relative amount of the two species 
depends on the reaction conditions, therefore a chemical reaction 
can also have different mechanistic pathways giving different 
products. Morover, thanks to the fact that the same catalyst can 
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adopt both methods of activation, aminocatalysis is widely 




Primary amine organocatalysts have been less exploited than 
secondary amines and their use is more recent because the 
equilibrium between the iminium ion and enamine is unfavorable, 
almost completely shifted to the left toward the iminium ion. 
Recently, primary amines have been used to activate more 
congested substrates that did not react with secondary amines.
23
 
α,α-Diarilprolinol ethers, such as 4a illustrated in Scheme 1.10 have 
been and are widely used in many α-functionalizations of carbonyl 
compounds and more recently in domino enantioselective 
reactions.
24
 For example, Jørgensen et al. reported a tandem 
synthesis of tetrahydrothiophenes in which the catalyst 4a catalyzes 
first a thia-Michael addition via iminium catalysis, and then an 
intramolecular aldol cyclization, via enamine catalysis, in the same 








Scheme 1.10 Tandem reaction catalyzed by prolinol catalyst. 
 
1.3.2 Lewis acid catalysis 
Lewis acid catalyst initiates the catalytic cycle activating the 
nucleophilic substrate accepting its electron pair. Brønsted acid 
catalysis is the major research field in acid organocatalysis.
26
 Until 
today, the Lewis acid organocatalysis was the field less explored, as 
it has proven the most challenging.
19,27
 
 The phase transfer catalysts are an important class of 
organocatalysts and they can be considered as Lewis acids. The 
reactions promoted by PTCs fall into the non-covalent catalysis 
category because the interactions between catalyst and substrate/s 
are ion pairing-type. In these reactions, anionic intermediates are 
formed and their countercation, formed by the catalyst, is chiral. If 
the ion pairing association is sufficiently strong, chirality in the 
product is induced. 




Figure 1.3 Phase-tranfer catalysis with chiral countercations (PTC).  
S = substrate, X
-
 = anion, NR4
+*
 = cationic chiral catalyst. 
 
The first efficient phase transfer catalyst has been discovered by a 
group at Merk, who used it for the enantioselective α-methylation 
of indanone 5.
28
 It is a N-benzyl cinchonidinium salt 6 that 
promoted the reaction giving the product in 95% yield and 92% ee 
(Scheme 1.11). 
 
Scheme 1.11 First example of a PTC catalyzed reaction. 




Figure 1.4 PTC catalysts. 
 
Since then, the phase-transfer catalysis has made enormous 
progress and many other PTC catalysts have been developed.
29
 In 
Figure1.4 are shown some examples. 
In 2006, the concept of ACDC, asimmetric counteranion-directed 
catalysis was introduced (Figure 1.5).
30
 This type of catalysis is 
conceptually the opposite of the phase-transfer catalysis. List 
defines it as: “the induction of enantioselectivity in a reaction 
proceeding through a cationic intermediate by means of ion pairing 









Figure 1.5 Asymmetric counteranion-directed catalysis (ACDC). 
S = substrate, X
-
 = anion. 
 
The concept can be expanded to all types of enantioselective 
catalytic reactions whose mechanism involves cationic 
intermediates in the stereodetermining step. 
In the mechanism of this type of catalysis ion pairs are involved. An 
ion pair was defined by Anslyn and Dougherty: “An ion pair is 
defined to exist when a cation and anion are close enough in space 
that the energy associated with their electrostatic attraction is 
larger than the thermal energy (RT) available to separate them.”
32
 
This definition, however, must not be used in a narrow sense 
because the ion pairs are stabilized by Coulomb attraction forces 
but different additional stabilizing interactions, such as hydrogen 
bonding, could be implicated. Inter alia, hydrogen bonds can be 
thought as a kind of ion pairing between an acceptor atom and the 
dipole of a donor bond and frequently, we cannot determine if a 
“real” ion pair is involved. So, the ion pair definition used, when we 
talk about ACDC, is a “broader” definition and the presence of 
different stabilizing interactions is allowed. In particular, List 
defines ACDC reactions as: “all those reactions in which a 
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considerable anion character can be attributed to the component 
responsible for the asymmetric induction”.
31 
As an example, the enantioselective Brønsted acid catalysis is a 
specific case of ACDC when, even if the ion pairs are stabilized by 
further stabilizing interactions (such as hydrogen bonds, in addition 
to Coulomb attraction), the ionic character of the intermediate is not 
negligible. Brønsted acid catalysts, which will be discussed in the 
following paragraph, can be divided into neutral hydrogen-bonding 
catalysts (such as TADDOLs and thioureas/ureas) and stonger 
Brønsted acid catalysts (such as binol-derived phosphoric acids) 
whose activation mode has an ion pair character.
19
 
The ACDC concept can be applied to transition-metal catalysis and 
to organocatalytic Bronsted acid catalysis and Lewis acid catalysis. 
The following example (Scheme 1.12) shows an application of the 
ACDC concept to Lewis acid organocatalysis, a field that has been 
unexplored until a few years ago.
27
 




Scheme 1.12 ACDC of Mukaiama-aldol reaction. 
 
Lewis acid catalysts are more “powerful” than Brønsted acid 
catalysts, in fact they are able to activate much less reactive 
substrates, such as ketones and aldehydes, on which the Brønsted 
acid catalysis doesn’t work.
33
 
In order to activate the aldehydes, the List’s research group has 
designed and developed chiral disulfonimides (DSIs), as 7 in 
Scheme 1.12, that are Lewis acid catalyst precursors.
34
 The DSIs 
are Brønsted acids,
35
 but, in the presence of a silicon nucleophile, a 
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protodesilylation takes place and they are transformed into Lewis 
acids.
36
 The Lewis acid catalyst is thus formed in situ and doesn’t 
need to be pre-formed, unlike the first reported silicon-based Lewis 
acid catalysts.
37
 List explored the activity of 7 in Mukaiyama-aldol 
reaction by using the ACDC strategy (Scheme 1.12). 
First, the disulfonimide 7 is silylated by silyl ketene acetal 9, thus 
forming the active Lewis acid 10. Then, 10 activates the aldehyde 
affording ion pair 11 which reacts with nucleophile 9 giving 
intermediate 12. In the last step of the catalytic cycle, the product 
13 is liberated and the catalyst is regenerated. Although Yamamoto 
reported another possible interpretation of the mechanism, via 
pentavalent silicon intermediates instead of ion-pairs, the ACDC 




1.3.3 Brønsted acid catalysis 
Chiral metal-based Lewis acids are well-known catalysts in 
asymmetric synthesis employed to activate electrophiles.
38
 In this 
strategy electron-poor metal sites interact with electron-rich sites 
(Lewis bases), typically heteroatom-centred (O, N, S, Halogen) or 
multiple bonds establishing a dative bond that accelerates the 
nucleophilic attack by lowering the LUMO (lowest unoccupied 
molecular orbital) energy of the electrophile. 
The same effect is carried out by the formation of iminium ions 
between secondary amines and carbonyl compounds in covalent 
catalysis, as illustrated above in paragraph 1.3.1. The third way to 
electrophilic activation is the formation of hydrogen bonds between 
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Figure 1.6 Electrophilic activation of the carbonyl group by hydrogen 
bonding, coordination to metal Lewis-acid and iminium ion formation. 
 
Also in this third case, the electrophile LUMO energy is lowered, 
thereby accelerating the reaction. In fact, when a weak nucleophile 
reacts with a rather stable electrophile, the intermediate conversion 
rate to the reactants is faster than the product formation by 




Scheme 1.13 Nucleophilic addition to a carbonyl compound. 
 
In the presence of an acid catalyst, the tetrahedral negatively 
charged intermediate, which has an accumulation of electron 
density on oxygen or nitrogen atom, and the transition state leading 
to it, are stabilized by hydrogen bonding thus increasing the 
reaction rate. 
As shown in Scheme 1.14,
39a
 first the carbonyl compound 
associates with the acid catalyst, then a partial proton transfer 
occurs leading to the formation of the hydrogen-bond complex 15 
and then a proton transfer forms an ion pair 16. 






Nucleophilic attack to provide addition product can take place by 
15 or by 16, it depends on the nature of the catalyst. If the catalyst 
forms a hydrogen-bond complex 15 and the nucleophilic attack 
takes place on it, the reaction is called hydrogen-bond catalyzed 
reaction. Instead, if the catalyst forms ion pair 16 and this species 
undergoes the nucleophilic addition, the reaction is termed as 
Brønsted-acid-catalyzed reaction (Scheme 1.15).
39 
 
Scheme 1.15 Hydrogen-bond and Brønsted-acid catalysis. 
 
In analogy with enzymatic catalysis, the term general acid catalysis 
is used when:  
i) the transition state of the rate-determining step is stabilized by 
pure hydrogen bonding, without full proton transfer (hydrogen bond 
catalysis) or ii) the reactions are initiated by hydrogen bonding but 
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the proton is fully transferred in the transition state of the rate-
determining step (General Brønsted-acid catalysis).
19,39,40
  
The term specific acid catalysis is used when: 
the proton transfer takes place on the electrophilic substrate in its 
ground state in a pre-equilibrium step and successively the 
nucleophilic attack occurs in the rate-determining step (Specific 






Given that between the hydrogen-bond complex 15 and ion pair 16 
there is an equilibrium and the formation of a hydrogen bond 
always precedes the proton transfer, it is often difficult to 
distinguish if hydrogen-bond or Brønsted acid catalysis is involved. 
In general, compounds able to furnish H-bonding catalysis may be 




INTRODUCTION                                                           1.3 Mechanistic Aspects 
 
 25 
Figure 1.7 Neutral and stronger Brønsted acids. 
 
Species such as ureas, thioureas, diols, BINOL derivatives are 
defined neutral Brønsted acids and usually named hydrogen-
bonding catalysts. Stronger Brønsted acids, instead, such as 
phosphoric acids, guanidinium and amidinium ions, have more 
acidic sites. The latter ones are more reactive general acid catalysts 
and they can provide also specific acid catalysis. For example, 




The hydrogen bonds can stabilize the charge of transition states and 
intermediates, can activate the reagents by polarization, and can 
pre-organize their spatial arrangement if the hydrogen donor-
acceptor sites are connected onto a chiral scaffold affording chiral 
products. For example, Jacobsen et. al. performed enantioselective 
Strecker and Mannich reactions of imines catalyzed by chiral ureas 










It is believed that in these reactions the catalyst activates the imine 
by means of hydrogen-bridge bonds between the urea/thiourea and 
the nitrogen of the imine forming an organized transition state 
responsible for the asymmetric induction. 
 
1.3.4 Brønsted base catalysis 
In analogy to Brønsted acid catalysis, Brønsted base catalysis 
mechanisms can be distinguished in: i) specific base catalysis when 
reactants are fully deprotonated prior to rate-determining step; ii) 
general base catalysis when proton transfer from reactants to base 
occurs during the rate-determining step or the proton is partially 
transferred to base in the transition state of the slow step. Generally, 
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the former type of catalysis requires strong bases while the latter 
needs a weak base. Basically, how the Brønsted acid catalysts, 
shown in the previous paragraph, help making the substrates more 
electrophilic, Brønsted base catalysts help making reactants more 
nucleophilic. 
For example, the addition reaction of HCN to aldehydes for the 
synthesis of chiral cyanohydrins reported by Inoue, shown in 
Scheme 1.6 in paragraph 1.2, is an example of Brønsted base 
catalysis.
17
 Another classical example of Brønsted base catalyzed 
reaction is the Strecker reaction. Corey and Grogan reported that 
this process is catalyzed by a C2-symmetric guanidine compound 17 
(Scheme 1.18).
44
 The authors suggested that in the first step of the 
catalytic cycle a hydrogen bond between HCN and the catalyst is 
created, generating a guanidinium cyanide complex 18. Then, 
binding of aldimine to this complex via hydrogen bond takes place 
forming the pre-transition-state termolecular assembly 19. Finally, 
cyanide ion attacks the hydrogen-bond-activated aldimine in the ion 
pair affording the Strecker product. They suggested that the rate-
determinig step is the last step of the catalytic cycle. 




Scheme 1.18 Strecker reaction catalyzed by a chiral bicyclic guanidine. 
 
This kind of catalysis has been applied to many different 
asymmetric reactions such as, among others, Michael reactions,
45
 or 
desymmetrization of cyclic meso-anhydrides. In particular, the last 
mentioned reaction (Scheme 1.19), reported by Deng,
46
 is an 
example of general base catalysis: the alcohol is activated by a 
cinchona alkaloid-derived catalyst towards nucleophilic attack via 
hydrogen bonding. 




Scheme 1.19 Desymmetrization of cyclic anhydrides with modified 
cinchona alkaloids. 
1.4 Bifunctional Organocatalysts 
As the organocatalysis progresses, the design and the synthesis of a 
steadily growing number of organic catalysts is developed. Most of 
the nowadays used efficient organocatalysts have more than one 
active centre and most of them are bifunctional organocatalysts. 
They usually have a Brønsted acid and Lewis base centre by means 
of which they can activate simultaneously both the donor and the 
acceptor. In this way the reaction is accelerated thanks to the spatial 
approaching of the reactants (that react in a more restricted reaction 
space) and becomes more stereoselective because the transition 
state is geometrically well-organized and rigid. The hydrogen bonds 
are the forces that most frequently stabilize the intermediates and 
the transition state by forming definite geometries and increasing 
the reaction rate. A typical example of this kind of catalyst is the 
Takemoto’s thiourea 20 (Scheme 1.20). This catalyst has a tertiary 
amino group close to the thiourea H-bonding donor site. Takemoto 





 catalyzed reactions 
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(Scheme 1.20). Since then catalyst 20 has been used in several 
different reactions and it has become commercially available. 
 
Scheme 1.20 Michael and aza-Henry reaction catalyzed by Takemoto’s 
thiourea. 
 
The authors proposed that the thiourea interacts with the nitro group 
via hydrogen-bonding, enhancing the electrophilicity of the 
nitroalkene, while, simultaneously, the neighboring dimethylamino 
group activates the pronucleophile. In this way, nucleophile and 
electrophile will approach stereoselectively in an organized 
transition state and the nucleophile will preferential attack one face 








Figure 1.8 Activation mode of a bifunctional thiourea. 
 
 The cinchona alkaloids such as quinine and quinidine, 
cinchonine and cinchonidine, are bifunctional organocatalysts and 
are among the most efficient catalysts.
50
 In their structure, tertiary 
quinuclidine basic nitrogen (Lewis base) and a proximal hydroxyl 
group, which is a H-bonding group, are contained (Figure 1.9). A 
very large number of their derivatives have been applied in a wide 
diversity of asymmetric reactions. 
 
Figure 1.9 Cinchona alkaloids catalysts. 
 
  Another class of efficient bifunctional organocatalysts are the 
readily available α,α-L-diaryl prolinols. They can provide non-
covalent general acid/base catalysis, in a similar way to cinchona 
alkaloids, as they have Lewis/Brønsted basic secondary amine 
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functionality and the hydroxyl H-bonding donating group (Figure 
1.10). Unlike cinchona alkaloids, thanks to the secondary amine 
moiety, they can also provide covalent catalysis by forming 
enamine or iminium ion with carbonyl compounds, in the same way 





 groups. In the field of covalent catalysis, α,α-L-diaryl 
prolinols have been investigated in Michael type additions, aldol 
reactions, cycloaddition reactions and carbon–carbon and carbon–
heteroatom bond forming reactions.
53,24a,b 
They can also promote 
asymmetric epoxidation and peroxidation of electron-poor olefins, 
Michael type additions, cyclopropanation, sulfenylation and 





  Figure 1.10 
 
The two types of catalysis provided by these compounds can be 
thought as two sides of the same coin (Figure 1.11) and they are a 
rare example of organic catalysts able to exploit two alternative 
mechanistic pathways. 






 Squaramides are among the youngest organocatalysts reported, 
originally born as anion receptors and only recently exploited as 
bifunctional organocatalysts.
54
 The first example of squaramides as 
bifunctional organocatalysts was reported by Rawal in 2008, who 
used a low loading of a cinchona alkaloid derived compound 21 to 
catalyze the enantioselective Michael addition of dicarbonyl 




Scheme 1.21  
 
Ureas and thioureas, likewise squaramides, show strong anion-
binding affinities, but their ability to recognize cations is much 
more limited. Squaramides, instead, can recognize both anions and 
cations (Figure 1.12).  




Figure 1.12 Squaramide recognition of cations and anions. 
 
Moreover, it has been demonstrated that they form 1-2 orders of 
magnitude more stable complexes with carboxylates and nitrates 
than ureas.
56
 They are nitrogenated derivatives of squaric acid so 
they have a conformationally rigid square-shaped structure. The 
ureas and thioureas are (thio)amides but squaramides are 
considered as vinylogous amides. In both (thio)ureas and 
squaramides the rotation of the C-N bond is restricted because the 
nitrogen lone pair is delocalized through the carbon-oxygen double 
bond (Figure 1.13). The cyclobutenedione system, however, is 
partially aromatic (n = 0, Hückel’s rule) so other resonance 
structures with two positive charges in the ring are possible giving 
further delocalization. It is believed that the ability to recognize 
cations is due to the “increase of aromatic character” in the 
cyclobutenic ring after complexation.
57
 They are bifunctional H-
bond donor and acceptor and, due to higher conformational 
restriction compared to ureas and thioreas, the carbonyl and the 




 It was calculated that 
the distance between the two N-H groups is bigger in squaramides 
(2.7 Å) than in thioureas (2.1 Å) and the two N-H bonds have a 
convergent orientation being bent of 6°.
55,59
  




Figure 1.13 Squaramide properties and comparison with urea/thiourea. 
 
This offers the possibility to form different hydrogen bonds 
compared to ureas and thioureas and squaramides can be able to 
bind substrates of different size and shape. Finally, the two different 
functionalities have also different pKa values. For the sake of 
comparison, pKa values of H2CO3 (pKa1: 3.62, pKa2: 10.3) and 
squaric acid (pKa1: 1.5, pKa2: 3.4) can be considered, so the 
squaramides are more acidic than ureas. Therefore, being more 
acidic and more conformationally rigid, squaramides are generally 
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more effective in the activation of substrates at a lower catalyst 
loading (0.1 – 5 mol %) with respect to ureas and thioureas. The 
only drawback of these catalysts is their self-association tendency, 
so the use of more polar solvents is often required. Although their 
discovery came quite late compared to ureas and thioureas, the 
development of structural changes for the improvement of their 
catalytic ability has been fast and many squaramides, bearing 
different chiral scaffolds, have been synthesized and exploited in a 
variety of reactions.
54 
 Bifunctional organocatalysts having a much stronger Brønsted 
acid group are BINOL-derived phosphoric acids (Figure 1.14). 
They have a single acidic proton (pKa: 1.39 for diethylphosphate), 
implicated in the electrophile activation, and a close Lewis base 
phosphoryl moiety that can simultaneously activate a nucleophile. 
This scaffold can be derived from either (R)- or (S)-BINOL 
introducing substituents at the 3,3’-positions to modulate the chiral 
induction. 
 






 groups, independently, firstly reported 
the application of these compounds in organocatalysis. In 
particular, they used chiral phosphoric acids 22 and 23 in 
enantioselective Mannich reactions of N-aryl and N-Boc substituted 
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imines with silyl ketene acetals and acetyl acetone, respectively 
(Scheme 1.22). 
 
Scheme 1.22 Stereoselective Mannich reactions catalyzed by phosphoric 
acids. 
 
Akiyama proposed a cyclic nine-membered zwitterionic transition 
state. Differently, Terada proposed a transition state structure in 
which the catalyst activates the imine via H-bonding with the acidic 
proton and, simultaneously, forms another hydrogen bond between 
the Brønsted basic phosphoryl oxygen and the hydroxylic proton of 
the enol form of acetyl acetone (Figure 1.15). These examples show 
how catalysis exploited by phosphoric acids is halfway between 
specific and general Brønsted acid catalysis, as mentioned above. 









2. ASYMMETRIC SYNTHESIS OF 
TETRAHYDROTHIOPHENES BEARING 
A QUATERNARY STEREOCENTRE  
 
2.1 Tandem Reactions 
In general, one-pot, domino, tandem, multi-component reactions are 
processes that allow us to perform two or more transformations of 
an organic substrate in a single reactor carrying out a single work-
up step. In these processes, the isolation and purification of 
intermediate products are avoided saving time, cost, purification 
solvents and reducing the amount of waste. 
Tietze defined a domino reaction as:” process involving two or 
more bond-forming transformations (usually C-C bonds) which 
take place under the same reaction conditions without adding 
additional reagents and catalysts, and in which the subsequent 




A reaction in which several functionalities of a substrate undergo 
individually a transformation in just one reactor is not a domino 
reaction.  
Tandem reaction, cascade reaction and sequential reaction are 
terms generally used as synonyms.
 
However, as regards their catalytic variants there is a distinction 
between domino catalysis or tandem catalysis and sequential 
reactions. In both domino and tandem catalysis, all catalytic species 
are present from the outset. On the contrary, in the sequential one-
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pot reactions an organic reagent is modified via successive 
chemical reactions in a single reactor (without purification or 
separation steps) but reagents and catalysts necessary in each 
transformation are added only after the previous transformation is 
complete. The reaction intermediates in a one-pot reaction are, in 
general, isolable and stable.
61
 A multicomponent reaction (MCR) is 
defined as a chemical transformation in which three or more 
organic molecules react in the same reaction pot, furnishing a 
product that includes in its structure considerable portions of all the 
reactants.
62
 In general, the chemical community uses the term 
multi-component in a more general sense, i.e. including both 
domino (reactions in which all the reagents are added at the 
beginning of the reaction) and one-pot reactions (in which the 
reagents are added one after the other). 
 
2.1.1 Domino catalysis 
 
Figure 2.1 is a representation of a catalytic domino reaction 
(domino catalysis): reagents A and B can react intra- or 
intermolecularly giving intermediate I. Then I reacts with another 
reagent R (or with another reactive portion in I itself, 




Figure 2.1 Catalytic domino reaction. 
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Takemoto and Takasu explained that in domino catalysis, substrates 
A and/or B are activated by the catalyst X only at the beginning of 
the process and, for the second reaction to give product C, 
additional activation of intermediate I by X is not necessary. They 
make clear also that the diversity and complexity of product C is 
determined in the first catalytic reaction step and the intermediate I 
is, in general, transient and not isolable.
61
 
Besides, Faber defined that in domino catalysis: “the starting 
material undergoes a transformation via two (or more) reactions 
one after another in an inseparable fashion” and “both individual 
reactions belong tightly together and are rather difficult to perform 
in a stepwise (independent) fashion. As a consequence, the 
intermediate between both steps is likely to be unstable and (often) 
eludes isolation and characterization”.
63
 Later, Fogg and dos 
Santos added that in domino catalysis, in contrast with tandem 
catalysis, multiple transformations are effected via a single catalytic 
mechanism.
64




This precise definition excludes from domino catalysis definition 
the reactions that consist of a single catalytic transformation 
followed by a stoichiometric modification. This process is classified 
as a domino reaction but does not constitute tandem or domino 
catalysis because the catalyst does not participate in the second 
transformation. In other words, a single catalytic transformation 
took place.
 
The terms domino and tandem catalysis refer only to sequential 
elaborations of an organic substrate via multiple catalytic 
CHAPTER 2                                                                       2.1 Tandem Reactions 
 
 42 




In Scheme 2.1 is shown a typical example of a catalytic domino 
intermolecular reaction.
66
 In the reaction sequence, first the Pd(0) 
catalyst formation occurs followed by oxidative addition of the aryl 
iodide to Pd(0) and regioselettive cis-carbopalladation of the 
internal alkyne to generate a vinyl palladium intermediate 24. Then 
Suzuki type transmetalation with phenyl boronic acid and reductive 
elimination produce the tetrasubstituted olefin, regenerating the 
Pd(0) catalyst.  
 
Scheme 2.1 Example of intermolecular domino catalytic reaction. 
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In this reaction, the catalytic activation event takes place only once 
and intermediate 24 is a transient species that cannot be isolated as 
a stable species. Likewise, sequential transformations may occur in 
intramolecular processes. In Scheme 2.2 is reported an example of 




Scheme 2.2 Example of intramolecular domino catalysis. 
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2.1.2 Tandem catalysis 
Fogg and dos Santos defined tandem catalysis as: “coupled 
catalyses in which sequential transformation of the substrate occurs 
through two or more mechanistically distinct processes”.
64
 
Previously, Faber stated that: ”tandem reactions are considered to 
be two-step reactions that proceed in a consecutive fashion where 
each of the steps can be performed separately. Thus the 
intermediate species will be a rather stable compound”.
63 
 
Figure 2.2 Tandem catalysis in domino reactions. 
 
In Figure 2.2 is reported a conceptual diagram of tandem 
catalysis.
61 
In this type of catalysis, intermediate I is isolable and both the 
conversion of A and B into I and the consecutive transformation of 
I into final product C are promoted by catalyst(s). How explained 
by Takemoto and Takasu, the two (or more) involved catalytic 
cycles are independent and different from a mechanistic point of 
view. The domino reaction involves two or more catalyst-controlled 
processes: in the reaction pathway the catalyst(s) interacts with the 
substrates and the intermediate. The diversity and complexity of 
product C is affected by the catalyst(s) and both the substrates.
 61
 
Fogg and dos Santos proposed three subcategories of tandem 
catalysis: orthogonal-, assisted-, and auto-tandem catalysis.
64
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In orthogonal-tandem catalysis two (or more) sequential and 
indipendent catalytic cycles operate simultaneously catalyzed by 
two (or more) noninterfering catalysts or precatalysts. Starting 
materials A and B undergo preferential reaction with catalyst X 
forming I, which in turn is the substrate for catalyst Y. 
 
Figure 2.3 Orthogonal-tandem catalysis. 
 
In assisted-tandem catalysis only one catalyst is used. Catalyst X 
catalyzes the first transformation and, after the first process is 
completed, catalyst X is transformed into catalyst X’ by addition of 
chemical triggers and the second catalytic cycle starts. Clearly, in 
this process, in contrast with orthogonal-tandem catalysis, the two 
catalytic cycles are not coexistent. 
 
Figure 2.4 Assisted-tandem catalysis. 
 
In auto-tandem catalysis the reaction sequence that consists of two 
(or more) mechanistically distinct catalytic cycles, is promoted by 
only one catalyst and no chemical triggers are needed. Both cycles 
take place concurrently and spontaneously. 




Figure 2.5 Auto-tandem catalysis. 
 
Each of the three types of catalysis has its advantages and 
disadvantages, but the auto-tandem catalysis is the less complex in 
terms of manual operations and takes full advantage of the catalyst. 
There are a lot of asymmetric organocatalytic domino reactions 
performed in organocatalysis.
61,65,68
 Many of these are performed 




The reaction illustrated in Scheme 2.3 is an example of auto 
tandem-catalysis.
70
 The amine catalyst 4b catalyzes three different 
reactions determining the stereoselective formation of four 
stereocentres. 




Scheme 2.3 Example of auto-tandem catalysis prolinol derivative-
catalyzed. 
 
Unlike covalent catalysis, non-covalent organocatalysis has been 
much less exploited in cascade processes, but this field is growing 
fast and the number of examples in the literature is increasing 
tremendously.
71
 In Scheme 2.4 is reported a sulfa-Michael/aldol 
cascade reaction between 1,4-dithiane-2,5-diol and various 
chalcones, catalyzed by a bifunctional squaramide.
72
 This is an 
example of H-bond-mediated cascade reaction in which the catalyst 
effectively controls the stereoselectivity of three contiguous 
stereocentres. Although the authors did not specify, it represents an 
example of auto-tandem catalysis. 




Scheme 2.4 Hydrogen-bond-mediated auto-tandem catalysis. 
 
Figure 2.6 shows a diagram that summarizes the classification of 
one-pot processes involving sequential elaboration of an organic 
substrate via multiple catalytic transformations.
64
 









Organic sulfur compounds are widely present in Nature and in 
disparate biological systems. Among the organosulfur compounds, 
dihydro- but especially tetrahydrothiophenes are particularly 
important because the tetrahydrothiophene moiety is found in a lot 
of natural and non-natural bioactive compounds. Some examples 
are: α-glucosidase inhibitors 26-29 (salacinol, kotalanol, salaprinol, 
ponkoranol),
73
 coenzyme biotin 30, which is a water-soluble 
vitamin involved in gluconeogenesis, fatty acid 
production/metabolism and amino acid metabolism,
74
 brain-type 
cholecystokinin (CCK) receptor antagonist tetronothiodin 31,
75
 oral 
hypocholesterolemic agents, such as breynin A-B and epibreynin 
B,
76
 agonists/antagonists form the human A3 adenosine receptor, 
such as 4’-thioadenosine derivative 32,
77
 33 active against HSV-1 
and HSV-2
78
 and potential inhibitors of HIV
79
 34-36 (Figure 2.7).  




Figure 2.7 Valuable biologically active tetrahydrothiophenes. 
 
Tetrahydrothiofenes have also proven to be useful chiral ligands for 










 (Figure 2.8). They have also been used as 
ligands in gold complexes.
84
  




Figure 2.8 Representative tetrahydrothiophenes used as chiral ligands. 
 
 Despite their importance, few methods have been reported for 
the stereoselective synthesis of tetrahydrothiophenes.
85
 
Recently, Wu et al. have developed an efficient stereospecific 
synthesis of enantioenriched tetrahydrothiophenes, which utilizes 








Scheme 2.5 Chiral tetrahydrothiophenes formation via phosphorothioic 
acids. 
 
In this methodology, the ketophosphorothioate esters 45 can be 
obtained from chloroketones 46, by reacting them with sodium 
diethylphosphorothioate 42, or treating the Weinreb amide 44 
(synthesized with the two pot procedure reported in Scheme 2.5 
starting from commercially available chloroester 41 and sodium 
diethylphosphorothioate 42) with various organomagnesium 
reagents. In particular, the latter strategy makes more flexible and 
general the methodology since it is possible to access to a wide 
assortment of ketones 45 from a single common intermediate.  
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The ketophosphorothioate esters 45 are converted with high 
enantioselectivity into the chiral alcohols 48 through the 
Corey−Bakshi−Shibata (CBS) asymmetric reduction, using the 
chiral oxazaborolidine catalyst 47. Treatment of chiral alcohols 48 
with NaH in DMF at 55 °C leads to efficient ring closure, without 
loss of enantiopurity in the carbon-sulfur bond formation. With 
respect to the mechanism of tetrahydrothiophene formation, the 
authors believe that the chiral alcohol is first deprotonated by NaH 
to generate a transient alkoxide. Then, in a second step, the transfer 
of the phosphate group onto the oxygen (driven by the relatively 
strong phosphorus−oxygen bond that is formed) occurs. The 
resultant highly nucleophilic thiolate displaces phosphate via a SN2 
pathway to furnish the desired 5-membered ring with high 
enantiopurity. This approach although flexible enabled the 
formation of enantioenriched tetrahydrotiophenes bearing only one 
stereocentre. 
 Chiral tetrahydrothiophenes have been synthesized using various 
strategies: employing chiral auxiliaries, manipulating synthons from 
the chiral pool, exploiting desymmetrization processes or more 





Using chiral auxiliaries, such as carbohydrates, camphorsultams, 
menthyl derivatives and 1-phenylethylamine, chiral dihydro- and 
tetrahydrothiophenes have been prepared. In this field, the 1,3-
dipolar cycloaddition reaction between achiral sulfur 1,3-dipoles 
and dipolarophiles containing the chiral auxiliary (camphorsultams 
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or carbohydrates) has proven to be very useful to obtain 
enantioenriched  dihydro- and tetrahydrothiophenes. 
Chiral tetrahydrothiophenes have been synthesized also starting 
from enantiopure molecules available from the chiral pool, such as 
α-amino acids, sugars, α-hydroxy acid esters, glycidols, and 
terpenes or exploiting desymmetrization processes on meso and 
prochiral compounds performed by either enzymatic or synthetic 
catalysts. In recent years, several organocatalytic cascade 
methodologies for the synthesis of these heterocyclic compounds 
have been developed. These cascade reactions, promoted by small 
readily available chiral molecules, have proven to be 
straightforward and convenient processes that allow us to obtain 
multifunctionalized chiral tetrahydrothiophene scaffolds, often with 
different stereogenic centres. 
 
2.2.1 Enantioselective organocatalytic sulfa-Michael additions 
Let's take a wider look at the formation of C-S bonds. The general 








Scheme 2.6 General approaches for the construction of C-S bonds. 
 
These C-S bond formation reactions can be promoted by transition-
metal-based catalysts, and in this respect a rich literature exists,
87
 
but recently organocatalysis is offering an increasing number of 
examples. Some organocatalytic methodologies for the creation of 
C-S bonds are antecedent to 2000s, but the majority has been 
reported in the last ten years. 
The utility of organocatalysts lies in the fact that, besides being able 
to catalyze the single C-C and C-heteroatom bond formations, they 
promote multistep domino more complex reactions and, with 
respect to the synthesis of chiral tetrahydrothiophenes, cascade 
organocatalytic Michael-Michael and Michael-aldol reactions are 
among the best-performing methods. The first step of all these 
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cascade methods is a sulfa-Michael addition (SMA), i.e. 1,4-
addition of sulfur nucleophiles to unsaturated acceptors.  
Secondary and primary amine catalysts, via covalent catalysis, and 
Lewis bases but especially bifunctional Lewis base – Brønsted acid 
catalysts, via non-covalent catalysis, were found to be effective in 
the asymmetric sulfa-Michael additions. 
 With regard to non-covalent catalysis, organocatalysts derived 
from either natural compounds, such as amino acids or cinchona 
alkaloids, or non-natural chiral amines have been used to promote 
sulfa-Michael additions to α,β-unsaturated carbonyl compounds, 
nitroalkenes, maleimides, sulfones, and sulfonates. 
One of the earliest successes in this area was reported by Wynberg 
in 1977, who developed the enantioselctive SMA of aromatic thiols 




Scheme 2.7 Enantioselctive SMA of aromatic thiols to cyclic enones. 
 
CHAPTER 2                                                                                   2.2 Background 
 
 58 
Quinine 50 was the most efficient catalyst and the reaction 
proceeded efficiently working at low catalysts loading, affording 
the desired products with low to good enantioselectivities (up to 
75% ee). The authors demonstrated the bifunctional character of 
quinine in the activation of the substrates by means of NOESY 
experiments, kinetic and computational studies. They proposed that, 
in the transition state, the catalyst forms a ternary complex with 
thiol, deprotonated by the tertiary amine of quinuclidine moiety, 
and the enone, bound to quinine hydroxyl group via H-bonding. 
Wynberg’s studies were among the first to highlight the 
bifunctional character of this catalyst. 
In the same year, Pracejus reported the first SMA of a thiol to an 
α,β-unsaturated ester: the enantioselective sulfa-Michael addition of 
benzylthiol to α-phthalimidomethacrylate, followed by 
protonation.
89
 After screening of several chiral amines (cinchona 
alkaloids, strychnine, brucine, N-methylephedrine, N,N-
dimethylphenylethylamine) cinchona alkaloids proved to be the 
most efficient in terms of enantioselectivity. 
In 1986, Keniya showed that quinidine 53 and quinine 50 were also 
effective for the sulfa-Michael addition of thiophenol to 56, 




Scheme 2.8 Enantioselective SMA of thiophenol to 56. 
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Furthermore, in 1977, Pracejus published an enantioselective SMA 
of benzyl and tert-butylthiol to β-nitrostyrenes catalyzed by 
brucine, which afforded the product in 27% ee.
89
 
In 1978, Kobayashi and Iwai described the first sulfa-Michael 
addition of a thiol to acyclic α,β-unsaturated ketone: 
SMA/protonation of dodecanethiol with 3-methylbut-3-en-2-one 
organocatalyzed by a quinine-acrylonitrile (1:4) copolymer 58. 
With this catalyst, after 7 days, product 59 was obtained in 76% 




Scheme 2.9 SMA of dodecanethiol to 3-methyl-butenone catalyzed by 
quinine-acrylonitrile copolymer. 
 
Another example of SMA on acyclic α,β-unsaturated ketones was 
published in 2001 by Sharżewski. A cinchonine-catalyzed sulfa-
Michael addition of thiol 60 to acyclic α,β-unsaturated ketone 61 
afforded the products in good yields and enantioselectivities 
ranging from 27% to 80% ee, increased in some cases up to 95% 









Scheme 2.10 SMA of acyclic enones to thiols catalyzed by cinchonine. 
 
A thiourea catalyst, in particular Takemoto’s catalyst 20, was used 
for the first time in an asymmetric SMA of thiols to α,β-unsaturated 
carbonyl compounds in 2005 by Chen (Scheme 2.11).
93
 In 
particular, in Chen’s reaction, various thiophenols were reacted 
with cyclic enones 62 at -40 °C in the presence of 10 mol % of 20 
to give the sulfa-Michael adducts in high yields (95-99%) and 
moderate to good enantioselectivity (63-85%). 
 
Scheme 2.11 Takemoto’s thiourea catalyzed SMA of thiols to cyclic 
enones. 
 
Later, in 2006, Wang used Takemoto’s thiourea 20 in SMA of 
thiocarboxylic acids to chalcones
94
 and SMA of thioacetic acid with 
nitroolefines
95
, isolating the products with low to moderate 
enantioselectivities (up to 65% ee for chalcones and up to 70% ee 
for nitroalkenes). 
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Between 2006 and 2007, the catalytic activity of L-proline in SMA 
of thiophenol to chalcones was investigated but a low level of 
enantioselectivity was achieved (up to 45% ee).
96
 
After the initial examples shown, the last decade has witnessed 
great strides in the area of organocatalytic sulfa-Michael 
additions.
85a 
Among the numerous organocatalytic examples of sulfa-Michael 
addition on α,β-unsaturated ketones, esters and nitroalkenes, 
subsequently reported by several research groups, amino acids and 
cinchona alkaloids and their derivatives, polymer supported 
cinchona alkaloids, supported thiourea catalysts, ureas and 
thioureas with various chiral scaffolds, amine-thiourea-sulfonamide 
catalysts and squaramides have been investigated.
85a
 
For example, in 2010 Singh reported a SMA of thiols with cyclic 62 
and acyclic enones 61, effectively promoted by a cinchona-derived 
amine-urea 63,
97
 and Chen discovered that a bifunctional cinchona 
alkaloid squaramide 25 was able to catalyze the enantioselective 
SMA of thiols to chalcones 61
98
. Both research groups obtained the 
products with good to excellent enantioselectivities (up to 99% ee) 
(Scheme 2.12). 




Scheme 2.12 SMA of thiols to cyclic and acyclic enones and chalcones. 
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During the past ten years, sulfa-Michael additions of thiols to 
unsaturated amides, imides, sulfonates and sulfones promoted by 
thioureas catalysts have been reported.
85a 
 With regard to covalent amino catalysis, the first application of a 
chiral secondary amine organocatalyst in asymmetric sulfa-Michael 
addition was described by Jørgensen’s group in 2005.
99
 They 
devised a multicomponent domino sulfa-Michael/amination 
reaction, starting from enals 64, azodicarboxylates 65 and alkyl 
thiols 60, catalyzed by α,α-L-diaryl prolinols ether 4a, to obtain 
highly functionalized oxazolidinones 67, after reduction of 
aldehyde product 66 and base-catalyzed cyclization (Scheme 2.13). 
The products were isolated in acceptable yields (38-72%) and high 
enantioselectivities (97-99% ee). 




Scheme 2.13 Domino Sulfa-Michael/Amination reaction. 
  
In the proposed mechanism of domino reaction, the amino 
organocatalyst forms an iminium ion intermediate with enal 64 
which undergoes the stereoselective addition by thiol, forming an 
enamine which, in turn, reacts with the azo-dicarboxylate 65 
forming an iminium ion subsequently hydrolyzed to aldehyde 66.  
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Later, the amino catalysis, using chiral secondary amines, has been 
exploited in many domino cascade reactions, expecially sulfa-
Michael/aldol reactions for the synthesis of sulfur containing 
heterocyclic compounds (some examples are reported below).
85 
Contrary, primary amine organocatalysts have been much less 
applied in asymmetric sulfa-Michael additions. The first reaction 
was developed by Melchiorre in 2008: the SMA of benzyl and tert-
butyl mercaptans to various enones, catalyzed by a salt derived 




Subsequently, this group reported a domino sulfa-
Michael/amination reaction on enals and a domino sulfa-
Michael/protonation on α-substituted α,β-unsaturated ketones, both 
catalyzed by cinchona alkaloids-derived primary amines.
101
 
However, there are no examples of heterocyclic product formation 
via primary amine catalysis. 
 
2.2.1.2 Organocatalytic cascade Michael/aldol and 






, independently, disclosed an 
asymmetric domino sulfa-Michael/aldol reaction between 2-
mercaptobenzaldehydes 68 and α,β-unsaturated aldehydes 64, 
promoted by α,α-L-diaryl prolinols ether 4a. In both 
transformations, benzothiopyrans 69 were obtained in good to high 
yields and high enantioselectivities (Scheme 2.14). In the reaction 
sequence of these domino sulfa-Michael/aldol reactions, amine 4a 
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activates enal 64 via iminium ion for the SMA of 
mercaptobenzaldehyde 68 and the subsequent intramolecular aldol 
reaction via enamine. Finally, the dehydration of aldol product 
affords benzothiopyrans 69.   
 
Scheme 2.14 Domino sulfa-Michael/aldol reaction promoted by a 
secondary amine organocatalyst for the synthesis of thiochromanes. 
 
In the same year, the Jørgensen’s group developed an asymmetric 
synthesis of functionalized tetrahydrothiophenes having three 
stereogenic centres via a similar organocatalytic Michael/aldol 
domino transformation, catalyzed by TMS-protected proline 








Scheme 2.15 Domino sulfa-Michael/aldol reaction promoted by a 
secondary amine organocatalyst for synthesis of tetrahydrothiophenes. 
 
Starting from ketothiols 70 and enals 64, in the presence of benzoic 
acid as an additive, tetrahydrothiophenes carbaldehydes 71, bearing 
a quaternary stereocentre, were obtained in 44-74% yields and 90-
96% ee. When using a base as an additive, isomeric 
tetrahydrothiophenes 72 were recovered in 43-66% yields and 60-
80% ee. The mechanism of domino sequence follows the known 
pathway of related domino Michael/aldol transformations, shown 
above. Nevertheless, under acid conditions, the iminium ion 73 is 
converted to enamine 74 which gives rise to 71 via intramolecular 
aldol-type reaction followed by hydrolysis. Under basic conditions, 
73 undergoes hydrolysis giving the free catalyst and thioether 75 
which forms 72 through an aldol reaction (Scheme 2.16). 




Schema 2.16 Catalytic cycle of Jørgensen’s domino Michael/aldol 
reaction. 
 
Similar organocatalytic cascade reactions have been devised by 
Wang for the synthesis of tetrahydrothiophenes. In 2007, his 
research group developed an enantioselective domino sulfa-
Michael/Michael reaction, organocatalyzed by α,α-L-diphenyl 
prolinol ether 4b, for the synthesis of tetrahydrothiophenes, starting 
from various α,β-unsaturated aldehydes 64 and 4-mercapto-2-
butenoate 76a (Scheme 2.17).
104
  




Scheme 2.17 Domino sulfa-Michael/Michael addition reaction. 
 
In 2009, the same research group published a domino sulfa-
Michael/aldol reaction between α,β-unsaturated aldehydes 64 and 
ethyl 3-mercapto-2-oxopropanoate 77, promoted by 5 mol % of 4a 
in the presence of water and benzoic acid as an additive (Scheme 
2.18).
105
 In this case, the tetrahydrothiophenes products have a 
quaternary stereocentre.  
 
Scheme 2.18 Domino sulfa-Michael/aldol reaction. 
 
 In the context of non-covalent organocatalysis, worthy of note 
are the Wang’s methodologies for thiochromanes and 
tetrahydrothiophenes synthesis. 
CHAPTER 2                                                                                   2.2 Background 
 
 70 
In 2008, Wang reported a highly stereoselective hydrogen-bond-
mediated Michael/Michael cascade process, catalyzed by a 




Scheme 2.19 Domino sulfa-Michael/Michael reaction. 
 
This example is particularly important because, for the first time, a 
novel activation mode by the chiral amine thiourea, which involves 
a dynamic kinetic resolution (DKR, see paragraph 2.3), has been 
disclosed. The domino transformation between various 
nitrostyrenes 79 and 3-(2-mercaptophenyl)-2-propenoic acid ethyl 
esters 80, catalyzed by only 2 mol % of cinchona-derived thiourea 
78a, afforded thiochromanes 82 in notably high stereoselectivity 
(93-99% ee). The authors proved the DKR mechanism isolating the 
racemic Michael adduct 81 and reacting it with the catalyst 78a 
under the standard conditions optimized for the cascade process. 
Product 82 was obtained in 94% yield, 95% ee, dr > 30:1 and with 
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the same absolute configuration of the product isolated from 79 and 
80 in the direct domino process. They rationalized that the first 
Michael adduct 81 undergoes a DKR process because it has a 
highly acidic nitroalkane proton which is deprotonated by amine 
thiourea catalyst, leading to a reversible stereoselective retro-
Michael/Michael/Michael process. Moreover, as a further 
confirmation, the enantioselectivity of adduct 81 isolated from the 
single conjugate addition reaction of thiophenol to trans-β-
nitrostyrene in the presence of the catalyst 78a was very low (12% 
ee).  
Another Michael/Michael cascade catalyzed by chiral bifunctional 
tertiary amine-thiourea 20 was developed by Wang in 2011.
107
 In 
this reaction 76a reacts with trans-β-nitroolefins 79 in CHCl3 at      
-40 °C in the presence of 20 mol % of 20 producing 3-nitro-
tetrahydrothiophenes 83, bearing three contiguous tertiary 
stereocentres, with good yields (51-93%), high diasteroselectivities 
(6:1-30:1 dr) and excellent enantioselectivities (92-99% ee) 
(Scheme 2.20).  
 
Scheme 2.20 Domino sulfa-Michael/Michael reaction of nitroolefins. 
 
Unlike the precedent cascade Michael/Michael reaction for the 
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synthesis of thiochromanes, in this case the authors demonstrated 
that cooperative direct stereocontrol and dynamic kinetic resolution 
are involved in the reaction mechanism. To verify the mechanistic 
hypothesis, the authors carried out several studies (Scheme 2.21). 
 
 
Scheme 2.21 Mechanistic studies of domino Michael/Michael reaction 
reported by Wang. 
 
Performing the same experiment reported for the synthesis of 
thiochromanes described above, the authors isolated the racemic 
adduct of the first Michael addition 84 and left it to react with 20 
mol % of 20, under the same reaction conditions of the cascade 
Michael/Michael reaction. However, in this case they obtained the 
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product in 93% yield, 4:1 dr and 32% ee (Scheme 2.21b), whereas 
the results achieved performing the cascade reaction were 12:1 dr 
and 93% ee (Scheme 2.21a). These results indicated that a DKR is 
involved in the domino reaction but this is not the only mechanism 
implicated. The stereoselectivity of the cascade process is governed 
both by DKR and direct stereocontrol by the catalyst. In fact, the 
enantioselectivity of the adduct 84, isolated from the single 
conjugate addition reaction of 76a to trans-β-nitrostyrene 79a in the 
presence of catalyst 20, was 84% ee (Scheme 2.21c). Besides, when 
the adduct 84 with 84% ee was treated with the catalyst at -40 °C, 
the tetrahydrothiophene 83a with 93% ee, in quantitative yield, was 
obtained, finding the same result of the direct cascade reaction 
(Scheme 2.21d vs 2.21a). 
In addition to Wang’s methodologies, Xu reported a sulfa-
Michael/aldol cascade reaction between 1,4-dithiane-2,5-diol 85 
and various chalcones catalyzed by a bifunctional squaramide, as 
shown above in Scheme 2.4.
72
 More recently, the same research 
group applied this methodology also to β-aryl-β-trifluoromethylated 
enones 86 (Scheme 2.22).
108
 




Scheme 2.22 Domino sulfa-Michael/aldol reaction. 
 
In 2012, Xiao developed a similar sulfa-Michael/aldol cascade 
reaction of 3-ylideneoxindoles 88 with 1,4-dithiane-2,5-diol 85 for 
the synthesis of spirocyclic oxindole derivative, fused with 
tetrahydrothiphene ring, 90. Even in this case, the process is 




Scheme 2.23 Domino sulfa-Michael/aldol reaction of 3-ylideneoxindoles. 
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2.3 Kinetic Resolution and Dynamic Kinetic Resolution 
The kinetic resolution allows the preparation of enantiomerically 
enriched molecules starting from a stereoisomeric mixture by 
exploiting the difference in reactivity of the substrate stereoisomers. 
The simplest scenario is when enantiomeric substrates form 
stereospecifically the corresponding chiral products. 
In standard kinetic resolution two enantiomers of a racemate are 
transformed under chiral conditions (using chiral reagents or 
catalysts, for example enzymes or non-enzymatic chiral catalysts) 
into products at different rates (Scheme 2.24).
110
 Noyori stated that, 
in a kinetic resolution: “Each enantiomer is transformed to a single 




When the kinetic resolution is effective, we can recover the 
unreacted enantiomer and the highly enantiomerically enriched 
product of the other enantiomer. The major limitation of this 
technique is that the theoretical yields for such process may not 
exceed the maximum theoretical of 50%, due to the consumption of 
only one enantiomer. This is a strong disadvantage especially for 




Scheme 2.24 Classical kinetic resolution. 
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Other inherent drawbacks are the following: i) separation of the 
product from the unreacted substrate is always needed and this step 
may be not easy; ii) only one product could be desired and not both; 
iii) how explained below, the ee of the substrate and/or product 
decreases around 50% conversion which is, from a preparative 
point of view, the most convenient point to stop the reaction.
112
  
 The drawbacks of classical kinetic resolution are overcome in 
the Dynamic Kinetic Resolution (DKR). In a DKR process, a 
kinetic resolution step is combined with an in situ equilibration or 
racemization of the chirally labile substrate (Scheme 2.25). If the 
rate of substrate epimerization is greater than the rate of substrate 
transformation, the enantioenriched product can theoretically be 




Scheme 2.25 Dinamic kinetic resolution. 
 
Contrary to standard kinetic resolution, where the reaction can 
reach a maximum of 50% conversion when the fast reacting 
enantiomer is consumed, the in situ fast racemization ensures the 
formation of other fast reacting enantiomer from the slow reacting 
counterpart while the reaction proceeds, so all of the racemic 
starting material can be transformed into the desired 
stereoisomer.
112 
The dynamic adjective before kinetic resolution 
indicates exactly the non-static feature of the process. 
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In such process two competitive reactions are closely interrelated 
by the steroinversion of the substrates and the effectiveness of the 




Racemization of the substrate can be induced either chemically, 
biocatalytically or can occur even spontaneously but the 
racemization of the product must be avoided.  
With a DKR process not only a selective synthesis of an enantiomer 
can be accomplished, but, if in the reaction a new stereocentre is 





Scheme 2.26 Formation of diastereomeric products in DKR. 
 
Noyori has given a very good description of this process: “This 
reaction system is characterized not only by the presence of the 
substrate stereoinversion    ⃗⃗⃗    but also by formation of 
diastereomeric products, where both enantioselection and 
diastereoselection are exhibited. Thus, under appropriate 
conditions, this kinetic resolution method can convert a racemic 
compound to one stereoisomer among many.”
115
 
 In classical kinetic resolution, for evaluating the efficiency of 
the resolution, S or krel = kfast/kslow is used. This value is dictated by 
the magnitude of ΔΔG
‡
 i.e. the difference in energies between the 
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diastereomeric transition states in the selectivity-determining step 
of the catalytic reaction (Figure 2.9).
110 
 
Figure 2.9 Relative rate constants in kinetic resolutions. 
 
As studied by Kagan, Sharpless, and others, krel or S is correlated to 
the extent of substrate conversion (conv) and the enantiomeric 
excess of the recovered substrate and product, ees and eep, 
respectively.
110,115 
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This means that the ee of the product and recovered starting 
material in a kinetic resolution changes as a function of conversion.  
 
 




Figure 2.10 Plots of ee vs. conversion (c) as a function of krel for a) 
recovered substrate and b) product. 
 
As we can see from the plots in Figure 2.10, in a kinetic resolution 
the unreacted substrate is recovered in high ee even if krel is not very 
high, quenching the reaction at a relatively high conversion. On the 
other hand, in order to isolate a product with high ee and acceptable 
yield, krel > 50 is generally required.
110,i
 
The plots in Figure 2.10 show that the ee of the product (eep) is 
maximum at the outset of the reaction and begins to decrease as the 
reaction proceeds, as the faster reacting enantiomer is consumed 
from the reaction mixture. In particular, the ee of the product drops 
around 50% of conversion. 
 In DKR process, the racemization of the substrate is faster than 
its transformation to product (Scheme 2.25) so the catalyst is 
always facing a racemic starting material. Therefore, the eep of the 
product is determined only by the krel value and is not a function of 
                                                     
i
 Generally, a first-order kinetic in substrate is assumed in kinetic resolutions. So, 
as reported by Jacobsen,
110
 a first order kinetic was assumed for calculation of 
plots in Figure 2.10 and for stereoselectivity factors krel. 
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Figure 2.11 Comparison of plots of ee vs. conversion for classical and 
dynamic kinetic resolution calculated for krel=10. 
 
The mathematical treatment of DKR has been realized by Noyori 
(see Ref. 111 and 115). In order to obtain products with high optical 
purity, certain requirements have to be respected: i) the resolution 
step should be irreversible; ii) krel should be at least 20; iii) the rate 
constant krac for the racemization should be faster or at least equal 
than the rate constant of the resolution step kfast; iv) if the 
selectivities are moderate, krac should be higher than kfast by a factor 
of  10; v) the formed products have to be configurationally stable 
under the reaction conditions (otherwise we have a 
thermodynamically derived product distribution) and the 
racemization of the product must not occur. 
 The dynamics of DKR processes can be explained with the 
Curtin-Hammet principle.
116
 As described by Seeman : “The 
simplest situation which examines the relationship between a 
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molecule’s conformations and its chemical reactivity is illustrated 
by Scheme II which is the basic Curtin-Hammett (C-H)/ Winstein-
Holness (WH) kinetic system. It reflects the reactivity of a molecule 
which exists in two interconverting forms, each of which gives a 
different product. Scheme II is also valid for any two molecules, A2 






The definition of Curtin-Hammett principle proposed by the 
I.U.P.A.C. Commission on Physical Organic Chemistry is:
117
 “In a 
chemical reaction that yields one product from one conformational 
isomer and a different product from another conformational isomer 
(and provided these two isomers are rapidly interconvertible 
relative to the rate of product formation, whereas the products do 
not interconvert), the product composition is not solely dependent 
on the relative proportions of the conformational isomers in the 
substrate; it is controlled by the difference in standard Gibbs 
energies of the respective transition states. (It is also true that the 
product composition is related to the relative concentrations of the 
conformational isomers -i.e., the conformational equilibrium 
constant- and the respective rate constants of their reactions: these 
parameters are generally -though not invariably- unknown.)”.
116b 
The Curtin-Hammett principle may be extended to rapidly 
interconvertible diastereomers, enantiomers or constitutional 
isomers as well.  
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Therefore, for a reaction in which two rapidly interconverting 
reactants are each transformed irreversibly in a different product, 
the product composition will not necessarily reflect the distribution 
of the reactants A/B at the equilibrium, but it will be controlled on 
the difference in energy between the two reactants (or conformers) 
and on the free energy of the transition state going to each product.  
 
Scheme 2.27 DKR. 
 
Indeed, Caddick and Jenkins showed that, using Winstein-Holness 
and Curtin-Hammett kinetics, the product distribution can be 
expressed as [B']/[A'] = kB’ KAB/kA’ were kA’, kB’ are the 
transformation rates and KAB is the equilibrium constant.
113c 
From this expression, equation in Scheme 2.28 can be obtained 
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(first order/pseudo first-order reactions) 
Scheme 2.28 
 
Caddick and Jenkis explained that: “Where the substrate 
stereoisomers are related as enantiomers, chiral discrimination 
must occur via a chiral catalyst/promoter or by using a chiral 
reagent. Since ΔG°AB =0, the relative transition state energies 
(ΔΔG
‡
) solely determines the kinetic preference. If the substrate 
stereoisomers are related as diastereoisomers, the stereoselection 





to the ground state energies (A,B) of the substrate isomers”.
113c 
 There are several strategies to perform the in-situ racemization 
and only racemization proceeding under mild reaction conditions, 
compatible with the subsequent resolution step, are suitable for 
DKR. Many DKR processes involve thermal racemization, base- or 
acid- catalyzed racemization, racemization via redox reaction, 
enzymatic racemization and formation of stereolabile intermediates 
such as organolithium or transition metal complexes.
118
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For example, when the compounds have a stereogenic centre 
bearing an acidic proton (for example a proton in the α-position to a 
carbonyl group), the racemization is promoted by a base that can 
deprotonate the compound forming an achiral enolate. When there 
is not this acidic proton, racemization is performed via a 
decomposition reaction, such as the cleavage of hemi(thio)acetals 
and cyanohydrins (Scheme 2.29).
112 
 
Scheme 2.29 In situ racemization of substrate in DKR process. 
 




The first example of DKR was reported in 1989: the stereoselective 
hydrogenation of racemic 2-substituted 3-oxo carboxylic esters 
catalyzed by BINAPRu(II) complexes (Scheme 2.30).
120
 




Scheme 2.30 Stereoselective hydrogenation via DKR. 
 
Until recently, enzymes have been almost exclusively used for 
DKR of racemic substrates
121
 but, in recent years non-enzymatic 
chiral catalysts and organocatalysts are gaining a widespread 
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2.4 Results and Discussion 
Despite the fact that the non-covalent activation methods have been 
widely used in single step asymmetric transformations, their 
potential application in cascade catalysis is still poorly investigated.
 
One of the aims of this PhD project has been the development of 
organocatalytic tandem processes for the construction of 
heterocyclic compounds bearing different stereocentres. Our plan 
has been focused on the investigation of different optically pure 
bifunctional organocatalysts, which may synergistically activate 
both the electrophile and the nucleophile via general acid-base 
catalysis provided by their acid and basic groups.  
In this context, an organocatalyzed tandem Michael-Michael 




Our investigation focused on trans-α-carbonyl-β-substitued 
acrylonitriles 99 as starting Michael acceptors, where both the issue 
of diastereo- and enantioselectivity should have been addressed.  
As described in the previous paragraph, up to now the 
organocatalytic tandem methodologies have been restricted to the 
use of α,β-unsaturated aldehydes, nitroalkenes and, to a lesser 
extent, esters as the Michael acceptors. We were interested in 
introducing a cyano group in the alkene given its potential 
usefulness, as a synthetic group susceptible of further 
transformation, and by considering that an ever-increasing number 
of important pharmaceuticals and natural products are nitrile-
containing compounds.
124
 Indeed, the expected 
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tetrahydrothiophenes 100 (Scheme 2.31) contain three different 




Furthermore, the tetrahydrothiophenes so far synthesized bear 
carbon tertiary stereocentres and there are a few examples in which 
quaternary stereogenic centres have been installed in the chiral 




The electron-poor olefins 99 have been easily synthesized via 
Knoevenagel reactions as reported in the literature,
126
 while the 4-
mercapto-2-butenoates 76 were obtained by a Wittig reaction of the 








A first screening of the catalysts has been carried out in toluene at 
room temperature on the model substrate 99a with 76a (Figure 
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2.12, Table 2.1). (DHQ)2PHAL 101 and catalysts bearing a single 
hydrogen bond donor site such as α,α-diarylprolinols 4b, 4a, 4c, 
quinine 50, indole derivatives catalysts having a tertiary amino 
group 102a, 102b and sulfonamide 103 allowed us to obtain the 
product with modest to good yields and in some cases with good 
diasteroselectivity but poor enantioselectivity (Table 2.1, entries 1-
9).  
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However, it should be noted that in all cases, only two 
diastereoisomers were formed with respect to the four potentially 
obtainable, considering that three stereocentres are formed. The 
enantioselectivity of the reaction considerably improved by using 
catalysts having two hydrogen bond donor sites as the squaramide 
104 (entry 10) and more markedly with thioureas. 
The cinchona alkaloid derived thioureas 78b, 78c, 78d, 78e (entries 
12-15) were found to be the best catalysts in this series affording 
good yields (up to 80%) and encouraging levels of enantio- (up to 
83% ee) and diastereoselectivity (up to 3:1). Takemoto’s thiourea 
20 was also an effective promoter, leading to the product with good 
yield (85%) enantio- (75% ee) and diastereoselectivity (3:1) (entry 
11). Given the ability of thioureas to catalyze the reaction, we 
decided to synthesize a thiourea having a different chiral scaffold 
and bearing a secondary rather than a tertiary amino group 105 via 
a simple two-step protocol (Scheme 2.33). Starting from 
commercially available (1R,2R)-(+)-1,2-diphenylethylenediamine 
106, the sterically demanding secondary amine portion was inserted 
via reductive amination with cyclohexanone. Diamine 107 was then 
reacted with isothiocyanate 108 to afford the final organocatalyst 
105 in good overall yield. 




Scheme 2.33 Synthesis of catalyst 105. 
 
With our great delight, we observed a marked improvement of the 
enantioselectivity in the tandem reaction when using catalyst 105 
(Table 2.1, entry 16). The product was isolated in good yield, 
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Table 2.1 Catalyst screening.
a 








(DHQ)2PHAL 90 89 1:1 32 
2 4b 70 76 3:1 19 
4 4a 70 68 5:1 -11 
5 4c 70 41 3:1 -9 
6 50 69 56 2:1 rac 
7 102a 41 50 1:1 4 
8 102b 42 46 1:1 17 
9 103 72 42 2:1 3 
10 104 70 65 3:1 -39 
11 20 89 85 3:1 -75 
12 78b 68 78 2:1 74 
13 78c 70 63 3:1 -80 
14 78d 70 54 3:1 -80 
15 78e 70 80 3:1 -83 
16 105 48 80 1:4 98 
aReaction conditions: 99a (0.1 mmol), 76a (1.2 eq.), anhydrous toluene (1 mL).bThe 
reaction was carried out with 30 mol % catalyst loading. cYields of isolated product. 
d Determined by 1H NMR spectra of crude reaction. eDetermined by chiral HPLC 
analysis. 
 
Amino thiourea 105 was then selected as the catalyst to optimize 
the reaction parameters, in order to improve the process (Table 2.2). 
It is known that in non-covalent catalysis, nonpolar solvents are 
generally the most suitable media, since they do not interfere with 
the hydrogen bonding interactions established between the 
organocatalyst and the reactants. Among the aromatic solvents 
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1 toluene 48 80 1:4 98 
2 CHCl3 74 69 1:4 98 
3 Et2O 74 76 1:4 94 
4 m-xylene 71 67 1:3 97 
5 ClC6H5 72 74 1:3 97 
6 CF3C6H5 70 74 1:3 94 
aReaction conditions: 99a (0.1 mmol), 76a (1.2 eq.), anhydrous solvent (1 mL). 
cYields of isolated product. cDetermined by 1H NMR spectra of crude reaction. 
dDetermined by chiral HPLC analysis. 
 
Subsequently, different 4-mercapto-2-butenoates 76 were employed 
with model compound 99a (Table 2.3). The steric hindrance of the 
ester group proved to positively affect the diastereoselectivity, and 
an excellent level of enantioselectivity was mantained (Table 2.3, 
entry 1). The catalyst loading could be decreased to 10 mol %, 
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Table 2.3 Screening of different 4-mercapto-2-butenoates 76 and reaction 
conditions for the tandem thia-Michael-Michael reaction.
a 
 




















76b –t-Bu 90 96 1:9 99 
4
g,h 
76b –t-Bu 91 96 1:9 99 
aReaction conditions: 99a (0.1 mmol), 76 (1.2 eq.), anhydrous toluene (1 mL). 
bIsolated yield after flash chromatography.  cDetermined by 1H NMR analysis of 
crude reaction mixture. dDetermined by chiral HPLC analysis. eThe reaction was 
carried out with 1.5 eq. of 76c. fThe reaction was carried out in 1.25 mL of toluene.  
gThe reaction was carried out with 1.3 eq. of 76b. hThe reaction was carried out 
with 10 mol % catalyst loading. 
 
Under the optimized conditions, several trans-α-carbonyl-β-
substitued acrylonitriles 99 were investigated to explore the 
substrate scope of the process. In all cases, the tetrahydrothiophenes 
100 were formed in high to excellent yields, good diastereoisomeric 
ratio and high to complete enantiocontrol for the major 
diastereomer, with both electron-rich and electron-poor phenyl 
substituted derivatives and also with compounds bearing 
heteroaromatic residues (Table 2.4, entries 1-9). Alkenes bearing 
electron-withdrawing groups on the aromatic R
1
 residue reacted 
faster than other compounds although the level of enantioselectivity 
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c ee%  
(major)
d 
1 Ph Ph 100b 50 94
 
9:1 99 
2 4-MeOC6H4 Ph 100d 120 70 12:1 99 
3
e 
4-t-BuC6H4 Ph 100e 150 70 7:1 99 
4 4-BrC6H4 Ph 100f 88 97 12:1 99 
5 3-BrC6H4 Ph 100g 93 99 9:1 99 
6
 
4-CNC6H4 Ph 100h 65 98 9:1 99 
7 4-NO2C6H4 Ph 100i 40 98 9:1 >99 
8 2-naphthyl Ph 100j 180 85 9:1 >99 
9
f 
3-furyl Ph 100k 160 72 9:1 99 
10 Ph 3-ClC6H4 100l 70 96 5:1 98 
11 Ph 4-MeOC6H4 100m 78 98 9:1 99 
12 cyclohexyl Ph 100n 69 98 1:1 >99(87) 
13 Ph (CH2)2Ph 100o 96 79 3:1 89 
aReaction conditions: 99 (0.1 mmol), 76b (1.3 eq.), anhydrous toluene (1 mL). 
bIsolated yield after flash chromatography. c Determined by 1H NMR spectra of crude 
reaction. dDetermined by chiral HPLC analysis. eThe reaction was carried out with 20 
mol % catalyst loading. fThe reaction was carried out with 1.5 eq. of 76b. In 
parentheses the enantiomeric excess of the other diastereoisomer. 
 
Both electron-withdrawing and electron-donating groups on the 
aroyl moiety R
2 
of alkene 99 did not affect the yield and 
stereoselectivity (entries 10 and 11). The diasteroselectivity of the 
reaction drastically drop to 1:1 ratio of diastereomers when an alkyl 
group was installed at the β-position of enone 99, but the product 
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100n was obtained in excellent yield and enantioselectivities (entry 
12). 
Starting from an alkene bearing an alkyl group at the keto-position, 
99o, it was possible to isolate the tetrahydrothiophene 110o, albeit 
with slightly reduced diastero- (3:1 dr) and enantioselectivity (89% 






Figure 2.13 Crystallografic structure of enantioenriched 
tetrahydrothiophene 100i and racemic 100e determined by X-ray analysis. 
ORTEP plot with 30% probability ellipsoids (disordered part is 
represented with dotted bond; for seek of brevity H atoms are not shown). 
 
X-ray analysis, performed on a single crystal of the major 
diastereomer of nitro-derivative 100i, allowed the determination of 
the absolute configuration as (3S,4R,5S) (Figure 2.13). The absolute 
configuration for all other compounds 100 was assigned by 





 Since we observed that the diastereoisomeric ratios 
obtained with catalyst 105 are inverted compared to those obtained 
when using the DABCO, we determined also the relative 
configuration of the minor racemic diastereomer of the tert-butyl 
derivative 100e, that proved to be (3S*,4S*,5R*) from X-ray 
analysis (Figure 2.13). 
As reported by Wang and described in Scheme 2.19, in cascade 
asymmetric organocatalytic thia-Michael/Michael reaction to 
thiochromanes starting from nitroalkenes, a dynamic kinetic 
resolution (DKR) was found to govern the stereochemical result. 
This DKR process was encouraged by the highly acidic nitroalkane 
proton which was deprotonated by amine thiourea catalyst leading 
to a reversible stereoselective retro-Michael/Michael/Michael 
process.  
In our cascade process, the intermediate adduct 109 has an acidic α-
proton, which could be deprotonated by the amine moiety of the 
organocatalyst promoting a retro-sulfa Michael reaction (Scheme 
2.34). Therefore, we hypothesized that the mechanism of our 
tandem reaction could involve a DKR process through a retro-sulfa 
Michael reaction followed by a highly stereoselective double 





                                                     
ii
 See the Experimental Section for details. 




Scheme 2.34 Suggested cascade patway involving DKR. 
 
To gain isight into the mechanism of the process, first we 
monitored the model reaction of 99a and 76b, catalyzed by 105, by 
1
H NMR spectroscopy, to examine the transformation of Michael 
adduct 109 over the time (Figure 2.14). 
 
Figure 2.14 Reaction progress profile (entry 1 of Table 2.4) monitored by 
1
H-NMR in deuterated toluene. 
 
The reaction progress profile in Figure 2.14, shows that the adduct 
109 is quickly produced and consumed. Nevertheless, we are able 
to isolate the racemic mixture of diastereoisomers 109 working 
under more controlled conditions using DABCO (in CHCl3 at -20 
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°C for 17 hours, Scheme 2.35b).
iii
 To confirm the mechanistic 
hypothesis, showed in Scheme 2.34, we carried out the 
intramolecular Michael addition of racemic adduct 109 under the 
optimized reaction conditions reported in Table 2.4 for the cascade 
double Michael reaction (Scheme 2.35c). 
 
Scheme 2.35 Mechanistic studies of tandem double Michael reaction. 
 
We were pleased to observe that, starting from the racemic mixture 
of diastereoisomers of the adduct 109, the organocatalyst was able 
to generate the chiral tetrahydrothiophene 100b in 75% yield, 9:1 
diastereoisomeric ratio, and 98% ee for the major diastereoisomer 
(Scheme 2.35c). In other words, the organocatalyst provided the 
tetrahydrothiophene product with the same result, in terms of yield 
and stereocontrol, achieved when reacting enone 99a and thiol 76b 
directly (entry1, Table 2.4 and Scheme 2.35a), thus validating our 
                                                     
iii
 See the Experimental Section for details. 
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hypothesis. This means that an efficient process of dynamic kinetic 
resolution is involved in our cascade double Michael reaction for 
the synthesis of highly functionalized tetrahydrothiophenes.  
It is important to underline that this represents the first case in 
which the stereoselectivity of an asymmetric synthesis of 
tetrahydrothiophenes is completely governed by dynamic kinetic 
resolution. 
Currently, tandem multicomponent reactions are getting more and 
more attention, as highlighted in the paragraph 2.1, thanks to their 
several advantages over traditional syntheses. These processes are 
becoming more and more popular in asymmetric synthesis and 
medicinal chemistry, since they allow the formation of complex 
scaffolds,
128
 bearing several stereogenic centres, starting from 
commercially available reagents, with a minimum number of 
synthetic operations. 
Prompted by these considerations, we evaluated the feasibility of a 
one-pot sequential synthesis of tetrahydrothiophenes (Scheme 
2.36). 
 
Scheme 2.36 Stereoselective one-pot sequential Knoevenagel/double 
Michael approach to tetrahydrothiophenes 100. 
 
Benzaldehyde 97a and benzoyl acetonitrile 96a were treated under 
typical Knoevenagel conditions to generate 99a and, when the 
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formation of the enone was completed (monitored by TLC), 
catalyst 105 and thiol 76b were added at room temperature. The 
Knoevenagel reaction conditions were found to be compatible with 
the cascade double Michael reaction herein developed. In fact, 
although the process has not been optimized, we were able to 
isolate product 100b in 93% yield, with 60:40 diastereoisomeric 













The first stereoselective cascade sulfa-Michael/Michael reaction for 
the synthesis of tetrahydrothiophenes from trans-α-carbonyl-β-
substituted acrylonitriles has been developed, by using a novel 
readily available secondary amine thiourea as an organocatalyst. 
Highly functionalized tetrahydrothiophenes, bearing three 
contiguous stereocentres, one of them quaternary, were effectively 
achieved by means of a highly stereoselective cascade 
transformation. The products were isolated in high yield, good 
diastereoselectivity and excellent enantiocontrol. This work 
represents an unprecedented case in which the stereochemical 
outcome was controlled exclusively by a dinamic kinetic resolution 
process. 
Finally, a highly convenient one-pot Knoevenagel/double Michael 
process, starting directly from commercially available reagents and 
involving a minimal number of operations has been demonstrated 
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3. ENANTIOSELECTIVE SYNTHESIS 
OF γ-BUTYROLACTONES BEARING 




γ-Butyrolactone scaffold is a common naturally-occurring motif, 
present in about 10% of all natural products.
129
 It is an important 
framework present in a wide variety of compounds possessing 
biological activities. Mono-, di- and trisubstituted monocyclic γ–
butyrolactones and mainly bicyclic and tricyclic ring systems show 
a wide range of biological activities, spanning from strong 




Sesquiterpene lactones, characteristic constituents of exceedingly 
large and widespread family of “Compositae” plants, represent an 
important class of natural compounds that exhibit interesting 
biological properties.
131
 These molecules are especially present in 
the leaf tissue, where they can constitute up to 5% of the dry weight 
and are colorless, lipophilic and often bitter-tasting.
129a
 




Figure 3.1 Examples of γ-butyrolactone natural products. 
 
They show in their structure an α-methylene-γ-butyrolactone ring, 
which is the core of their activity. In fact, these compounds have 
two reactive functionalities: the double bond, that is able to undergo 
Michael addition with nucleophilic sites of biomolecules, such as 
L-cysteine or thiol-containing enzymes, and the lactone unit that is 
a possible target for nucleophilic and electrophilic centres of the 
biomolecules. For example, these sesquiterpene lactones can act as 
inhibitors of cellular steroids, blockers of tumor necrosis factor 
production, DNA polymerase inhibitors or apoptosis inducers.
132
 
Some of them, sometimes present in the pollen, cause an allergenic 
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A lot of active sesquiterpene lactones, such as vernolepin, 
aromaticin and elephantopin, estracted from plants, display tumor 
inhibiting activity (Figure 3.2) but many others have bactericidal, 






Given the biological importance of these compounds, many 
methods to access α-methylene-γ-butyrolactones, for use in targeted 




γ-Butyrolactones bearing a carboxylic acid function at the β-
position to the carbonyl group, named paraconic acids, (Figure 3.3) 
are another important group of naturally occurring γ-
butyrolactones, endowed with a variety of biological and 








Figure 3.3 Most notable paraconic acids. 
 
Lichens are the natural source of paraconic acids, but, given their 
important properties, several synthetic routes towards these natural 
compounds have been devised using starting materials from the 
chiral pool, chiral auxiliaries or by using chiral catalysts.
136
  
Hydroxy-γ-butyrolactones bearing a hydroxyl-methyl group at β-
position of lactonic ring, constitute another important class of 
natural products. For example, they are implicated in the production 
of secondary metabolites such as antibiotics. In Figure 3.4 are 
shown some of these compounds useful in the synthesis of different 
antibiotics of which A-factor is the best known compound.
137
 




Figure 3.4 Factors from Streptomyces. 
 
Generally, the biological activity of γ-lactones is strictly related to 
the nature and position of the substituents in the heterocycle. It is 
known that substituted γ-butyrolactones are potent antagonists or 
agonists – depending upon the substitution pattern – of the γ-
aminobutiric acid (GABA) receptor, the principal inhibitory 
neurotransmitter receptor in the mammalian central nervous system.  
For example, the β-substituted γ-butyrolactones in Figure 3.5, 
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Many other natural and bioactive unnatural γ-butyrolactones have a 
quaternary stereocentre in their structure, such as the highly 
neurotrophic compounds jiadifenin and tricholomalide A and the 




Figure 3.6 Selected natural products containing a lactone subunit bearing 
a quaternary stereocentre. 
 
Chiral γ-butyrolactones have been used as valuable building blocks 
in the synthesis of several types of natural products or synthetic 
drugs: alkaloids, macrocyclic antibiotics, lignan lactones, 
pheromones, antileukemics and flavor components.
129b,138,140 
 Various methods for the stereoselective synthesis of such useful 
synthons have been developed. Some of these employ simple 
natural products such as amino acids, tartaric acid, ascorbic acids, 
carbohydrates or chiral sulfoxides, epoxides or substituted 
acetylenic acids as starting materials.
137
  
The enantioselective synthesis of chiral γ-butyrolactones has been 
performed by using chiral catalysts. In this context, examples of 
hydrogenations, C-H insertions, allylic alkylation, Baeyer-Villiger 
oxidations, 1,4-additions, kinetic resolutions, 1,4-hydrosilylation 
and aldol reaction/cyclization have been reported.
141
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In particular, the first catalytic synthesis of chiral γ-butyrolactones 





Scheme 3.1 Tandem tin-catalyzed asymmetric aldol reaction/cyclization. 
 
In this methodology, the starting material γ-substituted β,γ-
didehydro-γ-butyrolactone 110 reacts with various aldehydes 
(aliphatic aldehydes give the best results in terms of 
enantioselectivity) via enantioselective aldol reaction, followed by 
subsequent lactonization of a tin alkoxide of aldol adduct 
intermediate, affording the β,γ-disubstituted γ-butyrolactones 
bearing two tertiary contiguous stereocentres. The catalytically 
active species is a chiral tin bromide methoxide formed from chiral 
tin dibromide 111 and sodium methoxide.  
 However, among the stereoselective approaches to these 
important molecules, only a few methodologies to access 
enantioenriched γ-butyrolactones, possessing an all-carbon 
quaternary stereocentre at the β-position, were reported.  
The synthesis of these challenging frameworks is made particularly 
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difficult because (i) the stereoselective construction of all-carbon 
quaternary centres is a difficult target in a chemical synthesis due to 
the steric congestion imposed by the four attached carbons
125 
and 
(ii) the remote β-position of the stereocentre is a less “controllable” 
position respect to the α- and γ-positions. Multi-step approaches 
have been essentially developed. 
For example Koga, in the 1980s, reported the synthesis of optically 
active β,β-disubstituted γ-butyrolactones starting from the chiral 





Scheme 3.2 Synthesis of chiral β,β-disubstituted γ-butyrolactones via 
sequential dialkylation of 112. 
 
In this reaction, the chiral synthon 112 may be methylated (treating 
with LDA-THF and then with R
1
X= MeI) affording product 113 (in 
73% yield) which may in turn be alkylated with another alkyl halide 
(treating with LDA/(HMPA)-THF and then R
2
X). Otherwise, the 
sequential dialkylations can be performed with two different alkyl 
halides in one operation (performing both the sequential 
dialkylations using LDA in the presence of HMPA and alkylating 
the corresponding enolate in THF at -78 °C). The crude dialkylation 
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products are then detritylated with HCl in methanol, affording 
product 114 in high diastereomeric excess. Finally, removal of the 
hydroxymethyl stereocentre gives product 115 bearing one 
quaternary stereocentre. Inverting the introduction order of 
electrophiles leads to the opposite enantiomer of 115. 
In 1992, Fadel described a series of syntheses of efficient 
precursors of some natural products containing a cyclopentane ring 
with a quaternary stereocentre (the enantiomers of α- and β-
cuparenones), starting from monomethyl 2-methyl-2-p-tolylmalonic 
acid ester (R)-116. In one of these syntheses, a γ-butyrolactone, 
bearing a quaternary all-carbon stereocentre, 118 was obtained as 

















Scheme 3.3 Asymmetric construction of a quaternary carbon centre from a 
chiral malonate. 
 
In 2002, Hall’s research group reported a stereocontrolled synthesis 
of α-exomethylene γ-lactones 122 with a stereogenic quaternary 
carbon centre starting from isomerically pure tetrasubstituted 
allylboronates 120 (Scheme 3.4).
145
 
They were able to obtain tetrasubstituted 2-alkoxycarbonyl 
allylboronates 120 as pure isomers in a single operation by tandem 
carbocupration of alkynoate esters followed by electrophilic 
trapping with iodomethyl boronates 119 (Scheme 3.4a). Using 
chiral 3,3-dialkyl allylboronates in the subsequent addition onto 
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aldehydes, they isolated α-methylene γ-lactones 122 as aldol-like 
adducts, bearing a quaternary stereocentre in high 
diasteroselectivity (Scheme 3.4b). 
 
 
Scheme 3.4 Synthesis of γ-lactones from tetrasubstituted allylboronates. 
 
Using 3,3-dimethyl allylboronates having chiral auxiliaries on the 
alcohol and on the boronate, they obtained lactones 122 with up to 
98% ee, when a matched combination of the chiral inducers was 
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found (Scheme 3.4c). 
More recently, Fillion reported the synthesis of carboxylic acid 
derivatives 125, bearing an all-carbon quaternary stereocentre, and 
demonstrated their usefulness in the preparation of chiral 
succinimides 126 and γ-butyrolactones 127 and 128 (Scheme 
3.5).
146
 The chiral starting compounds 125 were prepared via 
copper-catalyzed 1,4-addition of dialkyl reagents to aryl acetate 
derivatives 123 in the presence of phosphoramidite ligand 124. 
 
Scheme 3.5 Preparation of succinimides and γ-butyrolactones from chiral 
carboxylic acid derivatives.  
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Recently, Cossy and Arseniyadis described a palladium-catalyzed 
allylic alkylation of cyclic dienol carbonates to enantioenriched γ-
butenolides 130. These compounds were then transformed, in two 
steps (reduction and oxidation), into -disubstituted -
butyrolactones 131, bearing an all-carbon quaternary stereocentre in 




Scheme 3.6 Synthesis of β-quaternary butyrolactones from 
enantioenriched γ-butenolides. 
 
In the same year, Sun et al. developed a chiral phosphoric acid 
catalyzed desymmetrization of prochiral 1,3-diol tethered to an 
acetal 132, to give five-membered cyclic acetals 134, that are useful 
starting material to obtain, via oxidation, enantioenriched β,β-
disubstituted γ-butyrolactones 135 (Scheme 3.7).
139 




Scheme 3.7 Synthesis of five-membered cyclic acetals and their oxidation 
to lactones. 
 
In both these methodologies, enantioenriched -butyrolactones were 
synthesized starting from chiral reagents through multiple synthetic 
steps with very good level of enantioselectivity (80-90% ee).  
It would be highly convenient to have a direct method for the 
synthesis of these compounds. 
With regard to direct methodologies, only the asymmetric Baeyer-
Villiger reaction on 3-disubstituted cyclobutanones has been 




 were able to isolate 
-disubstituted -butyrolactones exploiting the Bayer-Villiger 
reaction performed either under organocatalytic (Scheme 3.8a) or 
metal-catalyzed conditions (Scheme 3.8b), respectively. However, 
only in the few examples reported until now, a modest level of 
enantioselectivity was achieved. 




Scheme 3.8 Asymmetric Baeyer-Villiger reaction on 3-disubstituted 
cyclobutanones. 
 
A recent example on the asymmetric synthesis of paraconic acid 
derivatives bearing quaternary and tertiary stereocentre has been 
reported by Connon’s group.
150
 They illustrated a higly enantio- and 
diasteroselective organocatalytic one-pot process which provides a 
facile access to γ-butyrolactones paraconic acid derivatives 138 
from aryl succinic anhydrides 136 and aldehydes (Scheme 3.9). The 
proposed mechanism of the reaction involves initial enolization of 
the anhydride, followed by its addition to the electrophilic aldehyde 
to produce a tetrahedral intermediate which subsequently lactonizes 
forming the product. However, simple succinic anhydride does not 
react with benzaldehyde. The authors suggested that this is due to 
scarse enolizability of succinic anhydride in the presence of the 
organocatalyst. So, an appropriately substituted aryl succinic 
anhydride was chosen (having an electron withdrawing group, such 
as p-nitro substituted anhydride 136), which on the one hand 
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facilitated the keto-enol equilibrium, and, on the other hand, 
allowed the formation of aryl paraconic acid derivatives, having 
two stereocentres, one of which quaternary, in good to excellent 
diastero and enantioselectivity.  
 
 
Scheme 3.9 Organocatalytic stereoselective one-pot synthesis of paraconic 
acid derivatives. 
 
This reaction is promoted by a bifunctional organocatalyst 
squaramide via non-covalent catalysis. 
 As described in the numerous mechanistically different 
organocatalytic reactions promoted by bifunctional organocatalysts, 
such as chiral amine-thioureas, amine-squaramides or β-amino 
alcohols, it is recognized in the chemical community that these 
promoters are able to activate synergistically pronucleophiles via 
general base catalysis and electrophiles via general acid catalysis. 
In the next paragraph, it will be illustrated our methodology for the 
asymmetric synthesis of γ-butyrolactones bearing an all-carbon β-
quaternary stereocentre. For this purpose, we conceived a simple 
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aldol/lactonization organocatalytic cascade sequence starting from 
acylated succinic esters and formaldehyde, exploiting non-covalent 
activation of the reagents by a bifunctional organocatalyst.  
 As underlined above, the stereoselective construction of all-
carbon quaternary centres is a difficult target. In fact, few general 
methods for realizing this task in a highly diastereo- and 
enantiocontrolled fashion have been reported.
125
 
The preparation of an all-carbon quaternary stereocentre at the α-
position of a carbonyl group via aldol reaction represents one of the 
most challenging synthetic transformations. Ideed, the aldol-based 
methodologies are generally not applicable to the construction of 
chiral quaternary centre due to the absence of E/Z selectivity in the 
enolization of α,α-disubstituted (especially unfunctionalized) 






Therefore, strategies leading to complete control of the geometry of 
fully substituted enolates are highly desirable.
152
 
For monosubstituted ester and ketone enolates, the proper choice of 
solvent, base and temperature can often influence the 
stereochemistry
153
 and for monosubstituted tertiary amide enolates, 
minimization of A-1,3 (1,3-allylic strain) interactions generally 
promotes Z-enolate formation.
154
 For disubstituted enolates is more 
difficult to control the stereochemistry. Usually, a highest 
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stereocontrol is achieved with cyclic frameworks, including metal 




After the Shibasaki’s pioneering work on the intermolecular direct 
catalytic asymmetric aldol reaction,
156
 considerable efforts have 
been made to perform in situ activation of carbonyl compounds as 




However, the high reactivity of formaldehyde and glyoxylate likely 
has limited their use as C1 and C2 units. Consequently, the 
asymmetric hydroxymethylation reaction of 2-substituted-1,3-
dicarbonyl compounds has been a scarcely investigated process and 
modest success has been achieved. Remarkably, only transition-
metal based systems have been reported to catalyze this reaction 
reaching moderate to high enantioselectivity.  
In 2009, the Sodeoka’s group reported a catalytic 
hydroxymethylation of β-keto esters with formaldehyde, using Pd 
and Pt BINAP-complexes (Scheme 3.11).
158
 




Scheme 3.11 Hydroxymethylation of β-keto ester catalyzed by Pd and Pt 
BINAP-complexes. 
 
Subsequently, Shibasaki et al. developed a direct catalytic 
asymmetric aldol reaction of β-keto esters with formaldehyde 










Scheme 3.12 Asymmetric aldol reaction of β-keto esters with 
formaldehyde catalyzed by a dinuclear Ni2-Schiff base complex. 
 
Reaction conditions needed to be optimized according to the 
structure of the β-keto ester used. 
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3.2 Results and Discussion 
As described in the previous paragraph, β-substituted-γ-
butyrolactones are common motives in a wide range of natural 
products and pharmaceuticals. Many efforts have been made to 
develop stereoselective syntheses of these molecules.
 
Enantioenriched γ-butyrolactones, bearing one carbon quaternary 
stereocentre at the β-position, are the most challenging targets due 
to the enantioselective construction of an all-carbon quaternary 
stereocentre at the remote β-position, far from relatively more easy 
to manipulate α- and γ-positions.  
For this purpose, we devised and developed a simple 
aldol/lactonization organocatalytic cascade sequence to β,β-
disubstituted γ-butyrolactones, starting from acylated succinic 
esters and formaldehyde, exploiting non-covalent activation of the 





Scheme 3.13 Organocatalytic approach to β,β-disubstituted γ-
butyrolactones. 
 
We hypothesized that the cascade reaction could involve the 
formation of a prochiral enolate of acylated succinic esters, 
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generated by the bifunctional organocatalyst, which then 
would react in a chiral environment with formaldehyde to 
afford an enantioenriched aldol product. Next, assistance by 
the organocatalyst in the lactonization step of the aldol 
intermediate would lead to the desired γ-butyrolactone. 
(Scheme 3.14).  
 
 
Scheme 3.14 Tandem aldol/lactonization sequence. 
 
We demonstrated that this straightforward enantioselective 
route to β,β-disubstituted γ-butyrolactones is efficiently 
catalyzed by Cinchona alkaloids derived squaramides.  
The products obtained are paraconic acid derivatives, bearing a 
quaternary stereocentre, and they can be transformed into 
diversely functionalized hydroxy-γ-butyrolactone derivatives, 
that belong to another important class of γ-butyrolactones. 
Remarkably, preliminary results showed that the designed 
organocatalytic aldol/lactonization strategy can be applied for 
the synthesis of enantioenriched δ-valerolactones with an all-
carbon γ-quaternary stereocentre. 
To evaluate the feasibility of the organocatalytic sequence 
reported in Scheme 3.14, we began our study by reacting the 
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diethyl 2-benzoyl succinate 142a and paraformaldehyde in 
toluene at room temperature with 10 mol % of quinine 50 
(Table 3.1). We were pleased to observe that γ-butyrolactone 
143a was formed, although in low yield and without 
enantiocontrol (entry 1). By using Takemoto’s thiourea 20 
(entry 2) and epi-quinine derived thiourea 78a (entry 3), which 
are known to be better H-bond donating organocatalysts, the 
yield considerably improved but the enantioselectivity was still 
low. We thought that a better enantiocontrol would be 
achievable by placing two sterically different ester groups in 
the starting material 142. In fact, compound 142b, bearing the 
t-butyl and methyl ester groups, in the presence of amine-
thioureas 20 and 78a reacted with formaldehyde giving the 
product 143b in a good conversion and with a significant 
increase of the enantioselectivity (entries 4 and 5). 
Interestingly, the reaction catalyzed by 5 mol % of epi-quinine 
derived squaramide 25, in CHCl3 as solvent, afforded the 
product with 50% ee (entry 6), revealing that amine-
squaramides are suitable organocatalysts to promote our 
process. The presence of sterically demanding cyclohexyl, 2-
adamanthyl or 1-carbonaphthyl ester groups in reagents 142c-e 
consistently demonstrated catalyst 25 to be more effective than 









Table 3.1 Optimization of the one-pot sequence: bifunctional 


















1 Et Et 50 123 28 2 143a 
2 Et Et 20 122 80 7 143a 
3 Et Et 78a 86 88 -7 143a 
4 t-Bu Me 20 60 78 51 143b 
5 t-Bu Me 78a 20 64 -35 143b 
6
d,e,f
 t-Bu Me 25 21 31 -50 143b 
7 C6H11 Me 20 63 57 35 143c 
8
 d,e,f
 C6H11 Me 25 66 83 -42 143c 
9
f 
2-adamanthyl Me 20 23 92 -36 143d 
10
 d,e,f
 2-adamanthyl Me 25 24 74 40 143d 
11
f 
1-carbonaphthyl Me 20 44 78 20 143e 
12
 d,e,f
 1-carbonaphthyl Me 25 44 95 -42 143e 
13
f 
cumyl Me 20 42 58 11 143f 
14
f 
cumyl Me 78a 21 73 -32 143f 
15
 d,e,f 
cumyl Me 25 43 47 -59 143f 
16
 d,e,f
 cumyl Me 137a 66 74 -65 143f 
aReaction carried out at C = 0.05 M of 142 on 0.1 mmol scale. 
bIsolated yield. cDetermined by chiral HPLC analysis. dIn chloroform 
as solvent. e5mol % of catalyst was used. fReaction carried out at C 
0.1M of 142. 




Finally, reactions carried out on compound 143f, bearing a 
cumyl group as the R
1
 residue, confirmed catalyst 25 as the 
most enantioselective (entry 15) when compared to amine-
thioureas 20 and 78a (entries 13-14). With our delight, we 
found that more sterically demanding amine-squaramide 137a, 
bearing a phenyl group at 2’-position of the quinoline residue, 
provided the γ-butyrolactone 143f in good yield and 65% ee 
(entry 16). 
A solvent screening conducted with organocatalyst 137a, 
showed that in aromatic solvents, such as toluene, 
clorobenzene and ethereal solvent, such as methyl tert-butyl 
ether, poor conversions (30-36%) and moderate 
enantioselectivities (50-62%) were achieved (Table 3.2, entries 
2, 4-5). In hexafluorobenzene the yield improved, althogh not 
the enantioselectivity, and in α,α,α-trifluorotoluene the product 
was isolated in 72% ee, but in moderate conversion (49%) 
(entries 6-7). Dibromomethane, 1,1,1-trichloroethane and 
especially 1,2-dichloroethane proved to be the most suitable 
solvents for the reaction in terms of conversion and 











Table 3.2 Solvent screening.
a 
 




1 23 CH2Br2 53 71 
2 45 ClC6H5 36 62 
3 63 CCl3CH3 57 64 
4 67 t-BuOCH3 31 50 
5 64 toluene 30 60 
6 64 CF3C6H5 49 72 
7 158 hexafluorobenzene 70 62 
8 23 Cl(CH2)2Cl 70 73 
9
d 
18 Cl(CH2)2Cl 72 74 
aReactions conditions: 142f (0.10 mmol) and 137a (0.005 mmol) solvent (1 mL). 
bIsolated yields. cDetermined by chiral HPLC analysis. dReaction carried out at C = 
0.05 M of 142f. 
 
Product 143f was isolated in 72% yield and 74% ee, working 
in 1,2-dichloroethane at concentration of 0.05M of 142f (entry 
9). 
Differently 2’-substituted epi-quinine, epi-quinidine or epi-
cinchonidine derived squaramides were then employed under 
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1 137a 18 72 -74 
2 137b 23 65 -69 
3 137c 24 75 -69 
4 137d 19 71 -68 
5 137e 29 48 -70 
6 144 19 64 68 
7 137f 15 79 -78 
aReaction carried out at C = 0.05 M of 142 on 0.1 mmol 
scale. bIsolated yield. cDetermined by chiral HPLC 
analysis. 
 
Alkyl groups at the 2’-position of the epi-quinine (entries 2-3) 
or a sterically demanding 1-naphthyl group at 2’-position of 
epi-cinchonidine (entry 4) were detrimental to catalyst 
efficiency. The presence of a benzylic squaramide moiety as in 
catalyst 137e was unfavourable (entry 5). Catalyst 144, the 
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pseudo-enantiomer of catalyst 137a, gave the opposite 
enantiomer of product 143f but proved to be slightly less 
effective than compound 137a (entry 6). Finally, epi-
hydroquinine derived squaramide 137f was found to be the 
best catalyst as product 143f was isolated in 79% yield and 
78% ee (entry 7). 
To further improve the yield and the enantioselectivity, nature 
of formaldehyde, additives and reaction temperature were 
examined (Table 3.4). 
 














1 - r.t. 16 77 73 
2 Na2SO4 r.t. 15 83 75 
3
d,e 
- 0 40 35 82 
4
e
 - 0 17 94 80 
5
e
 - -20 67 70 84 
6
e
 3Å MS -20 65 80 83 
7
e
 3Å MS -30 60 58 79 
aReaction carried out at C = 0.05 M of 142f on 0.1 mmol scale with 2 eq. of 
formalin. bIsolated yield. cDetermined by chiral HPLC analysis. dParaformaldehyde 
was used. ePerformed at C = 0.1 M of 142f. 
 
We obtained a similar result using two equivalents of 37% water 
solution of formaldehyde (entry 1, Table 3.4) to that obtained when 
using 3 equivalents of paraformaldehyde (entry 7, Table 3.3). The 
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addition of a drying agent such as Na2SO4 slightly improved the 
reaction outcome (entry 2). Formalin proved to be a better reagent 
than paraformaldehyde (entry 3) when decreasing the reaction 
temperature to 0 or -20 °C. (entries 4 and 5). Higher conversion was 
observed at -20 °C in the presence of molecular sieves, with the 
product recovered in 83% ee (entry 6). However, lowering the 
reaction temperature at -30 °C had a detrimental effect both on 
conversion and enantiocontrol (entry 7). 
The effect of acidic additives was also investigated (Table 
3.5).
161
 In the presence of different loading of benzoic acid, an 
improvement of the ee up to 84% was observed working at 0 
°C (entries 1 and 2). Slightly less acidic 4-methoxybenzoic 
acid proved to be less efficient than benzoic acid (entry 3). 
Less acidic additives, such as p-substituted phenols, can be 
also used as useful additives (entries 4 and 5) and, in 
particular, the addition of 4-nitrophenol  significantly 
enhanced the reactivity of the system either at 0 °C or -20 °C 
and the product was isolated in high yield and up to 86% ee 
(entries 6 and 7). Importantly, the catalyst loading can be 
reduced to 3 mol % (entries 8 and 9), affording the product in 
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(2.5 mol %) 





(5 mol %) 





(2.5 mol %) 





 (2.5 mol %) 





 (2.5 mol %) 





(5 mol %) 





(5 mol %) 





(5 mol %) 





(5 mol %) 
-20 46 95 87 
aReaction carried out at C = 0.1 M of 142f on 0.1 mmol scale with 2 eq. of 
formalin. bIsolated yield. cDetermined by chiral HPLC analysis. d3Å MS (≈17 
mg) were added. 
 
The presence of an acidic additive significantly improved the 
activity of the bifunctional organocatalyst and to a lesser 
extent the enantiocontrol. It is plausible to suppose that the 
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additive might help to decrease catalyst self-aggregation 
leading to more active monomeric forms.
162
 
Under optimized reaction conditions, the reactivity of different 
acylated succinic esters 142 was investigated to study the 
scope of the cascade reaction to γ-butyrolactones 143 (Table 
3.6). 
The scope of the reaction was found to be quite general for 
various functionalized succinic esters. Either electron-donating 
or electron-withdrawing groups can be introduced on the 
phenyl ring of the aroyl residue affording the products in high 
yields and very good ee (up to 88%). (143f-l). Only 
substitution at the orto-position affects negatively the 
enantioselectivity (143i). The 2-naphthyl and heteroaromatic 
substituted reagents 142m,n showed to be good substrates for 
the process (143m,n). Remarkably, compounds 142o-q, 
bearing either linear or sterically demanding alkyl groups, 
were also checked in the process and the products (143o-q) 
were recovered in very good yield and the enantioselectivity 
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Table 3.6 Substrate scope of the asymmetric cascade 
aldol/lactonization sequence.
a 
aReaction carried out at C = 0.1 M of 142 on 0.1 mmol scale with 2 eq. of 
formalin and 3Å MS (≈17 mg). ee values determined by chiral HPLC 
analysis. Yields values refer to isolated products. 
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Finally, a preliminary investigation on the applicability of the 
process for the synthesis of enantioeriched γ,γ-disubstituted-δ-
valerolactones was undertaken. 1-Cumyl-5-methyl-2-
benzoylpentanedioate 142r was reacted under optimal 
conditions, but at 0 °C, and the corresponding δ-valeroactone 
145 was formed, after predictably longer reaction time, in 25% 
yield, but with an encouraging 70% ee. 
Additionally, we demonstrated that the paraconic acid 
derivatives 143 can be transformed into diversely 
functionalized hydroxy-γ-butyrolactone derivatives, important 




γ-Butyrolactones 143 were stereoselectively converted into β-
(hydroxyalkyl)-γ-butyrolactones 146 and 147 bearing 
contiguous quaternary and tertiary stereocentres (Scheme 
3.15). Treatment of enantioenriched compounds 143f-j with 
NaBH4/CeCl3 at -80 °C afforded β-(hydroxyalkyl)-γ-
butyrolactones 146f-j in high yield and 90:10 dr. Benzoylation 
of alcohol 146j led to product 148j in 75% yield. 
 




Scheme 3.15 Elaboration of lactones 143 to β-(hydroxyalkyl)-γ-
butyrolactones. 
 
By means of benzoylation of alcohol 146j we succeeded to obtain a 
single crystal of product 148j, whose X-ray analysis on major 
diastereoisomer, enabled us to assign relative and absolute 
configuration of the stereocentres as (R,R). So, we could assign, by 
analogy, the (R)-absolute configuration to γ-butyrolactones 143 












Figure 3.7 Crystallografic structure of 148j by X-ray analysis. ORTEP 
plot with 30% probability ellipsoids. 
 
Hydroxy-γ-butyrolactones are challenging targets to be 
synthesized: only a small number of stereoselective 
methodologies have been reported and the β-(hydroxyalkyl)-γ-




For example, in 2009 the Hajra’s group, reported a short 
synthesis of (-)-enterolactone 153 and (7’R)-7’-
hydroxyenterolactone 154, achieved by means of an 
organocatalyzed asymmetric cross-aldol reaction of aldehydes 
149 and 150 and a base-mediated alkylation of lactones 151 
and 152 (Scheme 3.16).
164b
 Enterolactone 153, found in human 
and animal urine, is involved in the metabolism of plant 
lignans and displays antiestrogenic and anticarcinogenic 
activities among other biological properties.
165
 (7’R)-7’-
hydroxyenterolactone 154 was detected in human urine and is 
also derived from the plant lignan 7’-hydroxymetairesinol.
166
 





Scheme 3.16 Asymmetric synthesis of β-(hydroxyalkyl)-γ-
butyrolactones bearing tertiary stereocentres. 
  
During the synthesis of 154, the authors attempted to protect 
the hydroxyl group of 151 with silylating reagents and they 
observed the formation of a rearranged lactone 156. No 
epimerization was observed during the rearrangement. They 
proposed that activation of the carbonyl oxygen with RSiOTf 
promotes the translactonization via either stepwise or a 
concerted mechanism (Scheme 3.17).  




Scheme 3.17 Proposed pathways for translactonization. 
 
In a similar way, our diastereoisomeric mixture of enantioenriched 
compound 146f (90:10 dr) was treated with TBDMSOTf and 2,6-
lutidine in CH2Cl2
116b,167
 and the rearranged O-protected-β,γ-
substitued-γ-butyrolactone 147f was isolated in 60% yield and 
82:18 dr (Scheme 3.15). No erosion of the enantioselectivity over 
the two-step sequence, occurred as verified by chiral HPLC 
analysis on major diastereomer 147f, whose relative configuration 









                                                     
iv
 See Experimental Section. 






In summary, we developed the first straighforward approach to 
enantioenriched β,β-disubstituted γ-butyrolactones through a 
cascade aldol/lactonization process. A variety of acylated 
succinic esters have been reacted with aqueous formaldehyde 
in the presence of 3 mol % loading of cinchona alkaloid 
derived squaramide and 4-nitrophenol as additive. Exploiting 
simple starting materials and working under mild reaction 
conditions we were able to obtain highly challenging γ-
butyrolactones, bearing an all-carbon quaternary stereocentre 
at the remote β-position. This methodology allows the 
preparation of functionalized paraconic acid derivatives, in 
high yields and fairly good level of enantioselectivity (up to 
88% ee). 
The methodology proved to be suitable to access γ,γ-
disubstitued-δ-valerolactones. Interestingly, this work 
represents the first example of enantioselective 
hydroxymethylation reaction of 2-substituted-1,3-dicarbonyl 
compounds catalyzed by an organocatalyst. 
Finally, we demonstrated that these products can be elaborated 
to prepare valuable hydroxy γ-butyrolactones, bearing 
contiguous tertiary and quaternary stereocentres, until now not 
accessible by alternative methods. 





ENANTIOSELECTIVE SYNTHESIS OF 




A large number of natural and biologically active molecules exhibit 
chiral oxiranes in their structure and their activity often lies in the 
epoxy functional group. 
For example fumagillin and epoximicin in Figure 4.1 bind 
covalently proteases, trapping them by means of their reactive 
epoxide.
168
 Fumagillin inhibits the methionine aminopeptidase type 
2, thus repressing the angiogenesis
169
 (the formation of new blood 
vessels). For this property fumagillin and its derivatives are thought 
to have anti-cancer activity. Epoxomicin is able to inhibit the 






Torreyanic acid, isolated from fungal species P. microspora, causes 
cell death by apoptosis in human cancer cells and the monomeric 
jesterone, isolated from P. jester, is active against the oomycetous 
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Manumycin antibiotics are a subset of widely distributed natural 
compounds having an epoxyquinone structure endowed with 
interesting biological properties such as, among others, antitumor, 
antibacterial, antifungal and enzyme-inhibition.
172, 173
 
Manumycin antibiotics (Figure 4.3) are characterized by having in 
their structure the active epoxyaminocyclohexanone central core. 
The most known member of this large family of natural 
compounds, isolated from Streptomyces species,
174
 is manumycin A 
(Figure 4.3). Generally, manumycins have biological activities such 
as antibacterial, especially against Gram-positive bacteria, 
antifungal, cytotoxic, elastase and Ras farnesyltransferase
175
 
inhibitory effects.  




Figure 4.3 Manumycins. 
 
The triptolide is another example of strongly biologically active 
compound (Figure 4.4). It is a diterpenoid triepoxide whose three 
epoxy groups have been recognized to determine its biological 
activities.
176
 Triptolide is the principal bioactive constituent of 
Tripterygium wilfordii Hook F and is a potent antitumoral, showing 
in vivo and in vitro activities against mouse models of polycystic 
kidney disease
177
 and pancreatic cancer
178
. It exhibits also anti-
inflammatory, immunosuppressive, anti-fertility and anti-
cystogenesis effects. Unfortunately, its toxicological properties 
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towards multiple tissues and organs limit its therapeutic potential 
and many efforts to overcome its toxicity by chemical 




Figure 4.4 Triptolide. 
 
All the examples illustrate just some of the diverse natural 
substances whose biological activity can be ascribed to chiral epoxy 
units. Optically active epoxides are also highly useful intermediates 
exploited in total syntheses.
172,173,176 
In fact, they are able to undergo 
regio- and stereoselective ring opening by nucleophiles giving 
access to a wide variety of differently functionalized products.
179 
 
4.1.1 Epoxidation of nitroalkenes 
Generally, the epoxides can be synthesized by different methods: 
olefin peroxidation, intramolecular SN2 substitution (including the 
Darzens reaction), the Corey-Chaykovsky reaction (sulfur ylides 
with carbonyl compounds) and nucleophilic epoxidation. With 
eletron-rich olefins, alkene acts as the nucleophile and peroxide as 
the electrophile and the reaction proceeds via the so-called 
concerted “butterfly mechanism”. When an alkoxide ion can 
intramolecularly displace a leaving group in the molecule, a SN2 
substitution occurs leading to the formation of an oxirane ring. In 
order to epoxidize electron-poor olefins, such as enones, enals or 
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acrylate derivatives, nucleophilic epoxidation conditions are 
required. A nucleophilic peroxide species, generated from an alkyl 
hydroperoxide under basic conditions, attacks in a conjugate 
fashion the electron-poor alkene. Then ring closure occurs in a non-
concerted pathway. Asymmetric epoxidation of alkenes is the most 
exploited methodology to synthesize chiral epoxides.
7,180
 In the 
context of asymmetric nucleophilic epoxidation reactions, in recent 





 have been developed.  
On the contrary, the asymmetric epoxidation of nitroalkenes has 
proven to be a challenging transformation and, indeed, only a few 
diasteroselective methods have been reported.
183
 Nitroolefins are 
one of the most attractive Michael acceptors, thanks to the synthetic 
usefulness of nitro group, which can be readily transformed into a 
variety of functional groups such as ketone, carboxylic acid, amine, 
nitrile oxide, hydrogen, and so on.
184
 
In the 1980s, a pioneering attempt at an enantioselective 
epoxidation was published by Juliá and Colonna, who illustrated 
the epoxidation of nitroalkenes catalyzed by polyaminoacids in the 
presence of NaOH/H2O2. This process afforded the epoxide in 





Scheme 4.1 Juliá-Colonna epoxidation of trans--methyl--nitro-styrene. 
CHAPTER 4                                                                                   4.1 Background        
 
 145 
Until today, only one example of epoxidation of nitro-olefins with 
modest success has been reported. In 1998, Enders developed a 
zinc-mediated enantioselective epoxidation of aliphatic trans-




Scheme 4.2 Enantioselective synthesis of aliphatic trans-2-nitro-oxiranes. 
 
The epoxidation was performed by using O2 in the presence of 
diethylzinc and an over-stoichiometric amount of the chiral reagent 
N-methyl pseudo-ephedrine 158. 
 
4.1.2 Ring-opening of α-nitroepoxides 
Racemic α-nitroepoxides are useful synthons in organic synthesis 
thank to the regioselective ring-opening reactions that they can 
undergo at the β-position in the presence of nucleophiles (Scheme 
4.3). The preparation of racemic α-nitroepoxides is easily achieved 
reacting nitro-olefins and hydrogen peroxide under basic 
conditions. The first studies on the reactivity of nitroepoxides with 
several nucleophiles dates back as early as 1970.
187
 Racemic α-
nitroepoxides can be transformed into heterocycles such as 1,3-
thiazoles and quinoxalines (Scheme 4.3A),
187,188
 functionalized α-





 and carbonyl compounds (Scheme 4.3B)
187,190
. 
Recently, González reported the stereoselective synthesis of vicinal 
diamines starting from racemic α-nitroepoxides through a dynamic 
kinetic asymmetric ring-opening / reductive amination sequence. 
The α-nitroepoxides were treated with chiral primary amines 
affording diastereomeric mixtures of aminoimines followed by 





Scheme 4.3 Synthetic elaborations of α-nitroepoxides. 
 
It is interesting to note that the chemical behaviour of α-
nitroepoxides towards nucleophiles could be, virtually, considered 





In particular, the regioselective ring-opening of nitro-oxiranes at the 
β-position by amines has been reported by Newman and Angier
187
 
in 1970 and Vankar
190
 in 1991 (Scheme 4.4). 




Scheme 4.4 First examples of ring opening of α-nitroepoxides by amines. 
 
 These reports and the paucity of asymmetric epoxidation 
reactions performed on nitroalkenes inspired us to develop a 
methodology for the asymmetric epoxidation of nitroalkenes. 
Having previously disclosed that bifunctional organocatalysts, such 
as prolinols and tertiary amine thioureas, are able to promote the 
asymmetric epoxidation of trans-chalcones and electron-poor 
terminal alkenes, we attempted, without success, the 
enantioselective epoxidation of trans-β-methyl-β-nitro-styrene.
192
 
Consequently, we decided to achieve our target exploiting, as an 
alternative process, the aminolitic kinetic resolution of racemic α-
nitroepoxides. 
 
4.1.3 Kinetic resolution of racemic epoxides 
The kinetic resolution of racemic compounds (see paragraph 2.3) 
represents a highly valuable and sometimes unique strategy to 
synthesize chiral products. 
The first pioneering example of kinetic resolution, performed on 
terminal racemic epoxides, has been reported by Jacobsen in 
1997.
193
 In this elegant work, he developed an efficient asymmetric 
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hydrolytic kinetic resolution of racemic terminal epoxides 162 
using water as the only reagent, without solvents and low loading 
(0.5 mol %) of a recyclable chiral cobalt-based salen complex 
catalyst 161 (Scheme 4.5). Highly valuable enantioenriched 
terminal epoxides and 1,2-diols, 163 were thus obtained. Due to the 
high values of krel of this process (> 400 for propylene oxide, 290 
and 260 for 1-hexene and 1-octene oxide, respectively) both 
recovered epoxides and chiral 1,2-diols were isolated in high yields 
(close to the theoretical maximum) and excellent enantioselectivity 
(84-99% ee).  
 
Scheme 4.5 Hydrolytic kinetic resolution of terminal epoxides. 
 
This class of racemic epoxides is inexpensive and easily available, 
the reaction proceeds with water under solvent-free conditions. 
These appealing features, together with the high efficiency of the 
process, made it applicable at an industrial scale.
110,194 
Another example of kinetic resolution of racemic epoxides was 
reported by Andersson et al. in the 2000s (Scheme 4.6).
195
 They 
reported the kinetic resolution of cyclic epoxides via catalytic 
CHAPTER 4                                                                                   4.1 Background        
 
 149 
enantioselective rearrangement to allylic alcohols using the Li-salt 
of (1S,3R,4R)-3-(pyrrolidinyl)methyl-2-azabicyclo [2.2.1] heptane 
164, an excess of DBU and LDA as the stoichiometric base. 
Unreacted epoxides and allylic alcohols were obtained in moderate 
to high ees. 
 
Scheme 4.6 Kinetic resolution of cyclic epoxides to allylic alcohols. 
 
In 2004, Melchiorre and Bartoli reported the first asymmetric 
aminolysis of trans-aromatic epoxides with anilines. The process 
was catalyzed by a commercially available [Cr(Salen)Cl] Lewis 
acid 167 and afforded anti-β-amino alcohols 170 in up to 99% ee 








Scheme 4.7 Aminolytic kinetic resolution (AKR) of aromatic trans-
epoxides. 
 
The same research group developed the asymmetric catalytic 
kinetic resolution of racemic terminal epoxides for the synthesis of 
aliphatic and aromatic N-Boc and N-Cbz-protected 1,2-amino 
alcohols. The reaction was catalyzed by the (salen)Co
III
 complexes 
171 using for the first time carbamates as nucleophiles. The levels 





Scheme 4.8 AKR of terminal epoxides with tert-butyl carbamate. 
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 In the field of organocatalysis, it has been reported that 







 are able to assist the regioselective ring-
opening reaction of epoxide affording differently substituted 
alcohols. 
For example, Schreiner in 2008 reported the regioselctive 
alcoholysis of styrene oxides using an organocatalytic system 
composed of two Brønsted acids, mandelic acid 174 and N,N-bis-
[3,5-bis-(trifluoromethyl)phenyl]-thiourea 173 (Scheme 4.9).
200a 
 
Scheme 4.9 Alcoholysis of styrene oxides promoted by cooperative 
Brønsted acid-type organocatalysis. 
 
In 2010, Chimni illustrated a thiourea catalyzed aminolysis of 
epoxides under solvent-free conditions (Scheme 4.10).
200b 
The 
authors proved by 
13
C NMR data and DFT calculations that the 
regioselectivity of the reaction is controlled by the electronic nature 
of the substituent on the styrene oxide. 




Scheme 4.10 Thiourea catalyzed aminolysis of epoxides. 
 
Very recently, a few examples on the desymmetrization of meso-
epoxides promoted by chiral organocatalysts, such as 
sulfinamides
201
 and phosphoric acids,
202
 have been developed. In 
2014, Chimni et al. developed an enantioselective ring opening of 
meso-stilbene oxides 178 with N-phenylpiperazines 179 catalyzed 
by a peptidyl thiourea derivative 177. β-Amino alcohols 180 were 
obtained with up to 95% ee after crystallization (Scheme 4.11).
203
 




Scheme 4.11 Desymmetrization of meso-stilbene oxides organocatalyzed 
by a peptidyl thiourea derivative. 
 
The authors reasoned that the catalyst, bearing a thiourea unit, 
would activate the epoxide ring through double hydrogen-bonding 
and the peptide, chosen intentionally with a β-turn scaffold, would 
anchor the nucleophile in a chiral environment (Figure 4.6). 
 
Figure 4.6 Proposed activation model of the reagents by a peptidyl 
thiourea organocatalyst. 
 




At the same time, independently, Kureshy reported the asymmetric 
ring-opening reaction of meso-epoxides 182 with aniline catalyzed 
by a chiral sulfinamide 181 as the organocatalyst. They obtained 
chiral β-amino alcohols 183 in high yield (up to 95%) and excellent 




Scheme 4.12 Desymmetrization of meso-epoxides with anilines catalyzed 
by chiral sulfinamide. 
 




C-NMR experiments was performed in CDCl3 
in order to investigate the interactions among the catalyst and the 
two reagents and a mechanism for the activation has been proposed 
(Figure 4.7).  
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4.2 Results and Discussion 
Given the lack in literature of a methodology for the synthesis of 
enantioenriched β-substituted α-nitroepoxides, we decided to 
embark upon this study. As anticipated in the previous paragraph,    
at the outset of our study, we tried to epoxidize β-methyl-β-
nitrostyrene with different bifunctional organocatalysts without 
success.
192
 However, we succeeded to achieve our target exploiting 
an aminolytic kinetic resolution of racemic α-nitroepoxides. The 
kinetic resolution proceeds through a completely regioselective 
ring-opening reaction by aniline, organocatalyzed by a bifunctional 
cinchona-alkaloid derived thiourea (Scheme 4.13).  
 
Scheme 4.13 Aminolytic kinetic resolution of racemic α-nitroepoxides 
promoted by a bifunctional thiourea. 
 
We reasoned that a bifunctional organocatalyst would activate 
simultaneously the epoxide and the aniline via general acid-base 
catalysis in a chiral environment, thus leading to the preferential 
regioselective opening of one enantiomer of the α-nitroepoxide 
(Figure 4.8). 
 




Figure 4.8 Proposed activation model of reagents by organocatalyst in the 
AKR. 
 




phenyloxirane 184a was treated with aniline 169a in the presence 
of 15 mol % of (R)-BINOL 186 at room temperature in toluene 
(entry 1, Table 4.1). At first, a catalyst bearing only H-bonding 
donating groups was employed to observe if it could be active 
enough for the ring-opening of epoxide. An excess of aniline 169a 
with respect to the epoxide 184a was added to neutralize nitrous 
acid formed as a deleterious by-product. In the presence of this 
organocatalyst, conversion of the epoxide to the expected ketone 
185 was very low after 48 h (entry 1). When using a similar 
organocatalyst, the amino alcohol derived thiourea 187, the 
conversion to the ketone slightly improved (entry 2), but the 
epoxide was isolated with 2% ee value. A Brønsted base catalyst 
(DHQD)2PHAL 101 provided a similar result, in terms of 
conversion and enantioselectivity (entry 3). A significant 
improvement was observed when a bifunctional organocatalyst, 
bearing both H-bonding and Brønsted base groups in its structure, 
was used. Indeed, Takemoto’s thiourea 20 afforded unreacted 
epoxide in 50% yield and an enacouraging 23% ee (entry 4). This 
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result demonstrated that a synergistic activation of both epoxide and 
aniline by the bifunctional organocatalyst, as proposed in Figure 
4.8, is needed to develop an efficient process of kinetic resolution. 
Next, the catalytic activity of other bifunctional readily available 
promoters was investigated. Cinchona derived thiourea 78a 
afforded a similar result in term of yield but the enantioselectivity 
of the process was lower (entry 5). The epi-cinchonidine derived 
thiourea 78c performed more effectively, allowing the isolation of 
the unreacted epoxide in 63% yield and 30% ee (entry 6). Its 
pseudo-enantiomer 78e proved to be a less efficient catalyst (entry 
7). The epi-quinidine derived squaramide 188, was also examined 
in the process. It catalyzed the AKR leading to the same result 
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Table 4.1 Screening of catalysts in the model aminolytic kinetic resolution 
of ( )-184a with aniline.a 
 
entry cat. t (h) 185
b
 yield 184a (%)
c
 ee 184a (%)
d
 
1 186 48 12 nd nd 
2 187 48 24 68 2 
3 101 48 21 74 6 
4 20 65 40 50 -23 
5 78a 69 37 51 -11 
6 78c 48 33 63 -30 
7 78e 48 40 47 28 
8 188 48 35 59 6 
aAll reactions were carried out using (±)-184a (0.15 mmol), 169a (0.18 mmol), 
catalyst (15 mol %) in toluene (1.5 mL). bDetermined by 1H NMR analysis. 
cIsolated yield. dDetermined by chiral HPLC analysis. 
CHAPTER 4                                                                4.2 Results and Discussion        
 
 160 
Having identified the best-perfoming catalyst 78c, the aminolytic 
kinetic resolution of the model racemic epoxide 184a was further 
optimized (Table 4.2). Aromatic amines of different steric demand, 
1- and 2-naphthyl amines 169b and 169c, did not improve the 
process (entries 1 and 2).  
 
Table 4.2 Optimization of reaction conditions.
a 
 













1 1-naphthyl toluene 63 34(b) 64 24 
2 2-naphthyl toluene 25 32(c) 61 20 
3 4-MeOC6H4 toluene 65 38(d) 47 40 
4 Benzyl toluene 46 nd 34 6 
5 Ph CHCl3 44 30(a) 65 18 
6 Ph tBuOMe 46 52(a) 43 22 
7 Ph p-xylene 48 36(a) 59 30 
8
e
 Ph toluene 113 65(a) 28 59 
9
f
 Ph toluene 113 55(a) 38 50 
10
g
 Ph toluene 96 70(a) 28 72 
11
h
 Ph toluene 96 35(a) 62 - 
aAll reactions were carried out using (±)-184a (0.15 mmol), 169 (0.18 mmol), 78c 
(15 mol %) solvent (1.5 mL). bDetermined by 1H NMR analysis. cIsolated yield. 
dDetermined by chiral HPLC analysis. eReaction carried out with 20 mol % of 
78c, 1.5 eq. of aniline at C184a (0.2 M). 
fReaction carried out with 20 mol % of 
78c, 3.0 eq. of aniline at C184a (0.05 M). 
gReaction carried out with 20 mol % of 
78c, 3.0 eq. of aniline at C184a (0.1 M). 
hReaction carried out without catalyst, 
with 3.0 eq. of aniline at C184a (0.1 M). 
 
Slightly more basic p-anisidine gave inferior results compared to 
aniline (entry 3). More nucleophilic amines, such as benzyl amine 
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provided the unreacted epoxide with lower ee and the formation of 
other unidentified by-products was observed (entry 4). 
Nonpolar aromatic solvents proved to be the most suitable media 
for the reaction (entries 5-7), according to what usually observed in 
non-covalent catalysis. Among the aromatic solvents tested for the 
reaction between ( )-184a and aniline 169a, toluene was found to 
be the most effective (Table 4.1, entry 6). 
The reaction was further optimized in toluene varying the reagents 
ratio and the concentration. The catalyst loading and the equivalents 
of aniline were increased to accelerate the reaction. The AKR were 
carried out with 20 mol % of catalyst loading and 3 equivalents of 
aniline at different concentrations in toluene (entries 8-10). The best 
result was observed working at C = 0.1 M of epoxide 184a. Under 
these conditions enantioenriched epoxide 184a was recovered in 
28% yield and 72% ee (entry 10). 
Finally, a control experiment was performed under the same 
conditions without the catalyst (entry 11). Unfortunately, the 
epoxide ring-opening proved to be not a negligible process, thus 
partially contributing to affect the efficiency of the kinetic 
resolution. 
Under the optimum reaction conditions illustrated in Table 4.2, 
entry 10, the scope of the aminolytic kinetic resolution was 
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Table 4.3 Scope of the AKR of α-nitroepoxides with aniline 






















1 Ph Me 96 65 28 (a) 72 3.5 
2 4-MeC6H4 Me 86 79 17 (e) 84 3.1 
3 4-ClC6H4 Me 91 67 29 (f) 86 5.9 
4 4-CF3C6H4 Me 158 48 36 (g) 77 5.5 
5 2-naphthyl Me 84 72 26 (h) 95 5.8 
6 Ph Et 91 59 21 (i) 92 4.5 
7 3-MeC6H4 Et 89 66 31 (j) 92 7.1 
8 4-BrC6H4 Et 86 64 33 (k) 90 7.3 
9 3,4-Cl2C6H3 Et 86 47 35 (l) 61 3.6 
10 Ph(CH2)2 Me 115 28 35 (m) 16 - 
aAll reactions were carried out using (±)-184 (0.2 mmol), 169a (0.6 mmol), 78c 
(20 mol %), toluene (2 mL). bIsolated yield. cDetermined by chiral HPLC 
analysis. dThe values for krel were calculated using the equation krel = ln [(1-
c)(1-ee)]/ ln [(1-c)(1+ee)], where ee is the enantiomeric excess and (1-c) is the 
yield/100 of recovered epoxide. 
 
The aminolytic kinetic resolution of different α-nitroepoxides has 
shown that both electron-donating and withdrawing groups in the 
aromatic ring of the α-methyl or α-ethyl nitroepoxide (entries 1-4, 
6-9) and 2-naphthyl group (entry 5) are well-tolerated in the 
process. The unreacted epoxides were isolated in acceptable yield 
and good to high enantioselectivity (up to 95% ee). Finally, we 
investigated the applicability of this protocol to an aliphatic α-
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nitroepoxide 184m. However, the AKR proved to be a poorly 
efficient process (entry 10), as the epoxide was recovered in 35% 
yield and 16% ee. The ee values of the α-amino ketones 185 were 
not calculated because low values have to be expected. This 
assumption is based on the following considerations: i) the 
estimated stereoselectivity factors of the AKR,
v
 shown in Table 4.3, 
are modest (3 < krel < 7) and, how explained in paragraph 2.3, low 
ee values for the α-amino ketone products are expected;  ii) it has 
been shown that enantiomerically enriched α-amino ketones are 
susceptible of partial racemization under basic conditions.
204
 
Indeed, as an example, the amino ketone 185a, reported in entry 1 
of Table 4.3, was recovered with 16% ee. It is important to note 
that, krel values are underestimated due to the contribution of the 
background ring-opening reaction by aniline. 
We have also demonstrated, for the first time, that enantiomerically 
enriched α-nitro epoxides can be useful intermediates in 
asymmetric synthesis. Indeed, they have been transformed into 
chiral anti-1,2-amino alcohols through a diasteroselective one-pot 
ring-opening reaction with pyrrolidine followed by reduction of the 
ketone intermediate (Scheme 4.14). 





illustrated a variety of ring-opening reactions of 
diastereoisomerically pure arylthionitroepoxides or spirocyclic bis-
sulfinyl oxiranes with amines, affording enantioenriched α-amino 
                                                     
v
 First order kinetics was assumed for the calculation of the stereoselectivity 
factors. See paragraph 2.3. 
 
CHAPTER 4                                                                4.2 Results and Discussion        
 
 164 
thioesters and amides, respectively. As expected these 
transformations occurred with inversion of configuration, thus 
demonstrating to be stereospecific. 
 
 
Scheme 4.14 Stereoselective one-pot ring-opening/reduction sequence to 
anti-1,2-amino alcohol 189. 
 
Enantiomerically enriched (-)-184a was reacted with pyrrolidine at 
0 °C to give the corresponding α-amino ketone, which was in situ 
reduced, after the addition of MeOH followed by CeCl3/NaBH4, in 
fairly good overall yield and highly diastereoselective manner to the 
anti--amino alcohol.
206
 It is important to highlight that a slightly 
erosion of the enantioselectivity occurs over the two steps of the 
one-pot procedure. By comparing the optical rotation of 189 with 
the value reported in literature,
207
 we were able to assign the 
absolute configuration of the amino-alcohol as (1R, 2S). From the 
absolute configuration of the amino alcohol we could determine the 
absolute configuration of 2-methyl-2-nitro-3-phenyloxirane 184a as 
(2R, 3S). Finally, we proved that the kinetic resolution of α-nitro 
epoxide can be performed using different nucleophiles such as a 
thiols and 1,2-diamines, as demonstrated by the preliminary results 
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showed in Scheme 4.15. 
 
Scheme 4.15 Kinetic resolution of racemic epoxide 184a with naphthyl 
thiol and o-phenylenediamine. 
 
When using o-phenylenediamine 191 as the nucleophile, besides 
the enantioenriched nitroepoxide, the pharmaceutically important 
quinoxaline 193
208
 was isolated in satisfactory yield. 
 







We have developed the first enantioselective synthesis of aromatic 
α-nitroepoxides exploiting an aminolytic kinetic resolution with 
aniline, catalyzed by an easily accessible cinchona alkaloid-derived 
thiourea. The unreacted epoxides were isolated in acceptable yield 
and good to high enantioselectivity. We also demonstrated that 
enantioenriched α-nitroepoxides can be used as synthetically useful 
intermediates: a convenient one-pot stereoselective approach to 
highly valuable anti-1,2-amino alcohols has been described. 
Despite this AKR process needs yet to be improved, in terms of 
efficiency, to be of practical value, this work is conceptually 
interesting in showing that bifunctional organocatalysts are able to 
catalyze the ring-opening reaction of epoxides. Improvements of 
this process are likely to be envisaged in the next future by 














5. ENANTIOSELECTIVE  




The α-hydroxy-β-dicarbonyl moiety is an important structural motif 
present in bioactive compounds of natural and synthetic origin.
209
 
The most convenient and direct approach to synthesize these 
scaffolds is the α-hydroxylation reaction of 1,3-dicarbonyl 
compounds, which allows to transform a carbon-hydrogen bond in 
a carbon-oxygen bond. In particular, the asymmetric α-
hydroxylation of α-substituted 1,3-dicarbonyl compounds 
constitutes an efficient route to directly access enantiomerically 





Scheme 5.1 α-Hydroxylation of α-substituted 1,3-dicarbonyl compounds. 
 
This class of densely functionalized alcohols 195, with a quaternary 
stereocentre, includes useful synthetic intermediates and this 
scaffold is an integral feature of a variety of natural products and 
pharmaceuticals (Figure 5.1). For example, α-acetolactate and α-
acetohydroxybutyrate are the biosynthetic precursors of valine and 






 Indoxacarb is an insecticide produced by Dupont,
212
 




Figure 5.1 Examples of biologically active compounds bearing α-
hydroxy-β-dicarbonyl moiety. 
This functional unit appears in key-intermediates in several multi-
step reaction sequences, for example in the synthesis of brazilin-
like compounds.
214
 Brazilin is a tetracyclic homoisoflavanoid, the 
major component present in the heartwood of Caesalpinia sappan 
L. (Leguminosae), used for a long time in traditional Chinese 
medicine. Biological studies demonstrated that brazilin improved 
rheological abnormalities in diabetes, had antiplatelet and anti-
inflammatory activity and modulated immune function. Recent 








5.1.1 α-Hydroxylation of aldehydes and ketones 
The first source of electrophilic oxygen introduced for the α-
oxidation of aldehydes was the nitroso benzene, in the asymmetric 
metal-catalyzed α-oxidation of tin-enolates.
215
 Subsequently, three 
different research groups used the nitrosobenzene in the 







 independently, showed the 
regio- and enantiocontrol of L-proline in different solvents and 
reaction conditions (Scheme 5.2). 
 
 
Scheme 5.2 α-Hydroxylation of aldehydes using nitrosobenzene, catalyzed 
by L-proline.  
 




The same functionalization can be extended to ketones. Their use, 
however, is hampered by the fact that the addition on both two 
enolizable carbons and poor regioselectivity can occur and, usually, 





were able to circumvent the problem by using a large excess of 
ketone and performing slow addition of nitrosobenene. In this way, 
good yields (44-91%) and high enantioselectivity (96-99% ee) were 
achieved.  




In 2004, the Córdova’s group reported the α-oxidation of aldehydes 
catalyzed by α-methylproline but, subsequently, they demonstrated 
that α,α-L-diphenyl prolinol ether 4b is a more effective catalyst 
(Scheme 5.3).
222
 The oxidizing agent is molecular singlet oxygen, 
generated from atmospheric oxygen in the presence of a catalytic 
amount of tetraphenyl porphyrin (TPP). The α-hydroxyaldehyde 
intermediate was reduced in situ with NaBH4 to the corresponding 
diol with good yields (50-76%) (Scheme 5.3). 
 
Scheme 5.3 α-Hydroxylation of aldehydes with molecular singlet oxygen 
catalyzed by α,α-L-diphenyl prolinol ether 4b.  
 
 
5.1.2 α-Hydroxylation of 1,3-dicarbonyl compounds 
Oxidations of β-dicarbonyl compounds 194 can be performed with 
different oxidants.
209  
In the context of oxidation with peracids, the first α-hydroxylation 
to the α-hydroxy-β-diketone 195 was reported in 1958, using the 










Scheme 5.4 Oxidation of β-diketone 194. 
 
However, performing analogous reactions between other diketones 
and peracids, only small amounts of the α-hydroxylated product 
was obtained together with other decomposition products. 
The first α-hydroxylation of a β-ketoester was reported in 1968 




Scheme 5.5 Oxidation of β-ketoester 197. 
 
The Rubottom oxidation is a well-established method for the 
hydroxylation of cyclic β-dicarbonyl compounds with mCPBA. 
This is a three-step sequence, consisting of deprotonation, silyl enol 
ether formation and epoxidation, followed by acidic hydrolysis. 





Scheme 5.6 Rubottom oxidation of cyclic silyl enol ethers.  
 
 




In a few cases, when the the enol form of the six-membered ring β-
oxo ester in the tautomeric keto-enol equilibrium is predominant, 
the direct hydroxylation with mCPBA can be performed. This is a 
different version of the Rubottom oxidation, whose mechanism is 




Scheme 5.7 Generally accepted mechanism of α-hydroxylation with 
mCPBA.  
 
The Rubottom oxidation is a well-established method and easily 
reliable on the laboratory scale, but it requires three steps and 
stoichiometric amounts of peracid, base and trialkylsilyl halide. 
 Therefore, more convenient oxidation methods have been 
devised, as those using dimethyldioxirane or atmospheric oxygen as 
the oxidants. The main advantage of these procedures is less 
amount of waste products formed during the reaction. 
Dimethyldioxirane (DMD) is prepared from acetone and hydrogen 
peroxide or persulfates and it is used for the epoxidation of olefins. 
However, several dicarbonyl compounds have been hydroxylated 
with this reagent, sometimes with the addition of fluoride in order 
to shift the keto-enol equilibrium in favour of the enol form. One 








Scheme 5.8 Oxidation with DMD. 
 
From an economic and ecological point of view, the oxidations with 
atmospheric oxygen in the presence of Mn, Co or Ce salts are the 
best methodologies.
209
 In particular, the cerium salt CeCl3
.
7H2O is 
the optimal catalyst since it is non-toxic and inexpensive. Just two 
examples are reported in Scheme 5.9.
228
 Unfortunately, this 
methodology is restricted to certain substrates such as carbo- and 
heterocyclic compounds. 
 
Scheme 5.9 Oxidations with molecular oxygen. 
 
By means of the methodologies shown above, only racemic 
products can be obtained.  
 Asymmetric α-hydroxylations can be performed using an 
optically active oxaziridine (Davis’ reagent).
229
 
In Scheme 5.10 is reported one example in which the hydroxylation 










Scheme 5.10 α-Hydroxylations with Davis’ oxaziridine. 
 
However, even if highly reliable in most cases, the α-hydroxylation 
with oxaziridines needs stoichiometric deprotonation before 
oxidation and an optimization of the chiral reagent is often required.  
A limited number of direct enantioselective α-hydroxylations have 
been developed and the majority is focused on β-ketoesters. 
Transition metal-chiral ligand complexes
210a
 with different oxidants 
on the one hand, and organocatalysis,
210b
 mediated by bifunctional, 
phase transfer catalysts and chiral phosphoric acids, on the other 
hand have been reported. 
The inherent acidity of β-ketoesters allows their reaction with 
electrophiles and the formation of metal enolates is not needed. 
Togni, Mezzetti et al. used a catalyst previously exploited by the 
same group in the asymmetric α-fluorination reaction of β-
ketoesters. The Ti(TADDOLato)complex 200 was found to 
catalyze the enantioselective α-hydroxylation of β-ketoesters, in the 




presence of racemic 2-(phenylsulfonyl)-3-(4-
nitrophenyl)oxaziridine 201 as the oxidant, obtaining the products 
with up to 94% ee (Scheme 5.11).
231
 However, the 
enantioselectivity of the reaction was strongly dependent on the 
substrate structure. 
 
Scheme 5.11 Asymmetric α-hydroxylation of β-ketoesters catalyzed by a 
Ti-chiral ligand complex. 
A ruthenium salt was also employed in the same study for the α-
hydroxylation of the β-ketoesters with H2O2, but the products were 
isolated in low yields and modest ees (up to 36%).
231
 
In 2006, Toru, Shibata and co-workers described the first example 
of a catalytic enantioselective hydroxylation reaction of 2-oxindoles 
202, using DBFOX ligand in combination with a Zn salt as Lewis 
acid, and oxaziridine 203 as the oxidant (Scheme 5.12a).
232
 
In an extension of the above investigations, the enantioselective 




hydroxylation reaction of a linear β-ketoesters 194 catalyzed by a 
DBFOX/Ni(II) salt, was reported (Scheme 5.12b). In 2009, the 
same group successfully applied the Ni-catalyzed procedure to 




Scheme 5.12 Hydroxylation reactions catalyzed by Lewis acid using 
DBFOX as chiral ligand. 
 
In 2009, Hii documented the ability of a dicationic Pd(II)-BINAP 
catalyst 206 OTf, air- and moisture-stable, to catalyze the α-
hydroxylation of β-ketoesters, using dimethyldioxirane as the 




oxidant. The methodology proved to be effective with cyclic 
substrates (Scheme 5.13), but unsuccessful with less reactive 




Scheme 5.13 Pd(II)-catalyzed α-hydroxylation of the β-ketoesters. 
 
 In 2004, the Jørgensen’s group demonstrated the ability of 
Cinchona alkaloids to organocatalyze the enantioselective 
hydroxylation of β-ketoesters (Scheme 5.14).
235
 After optimization 
of the reaction conditions, commercially available hydroquinine 52 
was found to be the best-performing catalyst, with cumyl 
hydroperoxide as the oxidant in CH2Br2 as the solvent. Under these 
conditions, optically active products were obtained in up to 80% ee.   
 





Scheme 5.14 Organocatalytic enantioselective hydroxylation of β-
ketoesters. 
In 2009, Zhong and co-workers illustrated the use of chiral 
phosphoric acids, at only 1 mol % loading, in the α-hydroxylation 
reaction of β-dicarbonyl compounds with nitroso benzene as the 
oxidizing agent. The reaction directly led to the enantioenriched α-





Scheme 5.15 Enantioselective α-hydroxylation of β-dicarbonyl 
compounds catalyzed by a chiral Brønsted acid. 
The protonation of the basic nitrogen atom of 208 occurs followed 




by a tandem aminoxylation of β-dicarbonyl compounds and 
subsequent heterolysis of the N-O bond. The selective protonation 
of the nitrogen atom instead of oxygen atom in the transition state is 




Gao and co-authors illustrated the first application of the 
diterpenoid alkaloid lappaconitine 209 as a chiral Brønsted base in 
the α-hydroxylation of β-ketoesters using tert-butyl hydroperoxide 
(TBHP) as the oxidant, achieving moderate enantioselectivity 









Scheme 5.16 α-Hydroxylation of β-ketoesters catalyzed by a terpenoid 
alkaloid. 
In 2010, the first PTC catalyzed oxidation of 1-adamantyl (1-Ad) β-
ketoesters with cinchonine-derived ammonium salt 210 in the 
presence of CHP as the oxidant was developed (Scheme 5.17).
238
 
However, this methodology is restricted to indanone based β-
ketoesters, whose products have been isolated with up to 74% ee. 
 
Scheme 5.17 PTC catalyzed α-hydroxylation of β-ketoesters. 
In 2012, Meng showed the enantioselective α-hydroxylation of β-
ketoesters catalyzed by a chiral S-timolol derivative 211 (Scheme 






 Again, the methodology is applicable only to indanone 
based β-ketoesters. 
 
Scheme 5.18 Enantioselective α-hydroxylation of β-ketoesters catalyzed 
by S-timolol derivative 211. 
 
5.1.2.1 α-Hydroxylation of β-ketoamides 
Unlike β-ketoesters, the enantioselective α-hydroxylation of β-
ketoamides has been a scarcely investigated transformation. The 
lack of enantioselective methodologies to install a hydroxyl group 
at the α-position of β-ketoamides is likely due to the higher pKa of 
their α-hydrogen, which determines the necessity of more basic 
reaction conditions to form the reactive enolate. The amido group is 
a versatile functionality in organic synthesis owing to the further 
tranformations it can undergo.
240
Hence, the development of 
enantioselective processes for the -hydroxylation of β-ketoamides 
is highly desirable. These procedures would directly allow the 
generation of tertiary alcohols, bearing an enantioenriched 
tetrasubstituted carbon with both ketone and amido functionalities, 
amenable to chemoselective manipulations. 
Very few examples of α-hydroxylation of β-ketoamides have been 





In 2012, Zhang developed a method for the racemic α-
hydroxylation of β-dicarbonyl compounds.
241
 Under a 
homogeneous solvent mixture of water and 1,4-dioxane at 60 °C, 
without the aid of a catalyst, a variety of cyclic  β-dicarbonyl 
compounds, including β-keto esters, β-diketones and β-ketoamides 
were reacted using oxone as the stoichiometric oxidant. The 
examples on β-ketoamides are reported in Scheme 5.19. 
 
Scheme 5.19 Racemic α-hydroxylation of β-ketoamides with oxone. 
A single example of enantioselective α-hydroxylation of a β-
ketoamide was reported in 2004 exploiting a ruthenium-based 




Scheme 5.20 Enantioselective ruthenium catalyzed hydroxylation of β-
ketoamide 213. 




Recently, a more successful protocol has been developed by 
Kumagai and Shibasaki who reported the first asymmetric 
hydroxylation of N-unsubstituted α-alkoxycarbonyl amides, using a 
catalytic system consisting of a rare earth metal alkoxide and a 
chiral amide-based ligand 215 (Scheme 5.21).
242
 Davis’s 
oxaziridine 214 was used as the oxidizing reagent. 
 
Scheme 5.21 Asymmetric hydroxylation of α-alkoxycarbonyl amides 
promoted by Pr(O
i
Pr)3/amide-based ligand catalyst. 
The optically active tertiary alcohols were isolated in moderate to 
good yields and good to high enantioselectivity. The authors 
suggested that metal coordination and hydrogen bonding of chiral 
ligand worked cooperatively to determine the stereochemical 
outcome of the reaction. 
 Given the paucity of protocols for the enantioselective α-
hydroxylation of a β-ketoamides, we decided to embark on this 
study in order to develop a simple organocatalytic oxidative system. 
 
 




5.2 Results and Discussion 
We set up the first organocatalytic enantioselective α-hydroxylation 
reaction of α-substituted β-ketoamides. On the basis of literature 
precedents,
235
 we assumed that a bifunctional organocatalyst would 
have been suitable to promote the process. Hence, we commenced 
our screening investigating the reaction of model β-ketoamide 216a 
with TBHP as the oxidant, in the presence of 20 mol % loading of a 
variety of readily available bifunctional organocatalysts (Scheme 
5.22), in toluene at room temperature (Table 5.1).  
 
Scheme 5.22 Organocatalysts screened in the α-hydroxylation of β-
ketoamide 216a. 
α,α-L-diphenyl prolinol 4b, bearing a secondary amine group, was 
able to promote the α-hydroxylation reaction of β-ketoamide 216a. 
 
 




Table 5.1 Screening of the reaction conditions.
a 





1 4b 69 51 18 
2 217 51 38 2 
3 218 40 62 rac 
4 20 65 22 4 
5
d
 78b 70 13 4 
6
e
 219 42 90 -30 
7 QN 50 43 79 50 
8 QD 53 72 57 -44 
9 HQN 52 65 99 54 
10 HQD 55 70 92 -50 
11
f
 HQN 52 48 81 45 
12
g
 HQN 52 8 88 14 
aReaction conditions: 216a (0.1 mmol), cat. (20 mol %), TBHP (1.2 eq.), 
solvent (0.5 mL) at r.t. bIsolated yield after silica gel chromatography. 
cDetermined by chiral HPLC analysis. Negative values indicate the 
preferential formation of the opposite enantiomer. d10 mol % of catalyst was 
used. eReaction conditions: 216a (0.1 mmol), 219 (5 mol %), CHP (1.5 eq.), 
K2HPO3 (50%) (0.5 mL), toluene (1 mL) at 0 °C. 
fCumyl hydroperoxide was 
used. gReaction conditions: 216a (0.1 mmol), HQN (20 mol %), H2O2 (50%) 
(1.2 eq.), MgSO4 (45 mg), toluene (0.5 mL). 
 
Indeed, the expected tertiary alcohol was obtained in 51% yield, 
although with 18% ee (entry 1). Other -aminol alcohols, such as 
the cis- derivative 217 and cis-(1R,2S)-amino indanol 218 afforded 
the almost racemic product (entries 2 and 3). Bifunctional tertiary 
amine-thioureas, such as epi-hydroquinine derived thiourea 78b and 
Takemoto’s thiourea 20, were not suitable catalysts for the process. 
Indeed, product 220a was recovered in low yield and in racemic 
form in both cases (entries 4 and 5). A PTC catalyst, the N-[4-
(trifluoromethyl)benzyl]- cinchoninium bromide 219 was checked 
using CHP as the oxidant at 0 °C (entry 6). The alcohol 220a was 
recovered in high yield and 30% ee. Common cinchona alkaloids 
were then tested and we were pleased to observe that they exhibited 




fairly good catalytic activity and stereocontrol in the model α-
hydroxylation reaction (entries 7-10). In particular, hydroquinine 
proved to be the most efficient promoter, affording the product in 
quantitative yield and 54% ee (entry 9). The effect of different 
oxygen sources was then examinated, although CHP and hydrogen 
peroxide gave inferior results (entries 11 and 12). 
Based on these data, hydroquinine was selected as the catalyst and 
TBHP as the oxidant for further optimization of the reaction 
conditions (Table 5.2). 
 
Table 5.2 Solvent and reaction conditions screening.
a 





1 CH2Cl2 12 90 52 
2 CH2Br2 16 82 52 
3 ClCH2CH2Cl 16 94 49 
4 C6H5Cl 21 89 50 
5 CHCl3 18 97 56 





CHCl3 118 83 76 
aReaction conditions: 216a (0.1 mmol), HQN (20 mol %), TBHP (1.2 eq.), 
solvent (0.5 mL) at r.t. bIsolated yield after silica gel chromatography. 
cDetermined by chiral HPLC analysis. dConversion of 220a determined by 1H 
NMR analysis in absence of the catalyst. eCHCl3 (2 mL) at -20 °C. 
 
By a solvent screening, product ee could be improved working in 
halogenated solvents (entries 1-5). Chloroform proved to be the 
most suitable as the product was isolated in 97% yield and with an 
encouraging level of enantioselectivity (56% ee) (entry 5). We 
checked if the racemic oxidative pathway was a negligible process 
in absence of the catalyst (entry 6). After 22 h the conversion to 
product 220a was only 10%. Finally, the highest ee value of 76% 




was achieved when the α-hydroxylation reaction was conducted at -
20 °C, under more diluted conditions (entry 7).  
Once the reaction conditions were optimized, we investigated the 
substrate scope of the reaction and the results are collected in Table 
5.3. According to the data in Table 5.3, the electronic nature of the 
substituent on the phenyl ring of the indane scaffold has no effect 
on both the yield and enantioselectivity. Higher yield (84-88%) and 
enantioselectivity (up to 83%) were observed for the products 
bearing either halogen atoms or electron-donating groups on the 
aromatic ring of the indane moiety compared to model product 
220a (entries 2-5). 
On the contrary, the substitution pattern at the secondary amido 
moiety affected the outcome of the reaction. The 1-naphthyl 
substituted compound 216f and substrate 216i, bearing an electron-
donating substituent, were converted into the product in almost the 
same manner as the model compound 216a (entries 6 and 9). 
Products 220g-h, bearing electron-withdrawing groups, were 
isolated with slightly lower ee values (entries 7 and 8). Substitution 
of the aromatic with an aliphatic group on the amide, as in 
substrates 216j-k, affected the reaction rate significantly and the 
products were recovered in modest yields and ee (entries 10 and 
11). 
Finally, the presence of the secondary amido functionality in the 



























1 Ph, H, H, 1, a 118 83 (66) 76 (87) 
2 Ph, H, 4-Br, 1, b 115 88 (66) 83 (96) 
3 Ph, H, 5-Cl, 1, c 92 85 79 
4 Ph, H, 5-Br, 1, d 117 87 78 
5 Ph, H, 6-OMe, 1, e 117 84 (60) 81 (98) 
6 1-Naphthyl, H, H, 1, f 64 82 74 
7 2-ClC6H4, H, H, 1, g 111 76 (48) 67 (99) 
8 3-CF3C6H4, H, H, 1, h 93 88 56 
9 4-O(n-pentyl)C6H4, H, H, 1, i 139 89 76 
10
d
 Cyclohexyl, H, H, 1, j 144 37 40 
11
d
 Bn, H, H, 1, k 142 50 29 
12
d
 Bn, Me, H, 1, l 142 - - 
13
d
 Ph, H, H, 2, m 164 - - 
14
d
 216n 160 - - 
aReaction conditions: 216a (0.1 mmol), HQN (20 mol %), TBHP (1.2 eq.), CHCl3 (2 
mL). bIsolated yield after silica gel chromatography. In parenthesis yield after 
crystallization. cDetermined by chiral HPLC analysis. In parenthesis ee after 
crystallization. dReaction performed at r.t. 
 
When substrate 216l, bearing a tertiary amide moiety, was reacted 
under standard conditions, unreacted starting material was observed 
(entry 12). Unfortunately, less reactive tetralone derived 216m and 
acyclic 216n β-ketoamides did not react under optimized conditions 
at room temperature (entries 13 and 14). 




Pleasingly, the ee values could be improved by single 
crystallization up to 99% ee (entries 1, 2, 5 and 7). The absolute 
configuration of the quaternary stereocentre for the tertiary alcohols 
products 220 was assigned to be (2S) in analogy to that determined 
on compound 220b by single-crystal X-ray analysis (Figure 5.3). 
 
 
Figure 5.3 Absolute configuration of (S)-220b by X-ray analysis. 
Ellipsoids set at 30% probability level. 
As shown in entry 12 of Table 5.3, the secondary amido group is 
indispensable for the reactivity. Hence, we anticipated that the 
amidic NH- could be involved in the organization of the transition 
state via H-bonding. 
Miller has previously illustrated the importance of secondary amido 
groups in the asymmetric epoxidation of functionalized alkenes 
promoted by peptide-based catalysts (Scheme 5.23).
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Scheme 5.23 Asymmetric catalytic epoxidation with peptide 223. 
 
The asymmetric epoxidation is based on an electrophilic 
mechanism, orthogonal to the well-known peptide-catalyzed
18,244
 
nucleophilic epoxidation. The authors suggested that a substrate-
catalyst hydrogen bonding complex might contribute to organize 
the transition state. Indeed, a confirmation of a plausible H-bonding 
interaction has been observed when reacting phenylcyclohexene 
224, which was epoxidized without enantiocontrol (10% ee). They 
performed several elegant experiments to study the mode of action 
of catalyst 223 and suggested the hypothetical transition state 
models illustrated in Figure 5.4. 





Figure 5.4 Hypothetical transition structures indicating potential catalyst-
substrate contacts.  
In the attempt to identify potential binding sites of interactions 
between hydroquinine 52 and the β-ketoamide 216a, we recorded 
1
H NMR spectra of HQN at room temperature in CDCl3 adding 
different amounts of compound 216a (up to 3 eq.) (Figure 5.5).  
Signals of the α-hydrogens to the quinuclidine nitrogen (*) appear 
to be broader, increasing the amount of reagent 216a. This result 
would be in agreement with the hypothesis that the quinuclidine 
nitrogen would be protonated by reagent 216a.
245
 A confirmation of 
nitrogen protonation would come from the significant line 
broadening of the β-ketoamide protons between 3.4-4.0 ppm. 
 







H-NMR spectra of HQN recorded with increasing amounts of 
compound 216a in CDCl3 (C 0.1 M) at room temperature. The HQN 
protons which were significantly shifted or broadened are marked with 
symbols. 
 
The carbinolic proton of the hydroquinine was found slightly 
downshifted (○) and the peak of hydroxyl group of the catalyst (**) 
gradually decreased, until it almost disappeared, increasing the 
amount of 216a. This observation would suggested that the OH 
group of the catalyst is likely involved in H-bonding interaction 
with the enolate of compound 216a. Rather surprisingly, we did not 
observe a significant shift of the CONH proton in 216a (signal at 
9.3 ppm). 
In 2011, Rodriguez and Constantieux documented a cooperative 
participation of the amido group in the organocatalytic Michael 









Scheme 5.24 Michael addition of β-ketoamides to methylvinylketone. 
 
In particular, they observed that there was a correlation between the 
acidity of the amide proton and the ee value. Substrates with 
polyaromatic substituents or bearing an electron-withdrawing 
substituent on the aromatic ring of the amide led to high ees. 
Amides bearing an electron-donating group on the aromatic ring 
proved to be the poorest substrates. Theoretical calculations 
confirmed that the ee increased with the acidity of the amide 
proton. The authors highlighted the crucial role of the amide proton 
in the activation of the substrate and proposed that the imidic acidic 
form of the β-ketoamide, in the presence of the bifunctional 
organocatalyst, would aid the deprotonation of the methine proton 
generating a reactive enolate intermediate, stabilized by the thiourea 
moiety (Figure 5.6). 





Figure 5.6 Amide and acidic imide forms of β-ketoamides and transition-
state model for the Michael addition of β-ketoamides. 
In our case, it appears that a comparable correlation between the 
acidity of the amide proton and the enantioselectivity does not hold. 
Indeed substrate 216i, bearing an electron-donating substituent on 
the amidic phenyl ring, was converted into the product similarly to 
model substrate 216a (entries 1 and 9, Table 5.3). Moreover, 
products 220g-h, bearing electron-withdrawing groups, have been 
isolated with slightly lower ee values (entries 7 and 8, Table 5.3). 






In summary, we developed a first enantioselective α-hydroxylation 
reaction of α-substituted β-ketoamides organocatalyzed by a 
bifunctional organocatalyst. The key features of this methodology 
are i) the use of commercially available HQN/TBHP system, which 
makes it very convenient and easy to reproduce; ii) this protocol 
enables a facile access to functionalized tertiary alcohols bearing a 
quaternary stereocentre in good to high yield and up to 83% ee. 
Moreover, the ee values can be improved by a single crystallization 
up to 99% ee. The isolated products bear on the quaternary 








In this PhD work the design, plan and development of new 
organocatalytic methodologies for the synthesis of optically active, 
densely functionalized, organic molecules has been accomplished. 
The molecules obtained are important motifs present in many 
biologically active natural and non-natural substances.  
 Non-covalent activation mode by means of bifunctional 
organocatalysts has been exploited. The design and synthesis of 
new bifunctional promoters has been reported and their catalytic 
ability documented. 
 Another challenging target of this doctoral work has been the 
synthesis of molecules bearing quaternary stereocentres. The 
stereoselective construction of a quaternary stereocentre, especially 
when it is an all-carbon quaternary stereocentre, represents one of 
the most difficult transformations in organic synthesis. 
 The methodologies developed in this PhD work allowed the 
stereocontrolled construction of carbon-carbon and carbon-
heteroatom bonds to give access to new and important cyclic and 
non-cyclic compounds, such as epoxides, tetrahydrothiophenes, γ-
butyrolactones and α-hydroxylate β-ketoamides.  
 A significant part of the PhD work was spent to develop tandem 
organocatalytic methodologies such as Michael/Michael and 
aldol/lactonization process, which allowed the synthesis of chiral 
densely functionalized molecules with a minimum number of 





The contributions given by this PhD work to the field of 
organocatalysis have been the following: 
The first stereoselective cascade sulfa-Michael/Michael reaction to 
access tetrahydrothiophenes from trans-α-carbonyl-β-substituted 
acrylonitriles has been developed. A novel readily available 
secondary amine thiourea proved to be the catalyst of choice. The 
products, bearing three contiguous stereocentres, one of them 
quaternary, were isolated in high yield, good diastereoselectivity 
and excellent enantiocontrol. This work represents an 
unprecedented case where the stereochemical outcome of an 
asymmetric synthesis of tetrahydrothiophenes has been controlled 
exclusively by a dinamic kinetic resolution process. Finally, a 
highly convenient one-pot Knoevenagel/double Michael process, 
starting directly from commercially available reagents and 
involving a minimal number of operations has been demonstrated 
applicable to obtain the tetrahydrothiophenes in comparable 
stereoselectivity. 
 A cascade aldol/lactonization process has been devised for the 
synthesis of enantioenriched β,β-disubstituted γ-butyrolactones. 
This represents the first direct approach to these highly challenging 
products. A variety of acylated succinic esters have been reacted 
with aqueous formaldehyde in the presence of 3 mol % loading of 
cinchona alkaloid derived squaramide and 4-nitrophenol as 
additive. We were able to obtain the γ-butyrolactones, bearing an 
all-carbon quaternary stereocentre at the remote β-position, in high 
yields and fairly good level of enantioselectivity (up to 88% ee). 





valerolactones. Moreover, we demonstrated that these products can 
be elaborated to prepare valuable hydroxy γ-butyrolactones, bearing 
contiguous tertiary and quaternary stereocentres, until now not 
accessible by alternative methods. 
 The first enantioselective synthesis of aromatic α-nitroepoxides, 
exploiting an aminolytic kinetic resolution of racemic aromatic α-
nitroepoxides with aniline catalyzed by an easily accessible 
cinchona alkaloid-derived thiourea, has been set up. The epoxides 
can be recovered in acceptable yield and good to high 
enantioselectivity. We also demonstrated for the first time that 
enantioenriched α-nitroepoxides can be used as synthetically useful 
intermediates: a convenient one-pot stereoselective approach to 
highly valuable anti-1,2-amino alcohols has been described. 
This work highlights the great potential and conceptual novelty on 
the employment of bifunctional organocatalysts in epoxides ring-
opening reactions and it would pave the way for future 
achievements in this underdeveloped area. 
 Finally, the first enantioselective α-hydroxylation reaction of α-
substituted β-ketoamides has been accomplished. This goal has 
been successfully achieved using the commercially available 
HQN/TBHP system, which makes it very convenient and easy to 
reproduce. The functionalized tertiary alcohols bearing a quaternary 
stereocentre were obtained in good to high yield and up to 83% ee. 
Interestingly, the ee values can be eventually improved by a single 
crystallization up to 99% ee. 
 
 




6. EXPERIMENTAL SECTION 
6.1 General experimental conditions  
General methods and material 
All reactions requiring dry or inert conditions were conducted in 
flame dried glassware under a positive pressure of nitrogen. THF 
and DCM were freshly distilled prior to use respectively over 
LiAlH4 and calcium hydride and stored under nitrogen, chloroform 
was dried over molecular sieves. Molecular sieves (Aldrich 
Molecular Sieves 3 Å, 1.6 mm pellets) were activated under 
vacuum at 200 °C overnight.  Reactions were monitored by thin 
layer chromatography (TLC) on Merck silica gel plates (0.25 mm) 
and visualised by UV light and, when necessary, by ninhydrin spray 
test, anisaldehyde or phosphomolybdic acid/ethanol spray test. 
Flash chromatography was performed on Merck silica gel (60, 
particle size: 0.040–0.063 mm). 
1
H NMR and 
13
C NMR spectra 
were recorded on Bruker Avance-400 spectrometer, Bruker 
Avance-300 spectrometer, Bruker Avance-250 or Bruker Avance 
III HD 600 spectrometer in CDCl3, methanol-d4 or DMSO-d6 as 
solvent. Where the temperature has not been specified, the spectra 
were recorded at room temperature. Chemical shifts are reported 
using residual solvent protons (
1
H NMR: δ = 7.26 ppm for CDCl3, 
δH = 3.33 ppm for Methanol-d4, δ = 2.50 ppm for DMSO-d6) as 
internal standard. Carbon spectra were referenced to the shift of the 
13
C signal of CDCl3 (δ= 77.0 ppm) or CD3OD (δ = 49.0 ppm), 
DMSO-d6 (δ = 39.5 ppm). Optical rotation of compounds was 




performed on a Jasco Dip-1000 digital polarimeter using the Na 
lamp (582 nm). FTIR spectra were recorded as thin films on KBr 
plates using Bruker Tensor 27 or Bruker Vertex 70 spectrometer 
and absorption maxima are reported in wavenumber (cm-1). ESI-
MS was performed using a Bio-Q triple quadrupole mass 
spectrometer (Micromass, Manchester, UK) equipped with an 
electrospray ion source. Elemental analyses were carried out by 
using Flash EA 1112 (Thermo Electron Corporation) analyzer. 
Melting points were measured with a Stuart Model SMP 30 melting 
point apparatus or a digital Electrothermal 9100 apparatus. Petrol 
ether (PE) refers to light petroleum ether (boiling point 40-60 °C). 
Anhydrous toluene, 1,2-dichloroethane, methanol and all starting 
materials (unless otherwise noted) were purchased from Aldrich 
and used as received. Catalysts 104, 78, 102 were synthesized 
according to literature procedure.
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 Cinchona alkaloids 50-55 were 
purchased from Aldrich and used as received. Catalysts 4a, 4b, 4c, 
103, 186, (DHQD)2PHAL 101, 218, 219, 217 were purchased from 
Aldrich and 20 from Strem Chemicals and used as received. 
Enantiomeric excess of tetrahydrothiophenes 100a-o, γ-
butyrolactones 143a-q, 145 and compounds 148j and 147f,  α-
nitroepoxides 184a, 184e-m, 185a and 1,2-amino alcohol 189, 
compounds 220  was determined by HPLC (Waters-Breeze 2487, 
UV dual λ absorbance detector and 1525 Binary HPLC Pump) 









6.2 Asymmetric synthesis of tetrahydrothiophenes bearing a 
quaternary stereocentre 
Experimental procedures and compounds characterization  
Alkenes 99 were synthesized via Knoevenagel reactions as reported 
in the literature.
248
 Compounds 76 were prepared using general 
procedures reported in the literature.
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Synthesis of catalyst 105  
 
Under a positive pressure of nitrogen, a flamed two necked round 
bottom flask was charged with anhydrous DCM (20 mL), (1R,2R)-
(+)-1,2-diphenylethylenediamine 106 (425 mg, 2 mmol), and 
cyclohexanone (622 μL, 6 mmol). Molecular sieves were then 
added (≈ 50 mg) and the mixture was stirred overnight at room 
temperature (TLC eluent CHCl3/ MeOH 9:1). Then, the solvent was 
removed under reduced pressure, anhydrous MeOH was added (40 
mL) followed by addition of NaBH4 (309 mg, 8 mmol) portionwise 
under nitrogen atmosphere. The mixture was stirred until 




completion at room temperature (TLC eluent CHCl3/ MeOH 9:1). 
The solvent was removed under reduced pressure and the residue 
was diluted with ethyl acetate (30 mL) and washed with water (3 x 
40 mL). The organic layer was dried over anhydrous Na2SO4 and 
then the solvent was removed under vacuum. The product was 
isolated by flash chromatography (eluent: PE/ ethyl acetate 8:2, 
then CHCl3 to CHCl3/ MeOH 9:1) to give (1R,2R)-N
1
-cyclohexyl-
1,2-diphenylethane-1,2-diamine 107 as a viscous pale yellow oil 
(489 mg, 83%). Spectral data for this compound were consistent 





-cyclohexyl-1,2-diphenylethane-1,2-diamine (489 mg, 
1.7 mmol) 107 was dissolved in anhydrous DCM (9 mL) in a 
flamed two necked round bottom flask under a positive pressure of 
nitrogen. The solution was cooled to 0 °C and 3,5-
bis(trifluoromethyl)phenyl isothiocyanate 108 (310 μL, 1.7 mmol) 
was added via syringe dropwised in 15 minutes. The reaction 
mixture was stirred at room temperature for 3 hours and after 
completion, monitored by TLC (eluent PE/ diethyl ether 8:2), the 
solvent was removed under reduced pressure. The product was 
purified by flash chromatography (PE/ ethyl acetate 8:2, then 












Pale yellow solid, mp 57.3-60.7 °C. 
[α]D
21
 = +8.7 (c 0.7, CHCl3). FTIR max 
(KBr)/cm
-1
 2930, 2855, 1496, 1473, 
1384, 1278, 1219, 1177, 1135, 773. 
1
H 
NMR (CD3OD, 400 MHz): δ 8.21 (s, 
2H), 7.64 (s, 1H), 7.45-7.21 (m, 11H), 5.66 (bs, 1H), 4.33 (d, 1H, 
J= 6.5 Hz), 2.30-2.25 (m, 1H), 1.91-1.53 (m, 6H), 1.17-0.89 (m, 
6H). 
13
C NMR (CD3OD, 100 MHz): δ 182.8, 143.2, 141.7, 141.0, 
132.6 (q, 
2
JCF= 33.1 Hz), 129.32, 129.27, 129.2, 128.4, 128.3, 124.7 
(q, 
1
JCF= 270.3 Hz, CF3), 123.5, 117.8, 65.1, 64.7, 54.6, 35.2, 33.0, 
27.1, 26.1, 25.7. MS (ESI m/z) 566.19 [MH+, 100%]. 
 
General procedure for the synthesis of racemic 
tetrahydrothiophenes 100  
A sample vial was charged with the appropriate (E)-alkyl 4-
mercaptobut-2-enoate 76 (0.13 mmol) and compound 99 (0.10 
mmol) in anhydrous toluene (1.0 mL) under a nitrogen atmosphere. 
1,4- Diazabicyclo[2.2.2]octane (5.6 mg, 0.05 mmol) was added and 
the solution was stirred at room temperature until completion (22-
113 hours), monitored by TLC (eluent PE/ ethyl acetate 90:10). The 
diastereoisomeric ratio was determined by 
1
H-NMR analysis of the 
crude reaction mixture. The product was isolated by flash 
chromatography (eluting in gradient from PE/ ethyl acetate 98:2 to 
90:10).  




General procedure for the asymmetric synthesis of 
tetrahydrothiophenes 100  
Under a nitrogen atmosphere, a sample vial was charged with the 
appropriate (E)-alkyl 4- mercaptobut-2-enoate 76 (0.13 mmol) and 
compound 99 (0.10 mmol) in anhydrous toluene (1.0 mL).  
Catalyst 105 (5.7 mg, 0.01 mmol) was added and the reaction 
mixture was stirred at room temperature until completion, 
monitored by TLC (eluent PE/ ethyl acetate 90:10). The 
diastereoisomeric ratio was determined by 
1
H-NMR analysis of the 
crude reaction mixture. The crude mixture of compound 100 was 
purified by flash chromatography (eluting from PE/ ethyl acetate 
98:2 to 90:10) to isolate the major and minor diastereomers or their 
mixture. The diastereoisomeric ratios obtained with catalyst 105 are 
inverted compared to those obtained when using the DABCO. The 
absolute configuration of the major diastereoisomers of compounds 
100a-m was assigned to be (3S,4R,5S) by analogy to the structure 
determined by single-crystal X-ray analysis performed on the major 
diastereoisomer of compound 100i (see the X-ray analysis section). 
The relative configuration of racemic minor diastereomer of 
compounds 100a-m was assigned to be (3S*,4S*,5R*) by analogy 
to the structure determined by single-crystal X-ray analysis 
performed on the minor diastereomer of compound 100e (see the 








Asymmetric one-pot sequential synthesis of 
tetrahydrothiophene 100b 
 
In a two necked round bottom flask containing anhydrous toluene 
(4 mL) and molecular sieves (≈ 20 mg), benzoylacetonitrile 96a (73 
mg, 0.50 mmol), benzaldehyde 97a (51 μL, 0.50 mmol) and 
piperidine (1 μL, 2 mol %) were added. The reaction was stirred at 
80 °C for 9 hours monitored by TLC till the formation of alkene 
99a was complete (eluent PE/ ethyl acetate 8:2). The reaction 
mixture was allowed to cool up to room temperature, then (E)-tert-
butyl 4-mercaptobut-2-enoate 76b (113 mg, 0.65 mmol), dissolved 
in 1 mL of anhydrous toluene, was added to the reaction mixture 
together with catalyst 105 (42.4 mg, 0.075 mmol). The reaction 
mixture was stirred at room temperature until completion as 
monitored by TLC (eluent PE/ ethyl acetate 9:1). The reaction 
mixture was purified by flash chromatography (eluent PE/ ethyl 












White wax, 30.3 mg, 80% yield. The 
diastereoisomeric ratio was found to be 
4:1 by 
1
H-NMR analysis. FTIR max 
(KBr)/cm
-1
 2932, 2237, 1734, 1684, 
1597, 1447, 1378, 1278, 1235, 1135, 1024, 699. MS (ESI m/z) 
380.12 [MH+, 15%], 402.10 [MNa+, 100%], 418.16 [MK+, 20%].  
1
H NMR (CDCl3, 400 MHz): δ 8.08 (d, 2H, J= 7.6 Hz), 7.71 (d, 
2H, J= 7.6 Hz), 7.61 (t, 1H, J= 7.5 Hz) [minor diast.: 7.56 (d, 
0.27H, J= 7.2 Hz)], 7.50-7.46 (m, 2H), 7.37-7.29 (m, 3H) [minor 
diast.: 7.23-7.18 (m, 0.44H)], 5.39 (s, 1H) [minor diast.: 5.02 (s, 
0.22H), 4.22 (q, 0.42H, J= 7.0 Hz), 4.15- 4.12 (m, 0.22H)], 4.08 (q, 
2H, J= 7.1 Hz), 3.94 (dd, 1H, J1= 11.0, J2= 5.8 Hz), 3.82-3.77 (m, 
1H) [minor diast.: 3.53 (dd, 0.22H, J1= 11.0 Hz, J2= 7.7 Hz), 3.20 
(t, 0.22H, J= 11.0 Hz ], 3.08 (dd, 1H, J1= 11.4, J2= 2.0 Hz), 2.83 
(dd, 1H, J1= 16.9, J2= 10.0 Hz) [minor diast.: 2.62 (dd, 0.22H, J1= 
15.6 Hz, J2= 9.7 Hz), 2.52 (dd, 0.23H, J1= 15.3 Hz, J2= 4.6 Hz)], 
2.42 (dd, 1H, J1= 16.9, J2= 2.8 Hz) [minor diast.: 1.31 (t, 0.67H, J= 
7.5 Hz)], 1.21 (t, 3H, J= 7.2 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 
190.5, 170.8 [minor diast.: 170.2], 135.4, 134.4, 134.3 [minor 
diast.: 133.8, 133.5], 129.8 [minor diast.: 129.6], 129.2 [minor 
diast.: 129.1, 128.9], 128.8, 128.7, 128.3 [minor diast.: 128.1], 
118.2, 64.8 [minor diast.: 67.3], 61.11 [minor diast.: 61.06, 60.0], 
53.8, 48.8 [minor diast.: 49.8], 35.8 [minor diast.: 35.7, 33.8], 33.6, 
14.0 [minor diast.: 14.2].  




HPLC analysis with Chiralpak IC column, 90:10 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 




Yellow wax, 38.3 mg, 94% yield. The 
diastereoisomeric ratio was found to be 9:1 
by 
1
H-NMR analysis.  FTIR max 
(KBr)/cm
-1 
2977, 2931, 2237, 1728, 1680, 









H NMR (CDCl3, 400 MHz): δ 8.07 (d, 2H, J= 7.7 Hz), 7.72 (d, 
2H, J= 7.4 Hz), 7.60 (t, 1H, J= 7.3 Hz) [minor diast.: 7.56 (d, 
0.22H, J= 7.6 Hz)], 7.49-7.46 (m, 2H), 7.37-7.30 (m, 3H) [minor 
diast.: 7.23-7.21 (m, 0.22H)], 5.40 (s, 1H) [minor diast.: 5.03 (s, 
0.11H)], 3.93 (dd, 1H, J1= 11.2, J2= 5.9 Hz), 3.81-3.76 (m, 1H) 
[minor diast.: 3.73-3.69 (m, 0.12H), 3.51 (dd, 0.12H, J1= 10.8 Hz, 
J2= 7.4 Hz ), 3.19 (t, 0.11H, J= 10.9 Hz)], 3.05 (dd, 1H, J1= 11.2, 
J2= 2.8 Hz), 2.72 (dd, 1H, J1= 16.7, J2= 9.9 Hz) [minor diast.: 2.53 
(dd, 0.12H, J1= 15.9, J2= 10.3 Hz), 2.44 (dd, 0.12H, J1= 15.9, J2= 
3.8 Hz)], 2.35 (dd, 1H, J1= 16.8, J2= 3.5 Hz) [minor diast.: 1.44 (s, 
1.07H)], 1.38 (s, 9H). 
13
C NMR (CDCl3, 100 MHz): δ 190.6 [minor 
diast.: 193.7], 170.0 [minor diast.: 169.3, 136.0], 135.4, 134.5, 
134.2 [minor diast.: 133.9], 129.8 [minor diast.: 129.5], 129.2 
[minor diast.: 129.1, 128.9], 128.8, 128.7, 128.3 [minor diast.: 
128.0], 118.4 [minor diast.: 117.1], 81.7 [minor diast.: 81.5, 67.5], 




64.9 [minor diast.: 60.0], 53.9 [minor diast.: 50.1], 49.0, 35.8 
[minor diast.: 36.9], 34.8 [minor diast.: 33.7], 27.9. 
HPLC analysis with Chiralpak IC column, 98:2 n-hexane:2-
propanol, 0.7 mL/min, detection at 254 nm; major diast.: minor 





Pale yellow wax, 32.9 mg, 90% yield. The 
diastereoisomeric ratio was found to be 4:1 
by 
1
H-NMR analysis.  FTIR max (KBr)/cm
-
1 
2927, 2237, 1738, 1679, 1597, 1447, 





H NMR (CDCl3, 400 MHz): δ 8.08 (d, 2H, J= 7.3 Hz), 7.71 (d, 
2H, J= 6.8 Hz), 7.61 (t, 1H, J= 7.3 Hz) [minor diast.: 7.56 (d, 
0.46H, J= 7.0 Hz)], 7.50-7.46 (m, 2H), 7.36-7.31 (m, 3H), 5.39 (s, 
1H) [minor diast.: 5.01 (s, 0.23H)], 3.93 (dd, 1H, J1= 10.7, J2= 5.2 
Hz), 3.82-3.79 (m, 1H) [minor diast.: 3.73-3.71 (m, 0.20H), 3.68 (s, 
0.62H)], 3.63 (s, 3H) [minor diast.: 3.54-3.50 (m, 0.23H), 3.20 (t, 
0.22H, J= 11.0 Hz)], 3.07 (d, 1H, J= 9.8 Hz), 2.86 (dd, 1H, J1= 
16.9, J2= 9.6 Hz) [minor diast.: 2.66-2.55 (m, 0.46H)], 2.44 (d, 1H, 
J1= 16.6 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 190.5 [minor diast.: 
193.5], 171.3 [minor diast.: 170.6, 135.8], 135.4, 134.3 [minor 
diast.: 133.8], 129.8 [minor diast.: 129.6], 129.2 [minor diast.: 
129.1, 128.9], 128.8, 128.7, 128.3 [minor diast.: 128.1], 118.2 




[minor diast.: 117.0, 67.2], 64.7 [minor diast.: 60.0], 53.8, 52.1 
[minor diast.: 51.7, 49.7], 48.7, 35.8 [minor diast.: 35.4, 33.8], 33.3. 
HPLC analysis with Chiralpak IC column, 90:10 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 




Pale yellow wax, 30.6 mg, 70% 
yield. The diastereoisomeric ratio 
was found to be 12:1 by 
1
H-NMR 
analysis. FTIR max (KBr)/cm
-1 
2926, 
2235, 1728, 1680, 1610, 1512, 1447, 1368, 1252, 1158, 1033, 836, 
772, 694. MS (ESI m/z) 438.21 [MH
+







H NMR (CDCl3, 400 MHz): δ 8.06 (d, 2H, J= 7.4 Hz), 7.64 (d, 
2H, J= 8.8 Hz), 7.60 (t, 1H, J= 7.4 Hz), 7.49-7.45 (m, 2H) [minor 
diast.: 7.30-7.28 (m, 0.10H), 7.25-7.22 (m, 0.09H)], 6.86 (d, 2H, J= 
8.8 Hz) [minor diast.: 6.83 (d, 0.18H J= 8.9 Hz)],  5.37 (s, 1H) 
[minor diast.: 5.01 (s, 0.09H)], 3.91 (dd, 1H, J1= 11.2, J2= 5.9 Hz), 
3.79-3.75 (m, 4H) [minor diast.: 3.71-3.68 (m, 0.09H), 3.48 (dd, 
0.09H, J1= 10.8, J2= 7.1 Hz), 3.17 (t, 0.09H, J= 11.0 Hz)], 3.02 (dd, 
1H, J1= 11.2, J2= 2.9 Hz), 2.70 (dd, 1H, J1= 16.8, J2= 10.0 Hz) 
[minor diast.: 2.53 (dd, 0.09H, J1= 15.7, J2= 10.1 Hz), 2.44 (dd, 
0.09H, J1= 15.7, J2= 4.4 Hz)], 2.33 (dd, 1H, J1= 16.8, J2= 3.5 Hz), 
1.38 (s, 9H) [minor diast.: 1.44 (s, 0.82H)]. 
13
C NMR (CDCl3, 75 
MHz): δ 190.7 [minor diast.: 194.0], 170.0 [minor diast.: 169.4, 




160.4], 159.9 [minor diast.: 136.1], 134.6, 134.2 [minor diast.: 
133.4], 131.0 [minor diast.: 130.3], 129.2 [minor diast.: 128.9], 
128.7 [minor diast.: 128.1], 127.0 [minor diast.: 125.6], 118.5 
[minor diast.: 117.3, 114.1], 113.6, 81.7 [minor diast.: 81.6, 67.6], 
65.0 [minor diast.: 59.5, 55.3], 55.2, 53.4 [minor diast.: 50.0], 48.9 
[minor diast.: 37.0], 35.8, 34.8 [minor diast.: 33.7, 29.7], 28.0. 
HPLC analysis with Chiralpak ADH column, 90:10 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 




32.4 mg, 70% yield. The 
diastereoisomeric ratio was found to be 
7:1 by 
1
H-NMR analysis. FTIR max 
(KBr)/cm
-1 
2967, 2869, 2237, 1727, 
1681, 1646, 1448, 1368, 1235, 1152, 
760, 699, 660. MS (ESI m/z) 486.50 [MNa
+




Major diast.: waxy pale yellow solid. [α]D
22
 = -78.9 (c 0.6, 
CHCl3), ee = 99%. 
1
H NMR (CDCl3, 400 MHz): δ 8.09 (d, 2H, J= 8.0 Hz), 7.63 (d, 
2H, J= 8.4 Hz), 7.62-7.58 (m, 1H), 7.49-7.45 (m, 2H), 7.35 (d, 2H, 
J= 8.4 Hz),  5.36 (s, 1H), 3.92 (dd, 1H, J1= 11.1, J2= 6.2 Hz), 3.81-
3.76 (m, 1H), 3.03 (dd, 1H, J1= 11.1, J2= 3.0 Hz), 2.72 (dd, 1H, J1= 
16.7, J2= 10.2 Hz), 2.33 (dd, 1H, J1= 16.7, J2= 3.5 Hz), 1.38 (s, 9H), 
1.29 (s, 9H). 
13
C NMR (CDCl3, 100 MHz): δ 190.4, 170.0, 151.7, 




134.4, 134.2, 132.2, 129.5, 129.3, 128.6, 125.2, 118.5, 81.6, 64.8, 
53.5, 48.9, 35.7, 34.8, 34.5, 31.2, 27.9. 
HPLC analysis with Chiralpak ADH column, 95:5 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 
enantiomer tR = 5.1 min, major enantiomer tR = 5.7 min, ee = 99%. 
Minor diast.: white solid, mp 114.9-115.7 °C.  
1
H NMR (CDCl3, 400 MHz): δ 7.48 (d, 2H, J= 8.4 Hz), 7.43-7.39 
(m, 1H), 7.32 (d, 2H, J= 8.4 Hz), 7.17-7.16 (m, 4H), 4.97 (s, 1H), 
3.79-3.70 (m, 1H), 3.50 (dd, 1H, J1= 10.7, J2= 7.2 Hz), 3.18 (t, 1H, 
J= 11.0 Hz), 2.52 (dd, 1H, J1= 15.6, J2= 10.0 Hz), 2.44 (dd, 1H, J1= 
15.6, J2= 4.4 Hz), 1.44 (s, 9H), 1.29 (s, 9H). 
13
C NMR (CDCl3, 100 
MHz): δ 193.7, 169.4, 153.0, 135.9, 133.3, 130.8, 129.0, 128.8, 





Colourless wax, 47.2 mg, 97% yield. 
The diastereoisomeric ratio was found 
to be 10:1 by 
1
H-NMR analysis. FTIR 
max (KBr)/cm
-1 
2931, 2237, 1729, 1680, 
1488, 1447, 1368, 1239, 1158, 1075, 1011, 759, 653. MS (ESI m/z) 
429.77 [M-C(CH3)3+2H
+




H NMR (CDCl3, 400 MHz): δ 8.06 (d, 2H, J= 7.6 Hz), 7.62-7.60 
(m, 3H), 7.50-7.43 (m, 4H), 5.37 (s, 1H) [minor diast.: 5.02 (s, 
0.09H)], 3.94 (dd, 1H, J1= 10.7, J2= 5.7 Hz), 3.84-3.78 (m, 1H) 
[minor diast.: 3.53-3.48 (m, 0.08H), 3.38 (d, 0.10H, J= 8.2 Hz), 




3.22-3.16 (m, 0.09H)], 3.04 (dd, 1H, J1= 11.3, J2= 2.4 Hz), 2.66 
(dd, 1H, J1= 16.6, J2= 9.9 Hz) [minor diast.: 2.54-2.47 (m, 0.20H)], 
2.35-2.26 (m, 1H) [minor diast.: 1.43 (s, 0.85H)], 1.37 (s, 9H). 
13
C 
NMR (CDCl3, 75 MHz): δ 190.3, 169.8, 134.4 [minor diast.: 133.7, 
131.9], 131.6, 131.4 [minor diast.: 130.7], 129.2 [minor diast.: 
128.9], 128.7 [minor diast.: 128.2], 122.9, 118.2, 81.8, 65.0 [minor 
diast.: 67.2, 59.1], 53.0 [minor diast.: 50.2], 49.1, 36.0 [minor 
diast.: 36.9], 34.7 [minor diast.: 33.9], 27.9. 
HPLC analysis with Chiralpak ADH column, 90:10 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 




Colourless wax, 47.7 mg, 98% yield. The 
diastereoisomeric ratio was found to be 
10:1 by 
1
H-NMR analysis. FTIR max 
(KBr)/cm
-1 
2929, 1728, 1678, 1635, 1447, 
1368, 1237, 1156, 1074, 757, 695. MS 




H NMR (CDCl3, 400 MHz): δ 8.08 (d, 2H, J= 7.4 Hz), 7.86 (t, 1H, 
J= 1.6 Hz), 7.68 (d, 1H, J= 7.9 Hz), 7.61 (t, 1H, J= 7.4 Hz), 7.51-
7.47 (m, 2H), 7.44-7.42 (m, 1H) [minor diast.: 7.38 (d, 0.10H, J= 
7.2 Hz), 7.29 (d, 0.20H, J= 8.2 Hz)], 7.21 (t, 1H, J= 7.9 Hz), 5.37 
(s, 1H) [minor diast.: 5.00 (s, 0.10H)], 3.95 (dd, 1H, J1= 11.2, J2= 
5.7 Hz), 3.85-3.80 (m, 1H) [minor diast.: 3.75-3.66 (m, 0.10H), 
3.51 (dd, 0.10H, J1= 10.7, J2= 6.9 Hz), 3.19 (t, 0.11H, J= 11.0 Hz)], 




3.04 (dd, 1H, J1= 11.3, J2= 2.3 Hz), 2.66 (dd, 1H, J1= 16.8, J2= 9.9 
Hz) [minor diast.: 2.56 (dd, 0.10H, J1= 15.8, J2= 10.0 Hz), 2.47 (dd, 
0.11 H, J1= 15.7, J2= 4.5 Hz)], 2.28 (dd, 1H, J1= 16.8, J2= 3.8 Hz) 
[minor diast.: 1.44 (s, 0.91H)], 1.37 (s, 9H). 
13
C NMR (CDCl3, 100 
MHz): δ 190.2, 169.8, 137.7, 134.4, 134.3, 133.0 [minor diast.: 
133.7, 132.6, 132.2], 131.9 [minor diast.: 130.2], 129.8, 129.3 
[minor diast.: 128.9], 128.7, 128.6 [minor diast.: 128.3, 127.8], 
122.2, 118.1, 81.8, 65.0 [minor diast.: 59.0], 53.0 [minor diast.: 
50.2], 49.2, 36.0 [minor diast.: 36.9], 34.7 [minor diast.: 33.9], 27.9. 
HPLC analysis with Chiralpak ADH column, 90:10 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 




42.4 mg, 98% yield. The 
diastereoisomeric ratio was found to be 
9:1 by 
1
H-NMR analysis. FTIR max 
(KBr)/cm
-1
 2927, 2230, 1728, 1681, 
1597, 1447, 1368, 1236, 1157, 839, 759, 694, 657. MS (ESI m/z) 
454.64 [MNa
+
, 50%], 470.99 [MK
+
, 40%].  
Major diast.: white solid, mp 130.8-132.7 °C. [α]D
24
 = -78.5 (c 0.5, 
CHCl3), ee = 99%.   
1
H NMR (CDCl3, 300 MHz): δ 8.10-8.07 (m, 2H), 7.87 (d, 2H, J= 
8.5 Hz), 7.66-7.61 (m, 3H), 7.52-7.47 (m, 2H), 5.47 (s, 1H), 3.99 
(dd, 1H, J1= 11.3, J2= 5.5 Hz), 3.91-3.86 (m, 1H), 3.07 (dd, 1H, J1= 
11.3, J2= 1.8 Hz), 2.65 (dd, 1H, J1= 16.8, J2= 9.9 Hz), 2.24 (dd, 1H, 




J1= 16.8, J2= 3.9 Hz), 1.37 (s, 9H). 
13
C NMR (CDCl3, 100 MHz): δ 
189.9, 169.6, 140.8, 134.7, 134.1, 132.0, 130.9, 129.3, 128.9, 118.4, 
117.9, 112.7, 82.0, 65.2, 53.0, 49.4, 36.2, 34.6, 27.9.  
HPLC analysis with Chiralpak ADH column, 90:10 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 
enantiomer tR = 17.3 min, major enantiomer tR = 12.6 min, ee = 
99%. 
Minor diast.: waxy white solid. 
1
H NMR (CDCl3, 400 MHz): δ 
7.66 (d, 2H, J= 8.3 Hz), 7.59 (d, 2H, J= 8.3 Hz), 7.50 (t, 1H, J= 7.4 
Hz), 7.39-7.38 (m, 2H), 7.30-7.28 (m, 2H), 5.11 (s, 1H), 3.73-3.68 
(m, 1H), 3.53 (dd, 1H, J1= 10.8, J2= 7.0 Hz), 3.22 (t, 1H, J= 11.0 
Hz), 2.56 (dd, 1H, J1= 15.8, J2= 9.8 Hz), 2.48 (dd, 1H, J1= 15.8, J2= 
4.6 Hz), 1.42 (s, 9H). 
13
C NMR (CDCl3, 100 MHz): δ 192.8, 169.1, 
139.6, 135.7, 134.0, 132.4, 130.0, 128.8, 128.4, 118.1, 116.7, 113.2, 




44.3 mg, 98% yield. The 
diastereoisomeric ratio was found to be 
9:1 by 
1
H-NMR analysis. FTIR max 
(KBr)/cm
-1 
2937, 1727, 1677, 1636, 
1525, 1447, 1368, 1349, 1236, 1156, 756, 697. MS (ESI m/z) 
475.13 [MNa
+
, 42%], 491.33 [MK
+
, 15%]. 
Major diast.: white solid, mp 122.0-125.0 °C.  [α]D
22
 = -92.3 (c 
0.8, CHCl3), ee >99%. 
1
H NMR (CDCl3, 400 MHz): δ 8.19 (d, 2H, J= 8.8 Hz), 8.09 (d, 




2H, J= 7.5 Hz), 7.94 (d, 2H, J= 8.8 Hz), 7.63 (t, 1H, J= 7.5 Hz), 
7.51-7.47 (m, 2H), 5.53 (s, 1H), 4.02 (dd, 1H, J1= 11.4, J2= 5.6 Hz), 
3.92-3.89 (m, 1H), 3.08 (d, 1H, J= 11.4 Hz), 2.66 (dd, 1H, J1= 16.8, 
J2= 10.0 Hz), 2.25 (dd, 1H, J1= 16.8, J2= 3.7 Hz), 1.37 (s, 9H).  
13
C NMR (CDCl3, 100 MHz): δ 189.8, 169.5, 148.0, 142.7, 134.7, 
134.0, 131.2, 129.3, 128.8, 123.3, 117.8, 82.0, 65.2, 52.7, 49.4, 
36.3, 34.5, 27.9. 
 HPLC analysis with Chiralpak ADH column, 98:2 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: major 
enantiomer tR = 34.4 min, ee >99%. 
Minor diast.: colourless waxy solid. 
1
H NMR (CDCl3, 400 MHz): 
δ 8.16 (d, 2H, J= 8.8 Hz), 7.73 (d, 2H, J= 8.8 Hz), 7.52-7.43 (m, 
3H), 7.31-7.29 (m, 2H), 5.19 (s, 1H), 3.76-3.67 (m, 1H), 3.55 (dd, 
1H, J1= 10.8, J2= 7.0 Hz), 3.24 (t, 1H, J= 11.0 Hz), 2.59 (dd, 1H, 
J1= 15.9, J2= 9.8 Hz), 2.50 (dd, 1H, J1= 15.9, J2= 4.6 Hz), 1.43 (s, 
9H). 
13
C NMR (CDCl3, 100 MHz): δ 192.8, 169.1, 148.4, 141.6, 
135.8, 134.1, 130.3, 128.8, 128.5, 123.8, 116.7, 81.9, 66.9, 58.7, 




38.9 mg, 85% yield. The 
diastereoisomeric ratio was found to 
be 9:1 by 
1
H-NMR analysis. FTIR 
max (KBr)/cm
-1
 2930, 2237, 1728, 
1678, 1597, 1447, 1368, 1238, 1156, 755, 694. MS (ESI m/z) 
480.19 [MNa
+
, 28%], 496.19 [MK
+
, 28%]. 




Major diast.: yellow solid, mp 63.5-65.7 °C. [α]D
21
 = -53.9 (c 0.7, 
CHCl3), ee >99%. 
1
H NMR (CDCl3, 400 MHz): δ 8.18 (s, 1H), 8.07 (d, 2H, J= 7.8 
Hz), 7.88-7.79 (m, 4H), 7.58 (t, 1H, J= 7.5 Hz), 7.48-7.44 (m, 4H), 
5.58 (s, 1H), 4.00 (dd, 1H, J1= 11.0, J2= 6.0 Hz), 3.88-3.82 (m, 1H), 
3.10 (dd, 1H, J1= 11.1, J2= 3.0 Hz), 2.76 (dd, 1H, J1= 16.8, J2= 9.9 
Hz), 2.39 (dd, 1H, J1= 16.9, J2= 3.7 Hz), 1.39 (s, 9H). 
13
C NMR 
(CDCl3, 100 MHz): δ 190.7, 170.0, 134.5, 134.2, 133.4, 132.9, 
132.7, 129.5, 129.2, 128.6, 128.2, 127.9, 127.5, 127.1, 126.5, 126.2, 
118.5, 81.7, 65.0, 54.0, 49.2, 36.0, 34.8, 28.0. 
HPLC analysis with Chiralpak IC column, 98:2 n-hexane:2-
propanol, 0.7 mL/min, detection at 254 nm; major diast.: major 
enantiomer tR = 21.6 min, ee > 99%. 
Minor diast.: pale yellow solid, mp 143.7-144.7 °C. 
1
H NMR (CDCl3, 400 MHz): δ 8.00 (s, 1H), 7.82-7.75 (m, 3H), 
7.68 (dd, 1H, J1= 8.5, J2= 1.8 Hz), 7.51-7.44 (m, 2H), 7.36-7.32 (m, 
1H), 7.28-7.27 (m, 1H), 7.26-7.25 (m, 1H), 7.11-7.07 (m, 2H), 5.24 
(s, 1H), 3.83-3.75 (m, 1H), 3.56 (dd, 1H, J1= 10.8, J2= 7.0 Hz), 3.25 
(t, 1H, J= 11.0 Hz), 2.57 (dd, 1H, J1= 15.7, J2= 10.2 Hz), 2.48 (dd, 
1H, J1= 15.7, J2= 4.4 Hz), 1.45 (s, 9H). 
13
C NMR (CDCl3, 100 
MHz): δ 193.9, 169.4, 136.0, 133.7, 133.4, 133.0, 131.3, 128.8, 
128.6, 128.2, 128.1, 127.6, 126.7, 126.5, 126.2, 117.2, 81.6, 67.5, 











28.6 mg, 72% yield. The diastereoisomeric 
ratio was found to be 9:1 by 
1
H-NMR 
analysis. FTIR max (KBr)/cm
-1 
2931, 
2237, 1728, 1677, 1598, 1447, 1368, 1239, 
1159, 1023, 874, 695. MS (ESI m/z) 420.20 [MNa
+
, 100%]. 
Major diast.: white solid, mp 109.0-110.4 °C. [α]D
22
 = -82.8 (c 0.6, 
CHCl3), ee = 99%. 
1
H NMR (CDCl3, 400 MHz): δ 8.12 (d, 2H, J= 7.7 Hz), 7.65-7.61 
(m, 2H), 7.52-7.48 (m, 2H), 7.35 (bs, 1H), 6.62 (bs, 1H), 5.31 (s, 
1H), 3.89 (dd, 1H, J1= 11.2, J2= 5.8 Hz), 3.82-3.78 (m, 1H), 2.98 
(dd, 1H, J1= 11.2, J2= 1.6 Hz), 2.59 (dd, 1H, J1= 16.7, J2= 10.0 Hz), 
2.21 (dd, 1H, J1= 16.7, J2= 3.6 Hz), 1.36 (s, 9H). 
13
C NMR (CDCl3, 100 MHz): δ 190.3, 169.8, 143.1, 142.5, 134.5, 
134.3, 129.3, 128.8, 120.7, 118.3, 110.9, 81.8, 64.5, 48.5, 45.3, 
35.5, 34.7, 27.9. HPLC analysis with Chiralpak ADH column, 
90:10 n-hexane:2-propanol, 1 mL/min, detection at 254 nm; major 
diast.: minor enantiomer tR = 7.1 min, major enantiomer tR = 6.3 
min, ee = 99%. 
Minor diast.: pale yellow solid, mp 81.2-83.7 °C. 
1
H NMR (CDCl3, 400 MHz): δ 7.64-7.61 (m, 2H), 7.56-7.52 (m, 
1H), 7.44-7.35 (m, 4H), 6.66 (d, 1H, J= 1.2 Hz), 4.98 (s, 1H), 3.68-
3.60 (m, 1H), 3.46 (dd, 1H, J1= 10.7, J2= 7.2 Hz), 3.13 (t, 1H, 11.0 
Hz), 2.54 (dd, 1H, J1= 15.8, J2= 9.7 Hz), 2.47 (dd, 1H, J1= 15.8, J2= 
4.8 Hz), 1.42 (s, 9H). 
13
C NMR (CDCl3, 100 MHz): δ 193.6, 169.3, 
143.8, 142.0, 136.1, 133.7, 129.0, 128.3, 119.7, 117.3, 110.4, 81.6, 








42.4 mg, 96% yield. The 
diastereoisomeric ratio was found to be 
5:1 by 
1
H-NMR analysis. FTIR max 
(KBr)/cm
-1
 2932, 2236, 1729, 1683, 
1645, 1455, 1368, 1233, 1159, 759, 700.  MS (ESI m/z) 441.89 
[MH
+
, 15%], 464.26 [MNa
+
, 52%]. 
Major diast.: pale yellow wax. [α]D
21
 = -86.2 (c 1.0, CHCl3), ee = 
98%. 
1
H NMR (CDCl3, 400 MHz): δ 7.98 (d, 1H, J= 8.1 Hz), 7.94 (s, 
1H), 7.69 (d, 2H, J= 7.4 Hz), 7.56 (d, 1H, J= 8.3 Hz), 7.42 (t, 1H, 
J= 8.0 Hz), 7.38-7.30 (m, 3H), 5.35 (s, 1H), 3.92 (dd, 1H, J1= 11.4, 
J2= 5.8 Hz), 3.78-3.72 (m, 1H), 3.04 (dd, 1H, J1= 11.2, J2= 3.0 Hz), 
2.71 (dd, 1H, J1= 17.0, J2= 9.5 Hz), 2.38 (dd, 1H, J1= 17.0, J2= 4.5 
Hz), 1.39 (s, 9H).  
13
C NMR (CDCl3, 100 MHz): δ 189.9, 169.8, 136.1, 135.1, 134.0, 
129.8, 129.7, 129.2, 128.9, 128.4, 127.0, 118.1, 81.7, 65.0, 54.0, 
48.9, 35.9, 34.9, 27.9. 
 HPLC analysis with Chiralpak ADH column, 90:10 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 
enantiomer tR = 5.9 min, major enantiomer tR = 5.4 min, ee = 98%. 
Minor diast.: Colourless wax. 
1
H NMR (CDCl3, 400 MHz): δ 
7.56-7.54 (m, 2H), 7.40-7.32 (m, 4H), 7.21 (t, 1H, J= 1.6 Hz), 7.11 
(t, 1H, J= 7.9 Hz), 7.00-6.99 (m, 1H), 4.98 (s, 1H), 3.78-3.70 (m, 




1H), 3.51 (dd, 1H, J1= 10.8, J2= 7.2 Hz), 3.18 (t, 1H, J= 11.0 Hz), 
2.53 (dd, 1H, J1= 15.8, J2= 9.8 Hz), 2.43 (dd, 1H, J1= 15.8, J2= 4.7 
Hz), 1.44 (s, 9H). 
13
C NMR (CDCl3, 100 MHz): δ 192.7, 169.3, 
137.3, 134.5, 133.6, 133.3, 129.8, 129.2, 129.1, 129.0, 128.9, 126.9, 




42.9 mg, 98% yield. The 
diastereoisomeric ratio was found to be 
9:1 by 
1
H-NMR analysis. FTIR max 
(KBr)/cm
-1 
2977, 2934, 1729, 1671, 
1600, 1574, 1455, 1369, 1251, 1174, 1134, 1023, 844, 772, 705. 
MS (ESI m/z) 438.21 [MH
+
, 3%], 460.14 [MNa
+




Major diast.: white wax. [α]D
18
 = -79.8 (c 0.7, CHCl3), ee = 99%. 
1
H NMR (CDCl3, 400 MHz): δ 8.12 (d, 2H, J= 8.8 Hz), 7.73 (d, 
2H, J= 7.6 Hz), 7.36-7.29 (m, 3H), 6.93 (d, 2H, J= 8.8 Hz), 5.42 (s, 
1H), 3.92 (dd, 1H, J1= 11.2, J2= 5.7 Hz), 3.87 (s, 3H), 3.78-3.73 (m, 
1H), 3.04 (dd, 1H, J1= 11.2, J2= 2.4 Hz), 2.70 (dd, 1H, J1= 16.7, J2= 
10.4 Hz), 2.27 (dd, 1H, J1= 16.7, J2= 3.3 Hz), 1.38 (s, 9H). 
13
C 
NMR (CDCl3, 100 MHz): δ 188.1, 170.1, 164.4, 135.6, 132.0, 
129.9, 128.7, 128.2, 127.0, 118.7, 113.9, 81.6, 64.5, 55.6, 53.6, 
49.1, 35.7, 34.6, 27.9. 
HPLC analysis with Chiralpak ADH column, 80:20 n-hexane:2-
propanol, 1 mL/min, detection at 254 nm; major diast.: minor 
enantiomer tR = 12.2 min, major enantiomer tR = 7.2 min, ee = 99%. 




Minor diast.: pale yellow wax. 
1
H NMR (CDCl3, 400 MHz): δ 
7.55-7.53 (m, 2H), 7.33-7.28 (m, 5H), 6.66 (d, 2H, J= 9.0 Hz), 4.96 
(s, 1H), 3.80-3.70 (m, 4H), 3.50 (dd, 1H, J1= 10.6, J2= 7.0 Hz), 3.19 
(t, 1H, J= 11.0 Hz), 2.51 (dd, 1H, J1= 15.6, J2= 10.2 Hz), 2.44 (dd, 
1H, J1= 15.6, J2= 4.3 Hz), 1.44 (s, 9H). 
13
C NMR (CDCl3, 100 
MHz): δ 191.0, 169.5, 163.8, 134.2, 131.9, 129.4, 129.2, 128.7, 




40.5 mg, 98% yield. The diastereoisomeric 
ratio was found to be 1:1 by 
1
H-NMR 
analysis. FTIR max (KBr)/cm
-1 
2928, 2853, 
2236, 1732, 1679, 1597, 1447, 1368, 1236, 





, 100%], 452.14 [MK
+
, 18%]. 
First diast.: Colourless wax. [α]D
22
 = -73.3 (c 0.5, CHCl3), ee 
>99%.  
1
H NMR (CDCl3, 400 MHz): δ 8.05 (d, 2H, J= 7.7 Hz), 7.65-7.62 
(m, 1H), 7.53-7.50 (m, 2H), 4.10 (d, 1H, J= 10.1 Hz ), 3.74-3.67 
(m, 2H), 2.89 (d, 1H, J= 10.5 Hz), 2.52 (dd, 1H, J1= 16.9, J2= 8.5 
Hz), 2.29-2.23 (m, 1H), 2.01-1.61 (m, 6H), 1.33 (s, 9H), 1.19-1.05 
(m, 3H), 0.96-0.83 (m, 2H).  
13
C NMR (CDCl3, 100 MHz): δ 191.9, 170.1, 135.0, 134.0, 129.2, 
128.6, 118.8, 81.5, 61.4, 56.8, 49.7, 43.6, 35.7, 34.9, 33.6, 33.4, 
27.9, 26.1, 26.0, 25.8. 
HPLC analysis with Chiralpak IC column, 98:2 n-hexane:2-




propanol, 0.7 mL/min, detection at 254 nm; first diast.: major 
enantiomer tR = 9.8 min, ee >99%. 
Second diast.: white solid, mp 101.7-104.5 °C. [α]D
22
 = +12.0 (c 
0.9, CHCl3), ee = 87%.   
1
H NMR (CDCl3, 400 MHz): δ 8.06 (d, 2H, J= 7.9 Hz), 7.65-7.61 
(m, 1H), 7.54-7.50 (m, 2H), 4.15 (d, 1H, J= 10.5 Hz), 3.33-3.25 (m, 
2H), 2.98-2.92 (m, 1H), 2.63 (dd, 1H, J1= 15.6, J2= 9.8 Hz), 2.54 
(dd, 1H, J1= 15.6, J2= 4.2 Hz), 1.85-1.60 (m, 4H), 1.45-1.42 (m, 
2H), 1.36 (s, 9H), 1.25-0.99 (m, 3H), 0.89-0.75 (m, 2H). 
13
C NMR 
(CDCl3, 100 MHz): δ 194.0, 169.1, 136.0, 133.8, 129.2, 128.7, 
117.1, 81.7, 63.6, 62.0, 52.0, 42.6, 36.9, 33.2, 33.0, 32.9, 27.9, 25.8, 
25.69, 25.66. 
HPLC analysis with Chiralpak IC column, 98:2 n-hexane:2-
propanol, 0.7 mL/min, detection at 254 nm; second diast.: minor 





Pale yellow wax, 35.3 mg, 79% yield. 
The diastereoisomeric ratio was found 
to be 3:1 by 
1
H-NMR analysis. FTIR 
max (KBr)/cm
-1 
2978, 2932, 1726, 
1652, 1497, 1454, 1393, 1368, 1154, 843, 751, 700. MS (ESI m/z) 
458.18 [MNa
+




H NMR (CDCl3, 400 MHz): δ 7.54-7.51 (m, 2H) [minor diast.: 
7.41-7.39 (m, 0.66H)], 7.34-7.27 (m, 4H), 7.25-7.11 (m, 4H) [minor 




diast.: 7.03-7.01 (m, 0.67H)], 5.11 (s, 1H) [minor diast.: 4.81 (s, 
0.33H)], 3.79 (dd, 1H, J1= 11.4, J2= 5.8 Hz), 3.50-3.44 (m, 1H) 
[minor diast.: 3.43-3.36 (m, 0.66H)], 3.18-3.10 (m, 1H) [minor 
diast.: 3.05 (t, 0.33H, J= 13.4 Hz)], 3.00-2.90 (m, 1H), 2.86 (dd, 
1H, J1= 11.4, J2= 2.5 Hz), 2.81 (t, 2H, J= 7.2 Hz) [minor diast.: 
2.78-2.71 (m, 0.66H), 2.53-2.47 (m, 0.33H], 2.42 (dd, 1H, J1= 17.5, 
J2= 7.2 Hz), 2.36 (dd, 1H, J1= 17.5, J2= 6.6 Hz) [partially 
overlapped with minor diast.: 2.35-2.24 (m, 0.66H)], 1.46 (s, 9H) 
[minor diast.: 1.44 (s, 2.96H)]. 
13
C NMR (CDCl3, 100 MHz): δ 
200.3 [minor diast.: 201.3], 170.2 [minor diast.: 169.4], 139.9 
[minor diast.: 139.8], 134.7 [minor diast.: 133.5, 129.4], 129.3 
[minor diast.: 128.9, 128.8, 128.6], 128.51, 128.48, 128.4, 126.36 
[minor diast.: 126.30], 118.5, 81.7 [minor diast.: 68.9], 67.4 [minor 
diast.: 59.5], 53.6, 48.9 [minor diast.: 48.2, 45.6], 44.4, 37.0, 35.1 
[minor diast.: 34.1, 29.7], 29.1 [minor diast.: 28.8], 28.1 [minor 
diast.: 28.0].  
HPLC analysis with Chiralpak IA-3 column, 100:1 n-hexane: 
ethanol, 1 mL/min, detection at 210 nm; major diast.: major 
enantiomer tR = 8.6 min, minor enantiomer tR = 9.5 min, ee = 89%. 
 
Michael reaction to racemic product 109 
A sample vial was charged with (E)-tert-butyl 4-mercaptobut-2-
enoate 76b (22.6 mg, 0.13 mmol) and compound 99a (23.3 mg, 
0.10 mmol) in chloroform (1.0 mL) under nitrogen atmosphere. 1,4-
Diazabicyclo[2.2.2]octane (3.3 mg, 0.03 mmol) was added and the 
solution was stirred at -20 °C for 17 hours. Michael adduct 109 was 
recovered by flash chromatography (eluent PE/ ethyl acetate 98:2 to 




95:5) as mixture of diastereoisomers (dr 1:1) and residual 99a (23.2 
mg, 70% purity) as these compounds have the same Rf (TLC eluent 





23.2 mg, 70% purity. 
1
H NMR 
(CDCl3, 400 MHz): δ [99a: 8.06-
8.02 (m, 2.57H)], 7.95 (d, 2H, J= 
7.7 Hz) [99a: 7.90 (d, 1.70H, J= 7.4 
Hz)], 7.81 (d, 2H, J= 7.6 Hz), 7.69-7.51 (m, 6H overlapped with 
99a: m, 5.10 H), 7.47-7.28 (m, 9H), 7.24-7.20 (m, 1H), 6.68-6.56 
(m, 2H), 5.66 (d, 1H, J= 15.4 Hz) partially overlapped with 5.65 (d, 
1H, J= 15.4 Hz), 4.822 (d, 1H, J= 8.4 Hz) partially overlapped with 
4.82 (d, 1H, J= 8.7 Hz), 4.51 (d, 1H, J= 8.4 Hz), 4.46 (d, 1H, J= 8.7 
Hz), 3.25 (dd, 1H, J1= 14.2, J2= 6.8 Hz), 3.16-2.99 (m, 3H), 1.47 (s, 
18H). 
13
C NMR (CDCl3, 100 MHz): δ [99a: 188.96] 188.63, 
188,60, 164.92, 164.89 [99a: 155.56], 140.98, 140.79, 137.55, 
136.68 [99a: 135.74], 134.70, 134.66, 134.57, 134.12 [99a: 133.42, 
133.39, 131.75, 131.09, 129.31, 129.30], 129.16, 129.02, 128.99, 
128.91, 128.88, 128.83 [99a: 128.67], 128.58, 128.45, 128.00, 
125.72 [99a: 116.84], 115.39, 115.04 [99a: 110.11], 80.70, 80.63, 








Michael reaction of adduct 109 
Compound 109 (23.2 mg, 70% purity) was dissolved in anhydrous 
toluene (460 μL), then catalyst 105 was added (2.6 mg, 0.0046 
mmol) and the reaction mixture was stirred at room temperature 
monitored by TLC (eluent PE/ ethyl acetate 90:10). The crude 
mixture was purified by flash chromatography (eluting from PE/ 
ethyl acetate 98:2 to 90:10) to give 100b (13.7 mg, 75% yield). The 
diastereoisomeric ratio was found to be 9:1 by 
1
H-NMR analysis of 
crude reaction mixture. 
X-Ray data for the absolute configuration assignment of 
compound 100i 
Single crystals of major diastereoisomer of compound 100i were 
obtained by slow evaporation of a n-hexane / ethanol solvent 
mixture at room temperature. 
Single crystal diffraction data were collected on a Oxford Xcalibur 
CCD area detector diffractometer, using graphite monochromatic 
Mo Kα (λ = 0.71069Å) radiation. Data reduction and absorption 
correction were performed using CrysAlisPRO 171.34.44 (Oxford 
Diffraction). The structure was solved by direct methods using 
SIR2011
251
 and refined by full-matrix least squares using SHELX-
97
252
. Hydrogen atoms were generated in calculated position using 
SHELX-97. The absolute structure of the title compound was 
determined on the basis of the Flack x parameter
253
. 
CCDC 937229 contains the supplementary crystallographic data for 
this paper. These data can be obtained free of charge from the 
Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  




Details of data collections and refinements are given in table below. 
 
ORTEP plot with 30% probability ellipsoids (for seek of brevity H 
atoms are not shown). 
 
Crystal data 
Empirical formula  C24 H24 N2 O5 S1 
Formula weight  452.51 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 10.107(1) Å = 90°. 
 b = 6.848(9) Å  
 c = 16.925(2) Å  
Volume 1171.49(14) Å 3 
Z 2 
Density (calculated) 1.283 Mg/m3 
Absorption coefficient 0.18 mm-1 
F(000) 476 
Crystal size 068 x 0.4 x 0.2 
mm3 




Theta range for data collection 4.1 to 28.2°. 
Index ranges -13<=h<=13, -
9<=k<=8, -22<=l<=22 
Reflections collected 48340 
Independent reflections 5483 [R(int) = 0.1] 
Completeness to theta = 25.0° 98.0 %  
Absorption correction Semi-empirical 
from equivalents 
Max. and min. transmission 1.000 and 0.978 
Refinement method Full-matrix least-
squares on F2 
Data / restraints / parameters 4481 / 1 / 249 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.051, wR2 = 
0.103 
R indices (all data) R1 = 0.1119, wR2 
= 0.0865 
Largest diff. peak and hole 0.15and -0.18 e.V.-3 
  




X-Ray data for the relative configuration assignment of the 
minor diastereoisomer of compound 100e 
Single crystals of minor diastereoisomer of compound 100e were 
obtained by slow evaporation of ethanol at room temperature. 
Single crystal diffraction data were collected on an Oxford Xcalibur 
CCD area detector diffractometer, using graphite monochromatic 
Mo Kα (λ = 0.71069Å) radiation. Data reduction and absorption 
correction were performed using CrysAlisPRO 171.34.44 (Oxford 
Diffraction). The structure was solved by direct methods using 
SIR2011
251
 and refined by full-matrix least squares using SHELX-
97
252
. The tert-butyl disordered part of the model was restrained 
with the SADI and EADP SHELX-97 instructions. Hydrogen atoms 
were generated in calculated position using SHELX-97. CCDC 
937228 contains the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from the 
Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. Details of data collections 














ORTEP plot with 30% probability ellipsoids (disordered part is 






Empirical formula  C28 H33 N O3 S 
Formula weight  463.61 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 11.835(5) Å = 61.205(5)° 
 b = 11.975(5) Å  
 c = 12.118(5) Å  
Volume 1334.0(10) Å 3 
Z 2 
Density (calculated) 1.154 Mg/m3 
Absorption coefficient 0.149 mm-1 
F(000) 496 
Crystal size 0.5 x 0.5 x 0.4 mm3 
Theta range for data collection 4.17 to 30.48°. 




Index ranges -15<=h<=15, -
16<=k<=17, -16<=l<=17 
Reflections collected 19077 
Independent reflections 6365 [R(int) = 
0.1110] 
Completeness to theta = 25.0° 89.1 %  
Absorption correction Semi-empirical 
from equivalents 
Max. and min. transmission 1.00000 and 
0.96940 
Refinement method Full-matrix least-
squares on F2 
Data / restraints / parameters 6365 / 30 / 293 
Goodness-of-fit on F2 1.069 
Final R indices [I>2sigma(I)] R1 = 0.1269, wR2 
= 0.2229 
R indices (all data) R1 = 0.2377, wR2 
= 0.2724 

















6.3 Enantioselective synthesis of γ-butyrolactones bearing an 
all-carbon β-quaternary stereocentre 
Experimental procedures and compounds characterization 
General procedure for synthesis of compounds 142a-r  
 
 




β-Keto esters were synthesized according to a slightly modified 
literature procedure.
255
 To a flask equipped with a Dean-Stark trap 
and reflux condenser was added β-keto ethyl ester (1 mmol), 
corresponding alcohol (2 mmol),
vi
 DMAP (36.7 mg, 0.3 mmol) in 
                                                     
vi For the synthesis of cyclohexyl 3-oxo-3-phenylpropanoate and 2-phenylpropan 
2-yl 3-  (naphthalen-2-yl)-3-oxopropanoate 3 mmol and 4 mmol of alchohol were 
respectively  added. 




toluene (20 mL). For the synthesis of 2-phenylpropan-2-yl 3-
(naphthalen-2-yl)-3-oxopropanoate cyclohexane was used as 
solvent. The mixture was heated to reflux, distilling the ethanol 
formed during the reaction. After completion, monitored by 
1
H 
NMR spectroscopy, the reaction mixture was directly loaded onto 
silica gel and purified by flash chromatography (eluting in gradient 
from PE/ ethyl acetate 98:2 to 95:5) to give the β-keto esters. 




Compounds 142b-q were synthesized as described here:
256b
  
METHOD A: In a screw capped vial containing acetone (3 mL) 
and dimethoxyethane (2 mL) the appropiate β-keto ester (1 mmol) 
and K2CO3 (152 mg, 1.1 mmol) were added. Methyl bromoacetate 
(99 L, 1.05 mmol) was then added and the mixture stirred until 
completion (17-90 h), monitored by TLC (eluent PE/ ethyl acetate 
90:10, visualized by UV and, when necessary, by anisaldehyde 
staining solution). The crude mixture was diluted with ethyl acetate 
and water was added, followed by HCl 1N to adjust at pH ~ 7. The 
organic layer was washed with water two times and then dried over 
anhydrous Na2SO4. The solvent was removed under vacuum and 
the residue was purified by flash chromatography (eluting with a 
gradient PE/ diethyl ether 95:5 to 80:20) to give compounds 142b-
q. 
Compound 142r was synthesized according to METHOD B:
257
 
NaH (60% w/w dispersion in mineral oil, 36 mg, 0.89 mmol) was 
suspended in dry THF (600 μL) under nitrogen atmosphere and the 
suspension was cooled to 0 °C. A solution of 2-phenylpropan-2-yl 




3-oxo-3-phenylpropanoate (250 mg, 0.89 mmol), in dry THF (200 
μL) was added dropwise over 30 minutes to the suspension of NaH. 
The mixture was stirred at room temperature for 15 min and then a 
solution of methyl 3-bromopropanoate (97 μL, 0.89 mmol), in dry 
THF (400 μL) was added dropwise over 20 minutes. The reaction 
was stirred at room temperature for 45 hours, monitored by TLC 
(eluent PE/ ethyl acetate 8:2). After cooling, the reaction mixture 
was quenched with water and extracted with diethyl ether. The 
organic phase was dried over anhydrous Na2SO4 and evaporated 
under reduced pressure. The residue was purified by flash 
chromatography (eluting with a gradient PE/ diethyl ether 90:10 to 
70:30) to give the product 142r (201 mg, 61% yield). 
 
1-tert-Butyl 4-methyl 2-benzoylsuccinate (142b) 
Colourless oil, 150.3 mg, 68% yield. 
1
H NMR 
(CDCl3, 300 MHz): δ 8.07-7.98 (m, 2H), 7.63-
7.53 (m, 1H), 7.52-7.40 (m, 2H), 4.80-4.72 
(m, 1H), 3.67 (s, 3H), 3.06 (dd, 1H, J = 17.3, 
7.7 Hz), 2.96 (dd, 1H, J = 17.3, 6.7 Hz), 1.32 (s, 9H). 
13
C NMR 
(CDCl3, 75 MHz): δ 194.5, 171.9, 167.6, 136.2, 133.4, 128.8, 
128.5, 82.5, 52.0, 50.8, 32.8, 27.6. MS (ESI m/z) 315.6 [MNa
+
, 
16%]. Elemental analysis calcd (%) for C16H20O5: C, 65.74; H, 









1-Cyclohexyl 4-methyl 2-benzoylsuccinate (142c) 
White wax, 332 mg, 85% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 8.04 (d, 2H, J= 7.6 
Hz), 7.62-7.55 (m, 1H), 7.51-7.45 (m, 2H), 
4.87-4.82 (m, 1H), 4.81-4.73 (m, 1H), 3.68 
(s, 3H), 3.11 (dd, 1H, J = 17.3, 7.9 Hz), 3.02 (dd, 1H, J = 17.3, 6.4 
Hz), 1.74-1.62 (m, 2H), 1.46-1.16 (m, 8H). 
13
C NMR (CDCl3, 100 
MHz): δ 194.2, 171.8, 168.0, 136.0, 133.5, 128.8, 128.6, 74.0, 52.0, 





, 7%]. Elemental analysis calcd (%) for 
C18H22O5: C, 67.91; H, 6.97; found C, 67.70; H, 7.09. 
 
2-Adamantyl 4-methyl 2-benzoylsuccinate (142d) 
White solid, 371 mg, 82% yield. mp 66.9-
69.8 °C. 
1
H NMR (CDCl3, 400 MHz): δ 
8.09-8.04 (m, 2H), 7.62-7.55 (m, 1H), 
7.52-7.44 (m, 2H), 4.92 (dd, 2H, J = 8.1, 
6.4 Hz), 3.68 (s, 3H), 3.15 (dd, 1H, J = 17.4, 8.1 Hz), 3.05 (dd, 1H, 
J = 17.4, 6.3 Hz), 1.89-1.82 (m, 2H), 1.81-1.72 (m, 3H), 1.71-1.54 
(m, 7H), 1.43-1.34 (m, 2H). 
13
C NMR (CDCl3, 100 MHz): δ 194.3, 
171.9, 167.9, 136.2, 133.5, 128.9, 128.6, 78.8, 52.0, 49.7, 37.2, 
36.15, 36.10, 32.9, 31.7, 31.5, 31.38, 31.35, 26.9, 26.8. MS (ESI 
m/z) 371.1 [MH
+
, 2%], 392.9 [MNa
+
, 100%], 409.0 [MK
+
, 11%]. 
Elemental analysis calcd (%) for C22H26O5: C, 71.33; H, 7.07; found 
C, 71.04; H, 6.83 
 
 




4-Methyl 1-naphthalen-1-ylmethyl 2-benzoylsuccinate (142e) 
Yellow oil, 573 mg, 91% yield. 
1
H 
NMR (CDCl3, 400 MHz): δ 7.95-7.89 
(m, 2H), 7.86-7.79 (m, 2H), 7.78-7.75 
(m, 1H), 7.53-7.30 (m, 7H), 5.57 (s, 
2H), 4.92-4.85 (m, 1H), 3.62 (s, 3H), 3.12 (dd, 1H, J = 17.4, 7.8 
Hz), 3.03 (dd, 1H, J = 17.4, 6.6 Hz). 
13
C NMR (CDCl3, 100 MHz): 
δ 193.7, 171.5, 168.5, 135.6, 133.5, 131.3, 130.4, 129.4, 128.7, 
128.5, 127.6, 126.5, 125.8, 125.0, 123.2, 65.8, 52.0, 49.5, 32.8. MS 
(ESI m/z) 399.3 [MNa
+
, 100%]. Elemental analysis calcd (%) for 
C23H20O5: C, 73.39; H, 5.36; found C, 73.10; H, 5.20. 
 
4-Methyl 1-(2-phenylpropan-2-yl) 2-benzoylsuccinate (142f) 
Colourless oil, 339 mg, 87% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 8.07-8.04 (m, 2H), 
7.64-7.60 (m, 1H), 7.52-7.48 (m, 2H), 7.24-
7.19 (m, 3H), 7.13-7.11 (m, 2H), 4.84 (dd, 1H, J1= 7.8 Hz, J2= 6.5 
Hz), 3.67 (s, 3H), 3.09 (dd, 1H, J = 17.3, 8.0 Hz), 2.97 (dd, 1H, J = 
17.3, 6.4 Hz), 1.64 (s, 3H), 1.63 (s, 3H). 
13
C NMR (CDCl3, 100 
MHz): δ 194.2, 171.8, 166.8, 144.7, 136.2, 133.6, 128.9, 128.7, 
128.2, 127.1, 124.1, 83.6, 52.0, 50.6, 32.7, 28.1, 28.0. MS (ESI m/z) 
355.4 [MH
+
, 13%]. Elemental analysis calcd (%) for C21H22O5: C, 









4-Methyl 1-(2-phenylpropan-2-yl) 2-(4-methylbenzoyl)succinate 
(142g) 
Yellow oil, 97 mg, 88% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 7.96 (d, 2H, J= 8.2 
Hz), 7.29 (d, 2H, J= 8.0 Hz), 7.24-7.17 (m, 
3H), 7.15-7.11 (m, 2H), 4.81 (dd, 1H, J = 7.6, 6.7 Hz), 3.66 (s, 3H), 
3.06 (dd, 1H, J = 17.3, 7.8 Hz), 2.97 (dd, 1H, J = 17.3, 6.6 Hz), 
2.44 (s, 3H), 1.65 (s, 3H), 1.64 (s, 3H). 
13
C NMR (CDCl3, 100 
MHz): δ 193.8, 171.8, 167.0, 144.8, 144.5, 133.6, 129.3, 129.1, 
128.2, 127.1, 124.1, 83.5, 52.0, 50.5, 32.8, 28.2, 28.05, 21.7. MS 
(ESI m/z) 369.4 [MH
+
, 43%], 391.4 [MNa
+
, 100%]. Elemental 
analysis calcd (%) for C22H24O5: C, 71.72; H, 6.57; found C, 71.51; 
H, 6.69. 
 
4-Methyl 1-(2-phenylpropan-2-yl) 2-(3-methylbenzoyl)succinate 
(142h) 
Colourless oil, 147 mg, 65% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 7.90-7.79 (m, 2H), 
7.47-7.33 (m, 2H), 7.25-7.17 (m, 3H), 7.16-
7.09 (m, 2H), 4.86-4.79 (m, 1H), 3.67 (s, 3H), 3.07 (dd, 1H, J = 
17.3, 7.8 Hz), 2.97 (dd, 1H, J = 17.3, 6.6 Hz), 2.42 (s, 3H), 1.65 (s, 
6H). 
13
C NMR (CDCl3, 100 MHz): δ 194.4, 171.8, 166.9, 144.7, 
138.5, 136.2, 134.4, 129.4, 128.6, 128.2, 127.1, 126.2, 124.1, 83.5, 





, 38%]. Elemental analysis calcd (%) for C22H24O5: C, 
71.72; H, 6.57; found C, 71.93; H, 6.44. 
 




4-Methyl 1-(2-phenylpropan-2-yl) 2-(2-methylbenzoyl)succinate 
(142i) 
Pale yellow oil, 202 mg, 48% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 7.83 (d, 1H, J= 7.7 
Hz), 7.46-7.36 (m, 1H), 7.35-7.27 (m, 2H), 
7.24-7.16 (m, 3H), 7.09-7.03 (m, 2H), 4.74 (dd, 1H, J = 7.9, 6.3 
Hz), 3.68 (s, 3H), 3.09 (dd, 1H, J = 17.3, 8.2 Hz), 2.90 (dd, 1H, J = 
17.3, 6.2 Hz), 2.47 (s, 3H), 1.62 (s, 3H), 1.59 (s, 3H). 
13
C NMR 
(CDCl3, 100 MHz): δ 197.1, 171.7, 166.7, 144.6, 138.7, 136.9, 
131.8, 131.7, 128.9, 128.1, 127.0, 125.6, 123.9, 83.3, 53.1, 51.9, 
32.5, 28.1, 27.7, 20.9. MS (ESI m/z) 369.4 [MH
+
, 2%], 391.3 
[MNa
+
, 100%], 407.3 [MK
+
, 10%]. Elemental analysis calcd (%) 
for C22H24O5: C, 71.72; H, 6.57; found C, 71.47; H, 6.72. 
 
4-Methyl 1-(2-phenylpropan-2-yl) 2-(4-chlorobenzoyl)succinate 
(142j) 
Colourless wax, 64 mg, 55% yield. 
1
H 
NMR (CDCl3, 400 MHz): δ 8.00 (d, 2H, 
J= 8.6 Hz), 7.47 (d, 2H, J= 8.6 Hz), 7.25-
7.19 (m, 3H), 7.15-7.10 (m, 2H), 4.77 (dd, 1H, J = 8.3, 6.0 Hz), 
3.67 (s, 3H), 3.11 (dd, 1H, J = 17.4, 8.3 Hz), 2.97 (dd, 1H, J = 17.4, 
6.0 Hz), 1.65 (s, 6H). 
13
C NMR (CDCl3, 100 MHz): δ 193.1, 171.8, 
166.5, 144.5, 140.1, 134.6, 130.3, 129.0, 128.2, 127.3, 124.1, 83.8, 
52.1, 50.6, 32.7, 28.2, 28.0. MS (ESI m/z) 411.6 [MNa
+
, 6%]. 
Elemental analysis calcd (%) for C21H21ClO5: C, 64.87; H, 5.44; 
found C, 64.50; H, 5.58. 
 




4-Methyl 1-(2-phenylpropan-2-yl) 2-(4-bromobenzoyl)succinate 
(142k) 
Pale yellow oil, 261 mg, 76% yield. 
1
H 
NMR (CDCl3, 400 MHz): δ 7.92 (d, 2H, 
J= 8.6 Hz), 7.64 (d, 2H, J= 8.6 Hz), 7.25-
7.19 (m, 3H), 7.14-7.10 (m, 2H), 4.76 
(dd, 1H, J = 8.3, 6.0 Hz), 3.67 (s, 3H), 3.11 (dd, 1H, J = 17.4, 8.3 
Hz), 2.96 (dd, 1H, J = 17.4, 6.0 Hz), 1.66 (s, 3H), 1.65 (s, 3H). 
13
C 
NMR (CDCl3, 100 MHz): δ 193.3, 171.7, 166.4, 144.4, 134.9, 
131.9, 130.4, 128.8, 128.2, 127.2, 124.0, 83.8, 52.0, 50.5, 32.7, 
28.1, 28.0. MS (ESI m/z) 457.6 [MNa
+
, 78%], 473.6 [MK
+
, 18%]. 
Elemental analysis calcd (%) for C21H21BrO5: C, 58.21; H, 4.89; 
found C, 57.91; H, 5.00. 
 
4-Methyl 1-(2-phenylpropan-2-yl) 2-(4 -
(trifluoromethyl)benzoyl)succinate (142l) 
Colourless oil, 247 mg, 45% yield. 
1
H 
NMR (CDCl3, 400 MHz): δ 8.15 (d, 2H, 
J= 8.4 Hz), 7.76 (d, 2H, J= 8.3 Hz), 
7.25-7.17 (m, 3H), 7.14-7.08 (m, 2H), 4.82 (dd, 1H, J = 8.7, 5.6 
Hz), 3.67 (s, 3H), 3.16 (dd, 1H, J = 17.4, 8.7 Hz), 2.98 (dd, 1H, J = 
17.4, 5.6 Hz), 1.65 (s, 6H). 
13
C NMR (CDCl3, 100 MHz): δ 193.7, 
171.7, 166.3, 144.3, 139.1, 134.7 (q, 
2
JC-F= 32.5 Hz), 129.2, 128.2, 
127.4, 125.74, 125.70, 124.1, 123.5 (q, 
1
JC-F= 271.2 Hz), 84.1, 52.1, 
50.8, 32.7, 28.1, 28.0. MS (ESI m/z) 445.2 [MNa
+
, 49%]. Elemental 
analysis calcd (%) for C22H21F3O5: C, 62.56; H, 5.01; found C, 
62.74; H, 5.03. 




4-Methyl 1-(2-phenylpropan-2-yl) 2-(2-naphthoyl)succinate 
(142m) 
Pale yellow wax, 93 mg, 60% yield. 
1
H 
NMR (CDCl3, 400 MHz): δ 8.62 (s, 
1H), 8.09 (dd, 1H, J1= 8.7 Hz, J2= 1.8 
Hz), 8.02-7.87 (m, 4H), 7.66-7.62 (m, 1H), 7.61-7.55 (m, 1H), 
7.16-7.07 (m, 4H), 5.00 (dd, 1H, J = 7.8, 6.6 Hz), 3.68 (s, 3H), 3.15 
(dd, 1H, J = 17.3, 7.9 Hz), 3.04 (dd, 1H, J = 17.3, 6.5 Hz), 1.64 (s, 
6H). 
13
C NMR (CDCl3, 75 MHz): δ 194.1, 171.9, 166.9, 144.6, 
135.8, 133.5, 132.4, 131.0, 129.8, 128.8, 128.6, 128.1, 127.8, 127.1, 
126.9, 124.3, 124.1, 83.7, 52.0, 50.8, 32.9, 28.2, 28.0. MS (ESI m/z) 
427.4 [MNa
+
, 100%], 443.7 [MK
+
, 39%]. Elemental analysis calcd 




Colourless oil, 124 mg, 82% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 8.26-8.23 (m, 1H), 7.63 
(d, 1H, J= 5.1 Hz), 7.36 (dd, 1H, J = 5.1, 2.8 
Hz), 7.25-7.19 (m, 3H), 7.17-7.13 (m, 2H), 4.66-4.60 (m, 1H), 3.67 
(s, 3H), 3.06 (dd, 1H, J = 17.4, 10.2 Hz), 2.97 (dd, 1H, J = 17.4, 6.7 
Hz), 1.68 (s, 6H). 
13
C NMR (CDCl3, 100 MHz): δ 187.7, 171.8, 
166.7, 144.7, 141.1, 133.9, 128.2, 127.4, 127.2, 126.5, 124.1, 83.6, 





, 19%]. Elemental analysis calcd (%) for C19H20O5S: C, 
63.32; H, 5.59; S, 8.90; found C, 63.59; H, 5.73; S, 9.08. 
 




4-Methyl 1-(2-phenylpropan-2-yl) 2-butyrylsuccinate (142o) 
Colourless oil, 133 mg, 35% yield. 
1
H NMR 
(CDCl3, 300 MHz): δ 7.38-7.29 (m, 3H), 
7.28-7.21 (m, 2H), 3.96 (dd, 1H, J = 8.4, 6.4 
Hz), 3.66 (s, 3H), 2.94 (dd, 1H, J = 17.5, 8.4 Hz), 2.79 (dd, 1H, J = 
17.5, 6.3 Hz), 2.71-2.60 (m, 2H), 1.77 (s, 6H), 1.65 (sextet, 2H, J= 
7.4 Hz), 0.92 (t, 3H, J= 7.4 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 
204.1, 171.9, 166.7, 144.7, 128.3, 127.3, 124.1, 83.5, 54.8, 51.9, 
44.8, 32.1, 28.4, 28.1, 16.8, 13.5. MS (ESI m/z) 358.5 [MK
+
, 26%]. 
Elemental analysis calcd (%) for C18H24O5: C, 67.48; H, 7.55; found 
C, 67.27; H, 7.70. 
 
4-Methyl 1-(2-phenylpropan-2-yl) 2-isobutyrylsuccinate (142p) 
Colourless oil, 118 mg, 32% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 7.37-7.29 (m, 5H), 4.15 
(dd, 1H, J = 8.1, 6.1 Hz), 3.66 (s, 3H), 3.01-
2.87 (m, 2H), 2.80 (dd, 1H, J = 17.3, 6.2 Hz), 1.76 (s, 6H), 1.18 (d, 
3H, J= 7.0 Hz), 1.14 (d, 3H, J= 7.0 Hz). 
13
C NMR (CDCl3, 100 
MHz): δ 208.0, 171.7, 166.7, 144.7, 128.3, 127.2, 124.1, 83.5, 53.0, 
51.9, 40.8, 32.2, 28.4, 28.1, 18.6, 17.7. MS (ESI m/z) 343.5 [MNa
+
, 
47%]. Elemental analysis calcd (%) for C18H24O5: C, 67.48; H, 












Colourless oil, 99 mg, 43% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 7.36-7.29 (m, 3H), 7.28-
7.21 (m, 2H), 4.18-4.13 (m, 1H), 3.67 (s, 3H), 
2.91 (dd, 1H, J = 17.4, 7.4 Hz), 2.83 (dd, 1H, J = 17.4, 7.2 Hz), 
2.27-2.18 (m, 1H), 1.79 (s, 3H), 1.78 (s, 3H), 1.17-1.10 (m, 2H), 
1.01-0.93 (m, 2H). 
13
C NMR (CDCl3, 100 MHz): δ 203.9, 171.8, 
166.7, 144.9, 128.3, 127.2, 124.2, 83.5, 56.1, 51.9, 32.0, 28.5, 28.2, 
20.6, 12.2, 12.1. MS (ESI m/z) 319.4 [MH
+





, 6%]. Elemental analysis calcd (%) for 
C18H22O5: C, 67.91; H, 6.97; found C, 67.66; H, 7.14. 
 
5-Methyl 1-(2-phenylpropan-2-yl) 2-benzoylpentanedioate 
(142r) 
Colourless oil, 201 mg, 61% yield. 
1
H NMR 
(CDCl3, 400 MHz): δ 8.05-8.00 (m, 2H), 
7.64-7.56 (m, 1H), 7.53-7.46 (m, 2H), 7.25-
7.19 (m, 3H), 7.18-7.13 (m, 2H), 4.54-4.39 
(m, 1H), 3.67 (s, 3H), 2.46-2.39 (m, 2H), 2.34-2.22 (m, 2H), 1.68 
(s, 3H), 1.65 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 194.8, 173.2, 
167.8, 144.9, 136.3, 133.5, 128.7, 128.1, 127.1, 124.1, 83.2, 53.8, 
51.6, 31.2, 28.4, 27.8, 23.6. MS (ESI m/z) 391.1 [MNa
+
, 22%]. 
Elemental analysis calcd (%) for C22H24O5: C, 71.72; H, 6.57; found 
C, 71.50; H, 6.75. 
 
 










 are known compounds, they were 










 and 137b-f, 144
259
 were 
synthesized according to procedures described in the literature. The 

























Prepared from hydroquinine (1.17 g, 3.58 mmol) 
and PhLi (1.8 M in Bu2O; 6 mL, 10.75 mmol) 
according to ref. 260. The raw mixture was 
purified by flash chromatography (Ethyl 
acetate/MeOH = 100:5 to 70:30) to give the 
product. Pale yellow solid, 770 mg, 53% yield. mp 74.8-78.6 °C. 
[α]D
23
 = -25.7 (c 0.63, CHCl3). FTIR max (KBr)/cm
-1
 3454, 2931, 
2871, 1622, 1598, 1499, 1352, 1231, 1031, 832, 755, 697. 
1
H NMR 
(CDCl3, 400 MHz): δ 8.05-8.02 (m, 3H), 7.91 (s, 1H), 7.45-7.38 
(m, 3H), 7.30 (dd, 1H, J = 9.2, 2.6 Hz), 7.13 (d, 1H, J = 2.5 Hz), 
5.51 (d, 1H, J = 3.2 Hz), 3.85 (s, 3H), 3.51-3.46 (m, 1H), 3.08-3.02 
(m, 2H), 2.66-2.60 (m, 1H), 2.38-2.35 (m, 1H), 1.75-1.70 (m, 3H), 
1.44-1.40 (m, 3H), 1.26-1.17 (m, 2H), 0.78 (t, 3H, J = 7.3 Hz). 
13
C 
NMR (CDCl3, 100 MHz): δ 157.6, 154.5, 148.2, 144.3, 139.7, 
131.8, 128.9, 128.7, 127.2, 125.5, 121.5, 116.2, 101.3, 72.1, 59.8, 
58.6, 55.6, 43.4, 37.5, 28.2, 27.6, 25.5, 21.2, 12.0. MS (ESI m/z) 
403.3 [MH
+
, 100%], 441.2 [MK
+
, 8%]. Elemental analysis calcd 
(%) for C26H30N2O2: C, 77.58; H, 7.51; N, 6.96; found C, 77.84, H, 









Prepared from quinidine (1.61 g, 5 mmol) and 
PhLi (1.8 M in Bu2O; 8.4 mL, 15 mmol) 
according to ref. 260. The raw mixture was 
purified by flash chromatography (Ethyl 
acetate/MeOH = 100:5 to 70:30) to give the 
product. Yellow solid, 1.073g, 54% yield. mp 182.6-185.7 °C. 
[α]D
31
 = +133.4 (c 0.63, CHCl3). FTIR max (KBr)/cm
-1
 3418, 2940, 
2878, 1622, 1556, 1500, 1353, 1231, 1031, 834, 757, 697. 
1
H NMR 
(CDCl3, 400 MHz): δ 8.08-8.04 (m, 3H), 7.95 (s, 1H), 7.50-7.31 
(m, 4H), 7.14-7.13 (m, 1H), 6.02 (ddd, 1H vinyl, J = 16.7, 10.7, 7.6 
Hz), 5.63 (d, 1H, J = 3.2 Hz), 5.06-5.02 (m, 2H), 3.87 (s, 3H), 3.37-
3-32 (m, 1H), 3.12-3.07 (m, 1H), 2.97-2.89 (m, 2H), 2.83-2.75 (m, 
1H), 2.27-2.21 (m, 1H), 2.08-2.03 (m, 1H), 1.77 (m, 1H), 1.58-1.47 
(m, 2H), 1.27-1.16 (m, 1H). 
13
C NMR (CDCl3, 100 MHz): δ 157.5, 
154.5, 147.9, 144.2, 140.4, 139.6, 131.8, 128.9, 128.7, 127.2, 125.5, 
121.6, 116.1, 114.7, 101.2, 71.9, 59.8, 55.6, 50.1, 49.5, 39.9, 28.2, 
26.2, 21.0. MS (ESI m/z) 401.3 [MH
+
, 19%]. Elemental analysis 
calcd (%) for C26H28N2O2: C, 77.97; H, 7.05; N, 6.99; found C, 
















phenylquinolin-4-yl)methanamine (B1)  
 
Prepared from A1 (719 mg, 1.79 mmol) 
according to the procedure reported in references 
247b,259. The residue was purified by flash 
chromatography (eluent: EtOAc to EtOAc 
/MeOH 9:1 and then to EtOAc/MeOH/aq. 
NH4OH = 80/20/5). Yellow solid, 339 mg, 47% yield. mp 60.0-
63.8 °C. [α]D
22
 = +17.6 (c 0.52, CHCl3). FTIR max (KBr)/cm
-1
 
2933, 2864, 1622, 1597, 1498, 1452, 1354, 1264, 1229, 1031, 831, 
755, 697. 
1
H NMR (CDCl3, 400 MHz): δ 8.17-8.10 (m, 3H), 8.00 
(br s, 1H), 7.70-7.57 (m, 1H), 7.54-7.50 (m, 2H), 7.46-7.38 (m, 
2H), 4.67 (br s, 1H), 3.98 (s, 3H), 3.30-3.11 (m, 3H), 2.84-2.77 (m, 
1H), 2.56-2.52 (m, 1H), 2.30 (br s, 2H), 1.59-1.24 (m, 7H), 0.81 (t, 
3H, J = 7.3 Hz) overlapped with 0.85-0.79 (m, 1H). 
13
C NMR 
(CDCl3, 100 MHz): δ 157.4, 154.8, 147.9, 144.8, 139.8, 132.1, 
128.9, 128.7, 127.6, 127.3, 121.3, 117.9 (br s), 102.1(br s), 62.2 (br 
s), 57.9, 55.5, 41.1, 37.4, 28.8, 27.6, 25.7, 25.2, 12.0. MS (ESI m/z) 
403.3 [MH
+
, 18%], 420.4 [M+H3O
+
, 100%]. Elemental analysis 
calcd (%) for C26H31N3O: C, 77.77; H, 7.78; N, 10.46; found C, 













Prepared from A2 (400 mg, 1 mmol) according 
to the procedure reported in references 
247b,259. The residue was purified by flash 
chromatography (eluent: EtOAc to EtOAc 
/MeOH 9:1 and then to EtOAc/MeOH/aq. 
NH4OH = 90/10/5). Yellow solid, 116 mg, 29% yield. mp 57.3-
60.0 °C. [α]D
30
 = +66.5 (c 0.54, CHCl3). FTIR max (KBr)/cm
-1 
2931, 2866, 1621, 1596, 1554, 1498, 1453, 1353, 1227, 1030, 831, 
758, 696. 
1
H NMR (CDCl3, 300 MHz): δ 8.18-8.09 (m, 3H), 8.06 
(br s, 1H), 7.70-7.61 (m, 1H), 7.54-7.37 (m, 4H), 5.91 (ddd, 1H 
vinyl, J = 16.8, 10.9, 6.5 Hz), 5.12-5.06 (m, 2H), 4.76 (d, 1H, J = 
9.8 Hz), 3.98 (s, 3H), 3.14-2.93 (m, 5H), 2.32-2.27 (m, 1H), 2.16-
2.01 (m, 2H), 1.64-1.54 (m, 3H), 1.26-1.18 (m, 1H), 1.04-0.95 (m, 
1H). 
13
C NMR (CDCl3, 75 MHz): δ 157.6, 154.8, 148.1, 144.8, 
140.7, 139.8, 132.0, 128.9, 128.7, 127.6, 127.3, 121.7, 117.7 (br s), 
114.5, 101.4 (br s), 62.7 (br s), 55.4, 49.5, 47.4, 39.4, 27.6, 26.6, 
24.9. MS (ESI m/z) 400.3 [MH
+
, 100%]. Elemental analysis calcd 
(%) for C26H29N3O: C, 78.16; H, 7.32; N, 10.52; found C, 78.44; H, 

















(150 mg, 0.36 mmol) according to procedure 
reported in references 247b,259. The residue was 
purified by flash chromatography (eluent: EtOAc 
to EtOAc /MeOH 9:1 and then to 
EtOAc/MeOH/aq. NH4OH = 90/10/5). Pale 
yellow solid, 68 mg, 45% yield.  mp 91.4-94.4 °C. [α]D
29
 = +28.9 (c 
0.55, CHCl3). FTIR max (KBr)/cm
-1 
2930, 2864, 1594, 1552, 1508, 
1455, 1346, 913, 803, 759. 
1
H NMR (CDCl3, 400 MHz): δ 8.47-
8.45 (m, 1H), 8.26 (d, 1H, J = 8.4 Hz), 8.10 (d, 1H, J = 8.2 Hz), 
7.97-7.93 (m, 2H), 7.82-7.73 (m, 3H), 7.67-7.59 (m, 2H), 7.54-7.45 
(m, 2H), 5.80 (ddd, 1H, J = 17.1, 10.3, 7.7 Hz), 5.02-4.94 (m, 2H), 
4.78 (br d, 1H), 3.30-3.14 (m, 3H), 2.85-2.78 (m, 2H), 2.29 (br s, 
3H), 1.67-1.57 (m, 3H), 1.28-1.24 (m, 1H), 0.90-0.85 (m, 1H). 
13
C 
NMR (CDCl3, 75 MHz): δ 159.2, 148.6, 148.4, 141.3,138.6, 134.0, 
131.2, 130.7, 129.4, 129.1, 128.4, 127.8, 126.6, 126.5, 126.4, 125.9, 
125.6, 125.4, 123.2, 121.7, 114.6, 61.9, 56.0, 40.9, 39.5, 27.7, 27.5, 
26.1. MS (ESI m/z) 420.3 [MH
+
, 100%]. Elemental analysis calcd 
(%) for C26H29N3: C, 83.02; H, 6.97; N, 10.02; found C, 82.80; H, 









General procedure for the synthesis of squaramide catalysts 
To a stirred solution of B1 (150 mg, 0.37 mmol) under nitrogen 
atmosphere in dry methanol (1 mL) a solution of C (123 mg, 0.36 
mmol) in dry methanol (1 mL) was added via syringe. The mixture 
was stirred at room temperature for 70 h. The solvent was removed 
under reduced pressure and product 137f was isolated by flash 





Yellow solid, 210 mg, 82% yield. 
mp 193 °C (Decomp.). [α]D
20
 = 
+112.7 (c 0.55, MeOH). FTIR max 
(KBr)/cm
-1 
3064, 2930, 2864, 1718, 
1637, 1593, 1552, 1508, 1455, 1418, 
1346, 1216, 913, 803, 777, 759. 
1
H 
NMR (DMSO-d6, 300 MHz, 100 °C): δ 8.27-8.24 (m, 2H), 8.16 (s, 
1H), 8.05 (d, 1H, J = 9.2 Hz), 7.99 (s, 2H), 7.78 (d, 1H, J = 2.5 Hz), 
7.60-7.46 (m, 5H), 6.08 (d, 1H, J = 9.9 Hz), 4.02 (s, 3H), 3.78-3.68 
(m, 1H), 3.42-3.32 (m, 2H), 2.80-2.65 (m, 2H), 1.68-1.28 (m, 7H), 
0.89-0.83 (m, 4H). 
13
C NMR (DMSO-d6, 100 MHz): δ 184.6, 
179.9, 168.6, 163.1, 157.8, 153.7, 144.3, 144.1, 141.0, 138.6, 131.7, 
131.2 (q, 
2
JC-F= 32.8 Hz), 129.2, 128.7, 127.0, 126.2, 123.0 (q, 
1
JC-F 
= 271.1 Hz), 122.2, 118.1, 116.9, 114.7, 101.4, 59.1, 56.7, 55.6, 
53.2, 40.7, 36.4, 28.4, 26.4, 25.1, 24.8, 11.7. MS (ESI m/z) 710.0 
[MH
+
, 100%], 731.2 [MNa
+
, 11%]. Elemental analysis calcd (%) 




for C38H34F6N4O3: C, 64.40; H, 4.84; N, 7.91; found C, 64.68; H, 




Yellow solid, 242 mg, 62 % yield. mp 
145 °C (Decomp.). [α]D
30
 = -17.2 (c 
0.54, MeOH). FTIR max (KBr)/cm
-1 
3271, 3094, 2957, 2933, 2864, 1794, 
1689, 1624, 1601, 1558, 1476, 1440, 
1381, 1279, 1182, 1134, 1035, 932, 
881, 835, 757, 680. 
1
H NMR (DMSO-
d6, 300 MHz, 100 °C): δ 8.00 (s, 2H), 7.90 (d, 1H, J = 9.2 Hz), 7.71 
(d, 1H, J = 2.3 Hz), 7.53 (s, 1H), 7.49 (s, 1H), 7.41-7.37 (m, 1H), 
6.01-5.88 (m, 2H), 5.12-5.02 (m, 2H), 3.97 (s, 3H), 3.64 (m, 1H), 
3.47-3-30 (m, 2H), 2.95-2.77 (m, 4H), 2.47-2.38 (m, 1H), 1.83-1.50 
(m, 6H), 1.40 (sextet, 2H, J = 7.2 Hz), 0.94 (t, 3H, J = 7.2 Hz), 0.86-
0.80 (m, 1H). 
13
C NMR (DMSO-d6, 75 MHz): δ 184.6, 179.9, 
168.5, 162.9, 159.6, 157.3, 143.9, 141.8, 140.9, 131.2 (q, 
2
JC-F= 
32.8 Hz), 131.0, 125.7, 123.1 (q, 
1
JC-F = 271.1 Hz), 121.5, 118.1, 
117.0, 114.9, 101.4, 58.9, 55.6, 55.4, 53.0, 37.6, 31.2, 27.0, 25.6, 
21.9, 13.8. MS (ESI m/z) 687.2 [MH
+
, 32%], 709.7 [MNa
+
, 37%]. 
Elemental analysis calcd (%) for C36H36F6N4O3: C, 62.97; H, 5.28; 











Ochre solid, 130 mg, 50% yield. mp 
174 °C (Decomp.). [α]D
31
 = -22.5 (c 
0.53, MeOH). FTIR max (KBr)/cm
-1  
3502, 3257, 2952, 1794, 1690, 1600, 
1556, 1474, 1450, 1381, 1279, 1182, 
1134, 1035, 932, 881, 834, 757, 700. 
1
H NMR (DMSO-d6, 300 MHz, 100 
°C): δ 8.03-7.96 (m, 2H), 7.91 (d, 1H, J = 9.2 Hz), 7.70 (d, 1H, J = 
2.7 Hz), 7.66 (s, 1H), 7.60-7.52 (m, 1H), 7.39 (dd, 1H, J = 9.2, 2.7 
Hz), 6.00-5.85 (m, 2H), 5.18-5.00 (m, 2H), 3.96 (s, 3H), 3.72-3.54 
(m, 1H), 3.46-3.25 (m, 2H), 3.00-2.87 (m, 1H), 2.85-2.72 (m, 1H), 
2.47-2.33 (m, 1H), 1.78-1.55 (m, 4H), 1.45 (s, 9H), 0.86 (m, 1H). 
13
C NMR (DMSO-d6, 100 MHz): δ 184.7, 180.0, 168.7, 165.8, 
162.7, 157.4, 144.7, 143.1, 142.1, 140.8, 131.4, 131.2 (q, 
2
JC-F= 
32.4 Hz), 127.3, 123.1 (q, 
1
JC-F = 271.3 Hz), 121.4, 118.2, 117.0, 
114.8, 114.1, 101.3, 58.5, 55.6, 55.3, 54.8, 37.7, 31.2, 29.9, 27.2, 
26.2. MS (ESI m/z) 687.0 [MH
+
, 5%]. Elemental analysis calcd (%) 
for C36H36F6N4O3: C, 62.97; H, 5.28; N, 8.16; found C, 62.70; H, 













Yellow solid, 44 mg, 66% yield. mp 
170 °C (Decomp.). [α]D
28
 = +59.4 (c 
0.51, MeOH). FTIR max (KBr)/cm
-1 
2953, 2869, 1794, 1655, 1626, 1596, 
1560, 1475, 1449, 1382, 1278, 1180, 
1133, 932, 881, 756. 
1
H NMR 
(DMSO-d6, 300 MHz, 100 °C): δ 
8.54 (d, 1H, J = 8.2 Hz), 8.17-8.03 (m, 3H), 7.97 (s, 2H), 7.91 (s, 
1H), 7.88-7.66 (m, 5H), 7.59-7.46 (m, 3H), 6.09 (d, 1H, J = 11.0 
Hz), 5.90 (ddd, 1H, J = 17.1, 10.4 Hz, 6.9 Hz), 5.07-4.97 (m, 2H), 
3.55-3.43 (m, 1H), 3.40-3.22 (m, 2H), 2.87-2.71 (m, 2H), 2.36 (br s, 
1H), 1.72-1.49 (m, 4H), 1.02-0.96 (m, 1H). 
13
C NMR (DMSO-d6, 
75 MHz): δ 184.5, 180.3, 168.9, 162.9, 158.3, 148.0, 145.7, 142.0, 
140.9, 137.8, 133.5, 131.2 (q, 
2
JC-F= 33.5 Hz), 130.5, 130.1, 129.9, 
129.1, 128.5, 128.0, 127.3, 126.6, 126.1, 125.4, 125.2, 123.4, 123.1 
(q, 
1
JC-F = 271.8 Hz), 118.2, 114.8, 114.3, 59.5, 55.2, 53.4, 27.1, 
25.5. MS (ESI m/z) 727.3 [MH
+
, 100%]. Elemental analysis calcd 
(%) for C41H32F6N4O3: C, 67.76; H, 4.44; N, 7.71; found C, 68.07; 













White solid, 20 mg, 28% yield. 
Decomposition before melting at 
230 °C. [α]D
31
 = +52.4 (c 0.53, 
CHCl3). FTIR max (KBr)/cm
-1 
3174, 2937, 2871, 1798, 1643, 
1622, 1572, 1557, 1474, 1456, 1381, 1347, 1279, 1231, 1176, 1131, 
1034, 837, 751, 702, 682. 
1
H NMR (DMSO-d6, 300 MHz, 100 °C): 
δ 8.18 (d, 2H, J = 6.7 Hz), 8.06 (s, 1H), 8.02 (d, 1H, J = 9.4 Hz), 
7.97 (s, 1H), 7.90-7.80 (m, 2H), 7.67-7.44 (m, 5H), 6.01-5.86 (m, 
2H), 5.06-4.96 (m, 2H), 4.88 (br d, 2H, J = 5.3 Hz), 3.98 (s, 3H), 
3.53-3.46 (m, 1H), 3.36-3.19 (m, 2H), 2.81-2.63 (m, 2H), 2.33 (m, 
1H), 1.64-1.48 (m, 4H), 0.88-0.78 (m, 1H). 
13
C NMR (DMSO-d6, 
75 MHz): δ 182.7, 181.9, 167.2, 167.0, 157.6, 153.4, 145.0, 144.0, 
142.11, 142.06, 138.6, 131.5, 130.3 (q, 
2
JC-F= 32.5 Hz), 129.1, 
128.6, 128.5, 126.8, 126.3, 123.1 (q, 
1
JC-F = 271.5 Hz), 122.0, 121.0, 
114.0, 101.6, 58.6, 55.5, 55.4, 53.8, 45.7, 27.3, 27.1, 25.8. MS (ESI 
m/z) 721.5 [MH
+
, 8%]. Elemental analysis calcd (%) for 














Yellow solid, 89 mg, 53% yield. 
mp 180 °C (Decomp.). [α]D
30
 = -
92.3 (c 0.53, MeOH). FTIR max 
(KBr)/cm
-1 
2926, 2854, 1791, 
1682, 1623, 1598, 1556, 1473, 
1437, 1381, 1277, 1229, 1180, 1133, 1030, 931, 832, 770, 697. 
1
H 
NMR (DMSO-d6, 300 MHz, 100 °C): δ 8.28-8.25 (m, 2H), 8.16 (s, 
1H), 8.05 (d, 1H, J = 9.2 Hz), 7.99 (s, 2H), 7.71 (d, 1H, J = 2.5 Hz), 
7.60-7.45 (m, 5H), 6.17 (d, 1H, J = 10.7 Hz), 5.94 (ddd, 1H, J = 
17.4, 10.6, 6.1 Hz), 5.25-5.12 (m, 2H), 4.02 (s, 3H), 3.65 (m, 1H), 
3.22-2.73 (m, 4H), 2.38 (bs, 1H), 1.69-1.62 (m, 3H), 1.22-1.10 (m, 
2H). 
13
C NMR (DMSO-d6, 100 MHz): δ 184.8, 179.9, 168.7, 162.6, 
157.8, 153.6, 144.4, 144.0, 140.9, 140.8, 138.6, 131.6, 131.1 (q, 
2
JC-
F= 32.1 Hz), 129.2, 128.6, 127.0, 126.3, 123.0 (q, 
1
JC-F = 270.8 Hz), 
122.3, 118.1, 116.8, 114.6, 114.4, 101.1, 58.8, 55.5, 52.5, 48.8, 
45.6, 27.1, 25.9, 24.8. MS (ESI m/z) 709.1 [MH
+
, 100%]. 
Elemental analysis calcd (%) for C38H32F6N4O3: C, 64.59; H, 4.56; 











General procedure for the synthesis of racemic γ-
butyrolactones 143a-q, 145 
A sample vial was charged with compound 142 (0.10 mmol), 
paraformaldehyde (9.0 mg, 0.30 mmol) and 1,4-
diazabicyclo[2.2.2]octane (5.6 mg, 0.05 mmol) in anhydrous 
toluene (0.5 mL). The reaction was stirred at room temperature 
until 1 disappeared (20-90 h), monitored by TLC (eluent PE/ ethyl 
acetate 9:1 or 8:2). The product was isolated (63-98% yield) by 
flash chromatography (eluting from PE/ ethyl acetate 98:2 to 
90:10). 
General procedure for the asymmetric synthesis of γ-
butyrolactones 143f-q, 145 
A sample vial was charged with compound 142 (0.10 mmol) and 
catalyst 137f (2.1 mg, 0.003 mmol) in anhydrous 1,2-dicholoethane 
(1.0 mL). 4-Nitrophenol (solution 0.25 M in dry 1,2-dichloroethane, 
20 L, 0.005 mmol), formaldehyde (solution 37 wt% in H2O, 15 
L, 0.20 mmol) and 3Å molecular sieves (≈ 17 mg) were added. 
The solution was stirred at -20 °C until completion, monitored by 
TLC (eluent PE/ ethyl acetate 9:1 or 8:2). Purification of the crude 
mixture by flash chromatography (eluting from PE/ ethyl acetate 
98:2 to 90:10 and PE/ ethyl acetate 95:5 to 8:2 for the compound 
145) gave -butyrolactones 143f-q, 145. Absolute configuration of 
-butyrolactones 143f-q was assumed to be (R) in analogy to that 








Ethyl 3-benzoyl-5-oxotetrahydrofuran-3-carboxylate (143a) 
Data for this compound were consistent with 
those reported in the literature.
262
 Colourless 
oil, 21 mg, 80% yield. 
1
H NMR (CDCl3, 400 
MHz): δ 7.83-7.77 (m, 2H), 7.65-7.58 (m, 1H), 
7.52-7.45 (m, 2H), 4.93 and 4.79 (AX, 2H, J= 9.8 Hz), 4.18 (q, 2H, 
J= 7.1 Hz), 3.30 (A2, 2H), 1.06 (t, 3H, J= 7.1 Hz). 
13
C NMR 
(CDCl3, 100 MHz): δ 191.0, 173.3, 170.3, 134.2, 133.4, 129.1, 
128.7, 70.9, 63.1, 59.8, 35.3, 13.6. Elemental analysis calcd (%) for 
C14H14O5: C, 64.12; H, 5.38; found C, 64.38, H, 5.50. HPLC 
analysis with Chiralpak AD column, 95:5 n-hexane:2-propanol, 1.0 
mL/min, 254 nm; minor enantiomer tR = 20.8 min, major 
enantiomer tR = 22.3 min, ee 7%. 
 
tert-Butyl 3-benzoyl-5-oxotetrahydrofuran-3-carboxylate (143b) 
White solid, 19.7 mg, 68% yield. mp 70.3-
72.1 °C. [α]D
20
 = -20.8 (c 0.50, CHCl3), ee 
47%. FTIR max (KBr)/cm
-1 
2980, 2932, 1791, 
1732, 1688, 1598, 1449, 1371, 1293, 1261, 1180, 1153, 1078, 1037, 
839, 709. 
1
H NMR (CDCl3, 400 MHz): δ 7.81 (d, 2H, J= 7.6 Hz), 
7.66-7.58 (m, 1H), 7.55-7.45 (m, 2H), 4.92 and 4.73 (AX, 2H, J= 
9.7 Hz), 3.30 and 3.22 (ABq, 2H, J= 18.0 Hz), 1.28 (s, 9H). 
13
C 
NMR (CDCl3, 100 MHz): δ 191.4, 173.5, 169.1, 134.0, 133.6, 
129.0, 128.6, 84.3, 70.9, 60.5, 35.2, 27.4. MS (ESI m/z) 291.7 
[MH
+
, 12%], 313.4 [MNa
+
, 48%]. Elemental analysis calcd (%) for 
C16H18O5: C, 66.20; H, 6.25; found C, 66.49, H, 6.39. HPLC 
analysis with Chiralpak AD-H column, 95:5 n-hexane:2-propanol, 




0.8 mL/min, 254 nm; minor enantiomer tR = 16.7 min, major 




White solid, 26.2 mg, 83% yield. mp 75.3-
78.1 °C. [α]D
22
 = +11.0 (c 0.56, CHCl3), ee 
45%. FTIR max (KBr)/cm
-1
 2937, 2860, 
1791, 1733, 1687, 1598, 1449, 1289, 1260, 1215, 1179, 1077, 1037, 
903, 691. 
1
H NMR (CDCl3, 400 MHz): δ 7.83-7.79 (m, 2H), 7.65-
7.58 (m, 1H), 7.52-7.45 (m, 2H),  4.93 and 4.77 (AX, 2H, J = 9.8 
Hz), 4.87-4.80 (m, 1H), 3.30 (A2, 2H), 1.51-1.38 (m, 4H), 1.33-1.12 
(m, 6H). 
13
C NMR (CDCl3, 100 MHz): δ 191.2, 173.3, 169.7, 
134.1, 133.4, 129.0, 128.6, 75.5, 70.9, 59.9, 35.3, 30.7, 30.6, 24.9, 
23.0. MS (ESI m/z) 339.4 [MNa
+
, 21%]. Elemental analysis calcd 
(%) for C18H20O5: C, 68.34; H, 6.37; found C, 68.60; H, 6.20. 
HPLC analysis with Chiralpak AS-H column, 70:30 n-hexane:2-
propanol, 0.9 mL/min, 254 nm; minor enantiomer tR = 21.4 min, 




White solid, 27.4 mg, 74% yield. mp 
84.5-88.1 °C. [α]D
26
 = +11.4 (c 0.29, 
MeOH), ee 40%. FTIR max (KBr)/cm
-1
 
2908, 2856, 1792, 1735, 1687, 1598, 1450, 1287, 1261, 1211, 1179, 
1074, 1038, 974, 916, 755, 691. 
1
H NMR (CDCl3, 400 MHz): δ 




7.85-7.81 (m, 2H), 7.64-7.58 (m, 1H), 7.51-7.44 (m, 2H), 5.01-4.99 
(m, 1H), 4.97 and 4.80 (AX, 2H, J= 9.7 Hz), 3.34 and 3.29 (ABq, 
2H, J= 18.2 Hz), 1.80-1.71 (m, 4H), 1.70-1.56 (m, 6H), 1.51-1.23 
(m, 4H). 
13
C NMR (CDCl3, 100 MHz): δ 191.2, 173.3, 169.7, 
134.2, 133.5, 129.1, 128.7, 80.1, 71.0, 60.0, 36.9, 36.1, 36.0, 35.3, 





, 13%]. Elemental analysis calcd (%) for 
C22H24O5: C, 71.72; H, 6.57; found C, 71.46; H, 6.72. HPLC 
analysis with Chiralpak AS-H column, 70:30 n-hexane:2-propanol, 
0.9 mL/min, 254 nm; minor enantiomer tR = 18.3 min, major 




White solid, 35.6 mg, 95% yield. mp 
87.9-91.0 °C. [α]D
24
 = +3.7 (c 0.57, 
CHCl3), ee 36%. FTIR max (KBr)/cm
-1
 
2925, 2853, 1789, 1739, 1687, 1598, 1449, 1286, 1258, 1177, 1075, 
1037, 941, 801, 777, 690. 
1
H NMR (CDCl3, 400 MHz): δ 7.82-7.76 
(m, 2H), 7.58-7.51 (m, 3H), 7.45-7.34 (m, 4H), 7.33-7.27 (m, 1H), 
7.17-7.11 (m, 2H), 5.59 (s, 2H), 4.87 and 4.76 (ABq, 2H, J= 9.8 
Hz), 3.26 (A2, 2H). 
13
C NMR (CDCl3, 100 MHz): δ 190.6, 173.1, 
170.2, 133.9, 132.9, 130.0, 129.3, 128.7, 128.6, 128.4, 126.7, 125.9, 
124.9, 122.9, 70.8, 67.1, 59.7, 35.2. MS (ESI m/z) 397.8 [MNa
+
, 
100%]. Elemental analysis calcd (%) for C23H18O5: C, 73.79; H, 
4.85; found C, 73.52; H, 5.00. HPLC analysis with Chiralpak IC 
column, 70:30 n-hexane:2-propanol, 1 mL/min, 254 nm; minor 








White wax, 33.5 mg, 95% yield. [α]D
21
 = 
+22.8 (c 0.78, CHCl3), ee 87%. FTIR max 
(KBr)/cm
-1
 2984, 2935, 1790, 1737, 1687, 
1598, 1449, 1368, 1260, 1218, 1181, 1134, 1102, 1075, 1037, 762, 
701. 
1
H NMR (CDCl3, 400 MHz): δ 7.80-7.78 (m, 2H), 7.65 (t, 1H, 
J = 7.4 Hz), 7.50-7.46 (m, 2H), 7.24-7.19 (m, 3H), 7.05-7.03 (m, 
2H), 4.96 and 4.72 (AX, 2H, J = 9.8 Hz), 3.26 (A2, 2H), 1.64 (s, 
3H), 1.62 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 191.1, 173.3, 
168.2, 143.6, 134.2, 133.4, 129.1, 129.0, 128.3, 127.7, 124.1, 85.1, 
70.7, 60.4, 35.0, 27.8, 27.5. MS (ESI m/z) 353.1[MH
+
, 3%], 375.2 
[MNa
+
, 100%], 391.1 [MK
+
, 18%]. Elemental analysis calcd (%) 
for C21H20O5: C, 71.58; H, 5.72; found C, 71.86; H, 5.91. HPLC 
analysis with Chiralpak IC column, 70:30 n-hexane:2-propanol, 1.0 
mL/min, 254 nm; minor enantiomer tR = 27.4 min, major 




White solid, 31.9 mg, 87% yield. mp 
107.7-110.0 °C. [α]D
21
 = +17.3 (c 0.76, 
CHCl3), ee 88%. FTIR max (KBr)/cm
-1
 
2924, 2854, 1791, 1737, 1684, 1606, 1450, 
1369, 1261, 1182, 1133, 1102, 1075, 1036, 835, 763, 700. 
1
H NMR 




(CDCl3, 400 MHz): δ 7.69 (d, 2H, J= 8.2 Hz), 7.30-7.26 (m, 2H), 
7.25-7.18 (m, 3H), 7.10-7.04 (m, 2H), 4.94 and 4.72 (AX, 2H, J= 
9.7 Hz), 3.27 and 3.23 (ABq, 2H, J= 18.1 Hz), 2.45 (s, 3H), 1.65 (s, 
3H), 1.63 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 190.6, 173.4, 
168.4, 145.3, 143.7, 130.9, 129.8, 129.1, 128.3, 127.6, 124.2, 85.0, 
70.7, 60.4, 35.1, 27.8, 27.5, 21.7. MS (ESI m/z) 367.4 [MH
+
, 11%]. 
Elemental analysis calcd (%) for C22H22O5: C, 72.12; H, 6.05; found 
C, 71.90; H, 6.18. HPLC analysis with Chiralpak IC column, 70:30 
n-hexane:2-propanol, 1.0 mL/min, 254 nm; minor enantiomer tR = 




Colourless waxy solid, 30.4 mg, 85% yield. [α]D
18
 = +19.8 (c 0.50, 
CHCl3), ee 83%. FTIR max (KBr)/cm
-1
 2922, 
2852, 1789, 1737, 1686, 1449, 1385, 1369, 
1265, 1236, 1176, 1134, 1101, 1076, 1037, 
762, 700. 
1
H NMR (CDCl3, 400 MHz): δ 7.61 (s, 1H), 7.55 (d, 1H, 
J = 7.5 Hz), 7.45 (d, 1H, J = 7.5 Hz), 7.35 (t, 1H, J = 7.6 Hz), 7.25-
7.18 (m, 3H), 7.06-7.03 (m, 2H), 4.94 and 4.72 (AX, 2H, J = 9.8 
Hz), 3.27 and 3.24 (ABq, 2H, J= 18.2 Hz), 2.38 (s, 3H), 1.65 (s, 
3H), 1.62 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ.191.2, 173.4, 
168.3, 143.6, 139.1, 134.9, 133.5, 129.5, 128.9, 128.3, 127.6, 126.1, 
124.1, 85.0, 70.7, 60.4, 35.1, 27.8, 27.5, 21.4. MS (ESI m/z) 367.4 
[MH
+
, 11%], 389.3 [MNa
+
, 26%]. Elemental analysis calcd (%) for 
C22H22O5: C, 72.12; H, 6.05; found C, 72.34; H, 6.23. HPLC 
analysis with Chiralpak IC column, 70:30 n-hexane:2-propanol, 1.0 




mL/min, 254 nm; minor enantiomer tR = 22.1 min, major 




White solid, 30.8 mg, 84% yield. mp 70.9-
72.6 °C. [α]D
23
 = +13.7 (c 0.66, CHCl3), ee 
48%.  FTIR max (KBr)/cm
-1
 2927, 2852, 
1790, 1740, 1692, 1451, 1385, 1369, 1252, 1180, 1132, 1100, 1073, 
1034, 764, 700. 
1
H NMR (CDCl3, 400 MHz): δ 7.49-7.42 (m, 1H), 
7.36 (d, 1H, J= 7.6 Hz), 7.25-7.18 (m, 5H), 7.06-6.99 (m, 2H), 4.87 
and 4.75 (AX, 2H, J= 9.7 Hz), 3.27 and 3.22 (ABq, 2H, J= 18.2 
Hz), 2.52 (s, 3H), 1.56 (s, 3H), 1.55 (s, 3H). 
13
C NMR (CDCl3, 100 
MHz): δ 194.8, 173.4, 168.2, 143.7, 140.2, 134.2, 132.7, 132.4, 
128.3, 127.6, 127.4, 125.9, 124.0, 84.8, 71.3, 61.8, 35.7, 27.5, 27.3, 
21.5. MS (ESI m/z) 388.8 [MNa
+
, 16%], 404.5 [MK
+
, 14%]. 
Elemental analysis calcd (%) for C22H22O5: C, 72.12; H, 6.05; found 
C, 72.39; H, 5.84. HPLC analysis with Chiralpak IC column, 80:20 
n-hexane:2-propanol, 1.0 mL/min, 254 nm; minor enantiomer tR = 




Colourless wax, 34.0 mg, 88% yield. 
[α]D
22
 = +29.7 (c 0.56, CHCl3), ee 86%. 
FTIR max (KBr)/cm
-1
 2924, 2852, 1791, 
1737, 1688, 1589, 1489, 1402, 1369, 1259, 1179, 1133, 1094, 1037, 




846, 763, 700. 
1
H NMR (CDCl3, 400 MHz): δ 7.72 (d, 2H, J = 8.6 
Hz), 7.44 (d, 2H, J = 8.6 Hz), 7.28-7.20 (m, 3H), 7.06-7.04 (m, 2H), 
4.94 and 4.70 (AX, 2H, J = 9.8 Hz), 3.25 and 3.22 (ABq, 2H, J = 
18.1 Hz), 1.67 (s, 3H), 1.64 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): 
δ 190.0, 173.0, 168.1, 143.3, 140.9, 131.7, 130.3, 129.5, 128.4, 
127.8, 124.2, 85.3, 70.5, 60.5, 34.9, 27.8, 27.5. MS (ESI m/z) 386.5 
[MH
+
, 63%]. Elemental analysis calcd (%) for C21H19ClO5: C, 
65.20; H, 4.95; found C, 65.49; H, 4.82. HPLC analysis with 
Chiralpak IC column, 70:30 n-hexane:2-propanol, 1.0 mL/min, 254 





White wax, 33.6 mg, 78% yield. [α]D
19
 = 
+21.6 (c 0.55, CHCl3), ee 85%. FTIR 
max (KBr)/cm
-1
 2924, 2851, 1790, 1737, 
1688, 1585, 1398, 1259, 1180, 1133, 1101, 1075, 1037, 1010, 844, 
763, 700. 
1
H NMR (CDCl3, 400 MHz): δ 7.65-7.59 (m, 3H), 7.25-
7.19 (m, 4H), 7.09-7.02 (m, 2H), 4.93 and 4.69 (AX, 2H, J= 9.8 
Hz), 3.27 and 3.19 (ABq, 2H, J= 18.2 Hz), 1.66 (s, 3H), 1.64 (s, 
3H). 
13
C NMR (CDCl3, 75 MHz): δ 190.2, 173.0, 168.0, 143.3, 
132.5, 132.1, 130.4, 129.7, 128.3, 127.8, 124.2, 85.4, 70.5, 60.5, 
34.9, 27.8, 27.5. MS (ESI m/z) 431.3 [MH
+
, 5%]. Elemental 
analysis calcd (%) for C21H19BrO5: C, 58.48; H, 4.44; found C, 
58.20; H, 4.59. HPLC analysis with Chiralpak IC column, 70:30 n-
hexane:2-propanol, 1.0 mL/min, 254 nm; minor enantiomer tR = 








Pale yellow wax, 26.9 mg, 64% yield. 
[α]D
19
 = +17.1 (c 0.50, CHCl3), ee 66%. 
FTIR max (KBr)/cm
-1
 2925, 2853, 1792, 
1740, 1695, 1410, 1328, 1259, 1173, 1133, 1069, 1039, 858, 764, 
700. 
1
H NMR (CDCl3, 400 MHz): δ 7.88 (d, 2H, J= 8.2 Hz), 7.73 
(d, 2H, J= 8.2 Hz), 7.25-7.16 (m, 3H), 7.03 (d, 2H, J= 7.2 Hz), 4.95 
and 4.71 (AX, 2H, J= 9.8 Hz), 3.28 and 3.21 (ABq, 2H, J= 18.1 
Hz), 1.67 (s, 3H), 1.64 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 
190.3, 172.8, 167.8, 143.0, 136.1, 135.4 (q, 
2
JC-F= 32.9 Hz), 129.3, 
128.3, 127.9, 126.2, 126.1, 124.2, 123.2 (q, 
1
JC-F= 271.4 Hz), 85.5, 





, 8%]. Elemental analysis calcd (%) for C22H19F3O5: C, 
62.86; H, 4.56; found C, 63.09; H, 4.79. HPLC analysis with 
Chiralpak IC column, 80:20 n-hexane:2-propanol, 1.0 mL/min, 254 





White solid, 34.2 mg, 85% yield. mp 
111.9-114.2 °C. [α]D
24
 = +23.4 (c 0.55, 
CHCl3), ee 83%. FTIR max (KBr)/cm
-1
 
2926, 2852, 1789, 1736, 1684, 1627, 1466, 1369, 1273, 1241, 1178, 




1133, 1100, 1074, 1036, 762, 700. 
1
H NMR (CDCl3, 400 MHz): δ 
8.18 (s, 1H), 7.98-7.90 (m, 3H), 7.84 (d, 1H, J= 8.0 Hz), 7.72-7.65 
(m, 1H), 7.63-7.56 (m, 1H), 7.17-7.09 (m, 1H), 7.05-6.95 (m, 4H), 
5.02 and 4.80 (AX, 2H, J= 9.8 Hz), 3.34 (A2, 2H), 1.63 (s, 3H), 
1.60 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 191.0, 173.4, 168.4, 
143.4, 135.8, 132.2, 130.9, 130.7, 129.9, 129.4, 129.2, 128.2, 127.8, 
127.6, 127.3, 124.2, 124.1, 85.1, 70.8, 60.5, 35.2, 27.8, 27.5. MS 
(ESI m/z) 403.1 [MH
+
, 10%]. Elemental analysis calcd (%) for 
C25H22O5: C, 74.61; H, 5.51; found C, 74.35; H, 5.40. HPLC 
analysis with Chiralpak IC column, 70:30 n-hexane:2-propanol, 1.0 
mL/min, 254 nm; minor enantiomer tR = 34.6 min, major 




White solid, 29.0 mg, 81% yield. mp 85.7-
88.9 °C. [α]D
22
 = +18.8 (c 0.54, CHCl3), ee 
82%. FTIR max (KBr)/cm
-1
 2923, 2851, 
1788, 1736, 1677, 1509, 1413, 1259, 1177, 1133, 1076, 1034, 828, 
763, 700. 
1
H NMR (CDCl3, 400 MHz): δ 7.93-7.91 (m, 1H), 7.52-
7.49 (m, 1H), 7.40-7.37 (m, 1H), 7.25-7.19 (m, 3H), 7.10-7.05 (m, 
2H), 4.95 and 4.70 (AX, 2H, J= 9.8 Hz), 3.25 (A2, 2H), 1.68 (s, 
3H), 1.66 (s, 3H). 
13
C NMR (CDCl3, 75 MHz): δ 184.8, 173.4, 
168.0, 143.5, 137.8, 134.0, 128.3, 127.7, 127.4, 127.1, 124.1, 85.1, 
70.3, 61.1, 34.6, 27.9, 27.6. MS (ESI m/z) 358.6 [MH
+
, 17%], 381.4 
[MNa
+
, 11%], 397.2 [MK
+
, 22%]. Elemental analysis calcd (%) for 
C19H18O5S: C, 63.67; H, 5.06; S, 8.95; found C, 63.51; H, 5.00; S, 




8.76. HPLC analysis with Chiralpak IC column, 70:30 n-hexane:2-
propanol, 1.0 mL/min, 254 nm; minor enantiomer tR = 38.5 min, 




Colourless oil, 31.2 mg, 98% yield. [α]D
24
 = 
+13.2 (c 0.57, CHCl3), ee 76%. FTIR max 
(KBr)/cm
-1
 2924, 2852, 1790, 1716, 1519, 
1497, 1464, 1450, 1369, 1338, 1274, 1242, 1175, 1135, 1098, 1031, 
896, 825, 765, 700, 556. 
1
H NMR (CDCl3, 300 MHz): δ 7.39-7.29 
(m, 5H), 4.62 and 4.58 (ABq, 2H, J = 9.8 Hz), 3.04 and 2.98 (ABq, 
2H, J = 17.9 Hz), 2.45-2.39 (m, 2H), 1.82 (s, 6H), 1.66 (sextet, 2H, 
J = 7.3 Hz), 0.91 (t, 3H, J = 7.3 Hz). 
13
C NMR (CDCl3, 100 MHz): 
δ 201.2, 173.3, 167.3, 143.7, 128.5, 127.9, 124.2, 85.1, 70.0, 63.1, 





, 47%]. Elemental analysis calcd (%) for 
C18H22O5: C, 67.91; H, 6.97; found C, 67.70; H, 6.78. HPLC 
analysis with Chiralpak IC column, 80:20 n-hexane:2-propanol, 1.0 
mL/min, 220 nm; minor enantiomer tR = 23.3 min, major 













Yellow oil, 22.0 mg, 69% yield. [α]D
25
 = +14.6 
(c 0.87, CHCl3), ee 82%. FTIR max (KBr)/cm
-1
 
2978, 2937, 1790, 1739, 1715, 1469, 1368, 
1274, 1238, 1171, 1136, 1100, 1030, 764, 700. 
1
H NMR (CDCl3, 
300 MHz): δ 7.41-7.28 (m, 5H), 4.66 and 4.58 (ABq, 2H, J= 9.7 
Hz), 3.04 (A2, 2H), 2.84 (sept, 1H, J= 7.0 Hz), 1.82 (s, 6H), 1.14 (d, 
3H, J= 7.0 Hz), 1.13 (d, 3H, J= 7.0 Hz). 
13
C NMR (CDCl3, 100 
MHz): δ 206.2, 173.3, 167.3, 143.6, 128.6, 127.9, 124.2, 85.3, 70.3, 





, 40%]. Elemental analysis calcd (%) for 
C18H22O5: C, 67.91; H, 6.97; found C, 68.19; H, 7.16. HPLC 
analysis with Chiralpak IC column, 70:30 n-hexane:2-propanol, 1.0 
mL/min, 220 nm; minor enantiomer tR = 15.9 min, major 




White solid, 26.3 mg, 83% yield. mp 66.3-
67.9 °C. [α]D
21
 = +4.6 (c 0.58, CHCl3), ee 69%. 
FTIR max (KBr)/cm
-1
 2984, 2926, 2853, 1789, 
1739, 1705, 1449, 1386, 1275, 1244, 1178, 1138, 1102, 1076, 1031, 
765, 700. 
1
H NMR (CDCl3, 400 MHz): δ 7.37-7.29 (m, 5H), 4.77 
and 4.62 (AX, 2H, J = 9.8 Hz), 3.11 (A2, 2H), 1.88-1-83 (m, 1H), 
1.81 (s, 6H), 1.24-1.20 (m, 2H), 1.08-1.03 (m, 2H). 
13
C NMR 
(CDCl3, 100 MHz): δ 201.4, 173.5, 167.2, 143.9, 128.5, 127.8, 




124.2, 84.9, 69.7, 63.2, 33.5, 28.05, 28.00, 18.1, 13.2, 13.1. MS 
(ESI m/z) 339.4 [MNa
+
, 100%]. %]. Elemental analysis calcd (%) 
for C18H20O5: C, 68.34; H, 6.37; found C, 68.60; H, 6.21. HPLC 
analysis with Chiralpak AD-H column, 90:10 n-hexane:2-propanol, 
1.0 mL/min, 254 nm; minor enantiomer tR = 9.7 min, major 




White wax, 9.2 mg, 25% yield. [α]D
24
 = 
+58.6 (c 0.46, CHCl3), ee 70%. FTIR max 
(KBr)/cm
-1
 2982, 2931, 2854, 1762, 1741, 
1679, 1598, 1448, 1369, 1271, 1236, 1215, 
1131, 1100, 1056, 767, 699. 
1
H NMR (CDCl3, 300 MHz): δ 7.86-
7.77 (m, 2H), 7.66-7.57 (m, 1H), 7.50-7.39 (m, 2H), 7.25-7.15 (m, 
3H), 7.12-7.04 (m, 2H), 4.84 and 4.75 (ABq, 2H, J= 11.9 Hz), 2.93-
2.80 (m, 1H), 2.75-2.51 (m, 2H), 2.35-2.23 (m, 1H), 1.70 (s, 3H), 
1.62 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 193.8, 171.1, 168.7, 
143.9, 134.0, 133.8, 129.0, 128.9, 128.3, 127.5, 124.2, 84.8, 70.4, 
56.9, 28.2, 27.3, 27.1, 25.4. MS (ESI m/z) 389.4 [MNa
+
, 11%]. 
Elemental analysis calcd (%) for C22H22O5: C, 72.12; H, 6.05; found 
C, 72.40; H, 6.20. HPLC analysis with Chiralpak AD-H column, 
95:5 n-hexane:2-propanol, 1.0 mL/min, 254 nm; minor enantiomer 








Reduction of γ-butyrolactones 143f and 143j 
Reduction of -butyrolactones 143f and 143j was performed by 
using a modified protocol reported in the literature.
263
 Finely 
ground CeCl3•7H2O was dried by heating at 100 °C under vacuum 
overnight. -Butyrolactone 143f or 143j (0.45 mmol) was dissolved 
in THF/EtOH= 3/1 (2.25 mL/750 μL) in a dried round-bottomed 
flask under nitrogen atmosphere and dry CeCl3 (73 mg, 0.30 mmol) 
was added. The reaction mixture was cooled at -80 °C and stirred 
for 10 min at this temperature. After 10 min, NaBH4 (10.2 mg, 0.27 
mmol) was added and the reaction mixture was left under stirring at 
-80 °C for 10 h and 16 h, respectively (TLC eluent PE/ ethyl acetate 
7:3). The reaction was quenched diluting with brine (50 mL) and 
extracted with ethyl acetate (3x50 mL). The combined organic layer 
was washed with brine, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. Purification by column 
chromatography was not necessary and compounds 146f (91% 
yield) and 146j (95% yield) were obtained as an inseparable 
mixture of diastereomers (90:10 dr), as white solids. The 
diastereisomeric ratio was determined by 
1




White solid, 90.2 mg, 91% yield. FTIR max 
(KBr)/cm
-1 
3418, 2925, 2854, 1783, 1732, 
1455, 1221, 1137, 1027, 770, 701. 
1
H NMR 
(CDCl3, 400 MHz): δ 7.38-7.26 (m, 8H), 7.26-7.20 (m, 2H), 5.04 
(s, 1H) [minor 5.10 (s, 0.11H)], 4.47 (A2, 2H) [minor 4.62 and 4.53 




(AX, 0.22H, J= 9.6 Hz)], 3.05 (br s, OH), 2.93 and 2.87 (ABq, 2H, 
J= 17.8 Hz) [partially overlapped with minor 2.90 and 2.84 (ABq, 
0.22H, J= 18.0 Hz)], 1.75 (s, 3H), 1.74 (s, 3H) [minor 1.72 (s, 
0.33H), 1.70 (s, 0.33H)].
 13
C NMR (CDCl3, 100 MHz): δ 174.9 
[minor 175.1], 171.0 [minor 170.7], 144.2, 138.6 [minor 138.7], 
128.8, 128.6, 128.4, 127.5 [minor 127.7], 126.7 [minor 127.1], 
124.1 [minor 126.4, 124.3], 84.5 [minor 84.3], 75.6 [minor 74.1], 
71.1 [minor 71.6], 56.4 [minor 56.7], 34.3 [minor 32.7], 28.1 
[minor 29.6], 27.8 [minor 27.7]. MS (ESI m/z) 377.6 [MNa
+
, 
100%]. Elemental analysis calcd (%) for C21H22O5: C, 71.19; H, 





White solid, 165.8 mg, 95% yield. FTIR 
max (KBr)/cm
-1 
3435, 2928, 1779, 1732, 
1494, 1449, 1414, 1368, 1273, 1234, 
1195, 1136, 1028, 843, 764, 700. 
1
H NMR (CDCl3, 400 MHz): δ 
7.39-7.26 (m, 5H), 7.26-7.18 (m, 4H), 5.00 (d, 1H, J= 6.0 Hz) 
[minor 5.07 (d, 0.11H, J= 3.0 Hz)], 4.46 and 4.44 (ABq, 2H, J= 9.7 
Hz) [minor 4.58 and 4.49 (ABq, 0.22H, J= 9.6 Hz)], 3.16 (br d, OH, 
J= 6.0 Hz), 2.91 and 2.82 (ABq, 2H, J= 17.6 Hz) [overlapped with 
minor 2.90 and 2.78 (m, 0.22H)], 1.75 (s, 6H) [minor 1.722 (s, 
0.33H), 1.718 (s, 0.33H)].
 13
C NMR (CDCl3, 100 MHz): δ 174.8 
[minor 175.1], 170.8 [minor 170.5], 143.96 [minor 144.0], 137.3 
[minor 137.4], 134.5, 128.7, 128.4, 128.1, 127.6 [minor 127.5], 




124.1 [minor 124.3], 84.7 [minor 84.4], 74.8 [minor 73.2], 70.9 
[minor 71.7], 56.3 [minor 56.8], 34.5 [minor 32.2], 28.1, 27.9 
[minor 27.8]. MS (ESI m/z) 411.5 [MNa
+
, 49%], 427.5 [MK
+
, 
23%]. %]. Elemental analysis calcd (%) for C21H21ClO5: C, 64.87; 
H, 5.44; found C, 64.62; H, 5.58. 
Synthesis of compound 148j 
To the diastereoisomeric mixture of alcohol 146j (100 mg, 0.26 
mmol) in dry pyridine (1.3 mL) was added DMAP (9.5 mg, 0.078 
mmol) and then 4-bromobenzoyl chloride (282 mg, 1.29 mmol) at 0 
°C. The resulting mixture was stirred for 4 hours at 30 °C. The 
reaction was quenched by addition of saturated NaHCO3 (TLC 
eluent: PE/ethyl acetate 8:2). The organic materials were extracted 
three times with CHCl3, the combined organic layer was dried over 
anhydrous Na2SO4, and concentrated under reduced pressure. The 
diastereoisomeric ratio was determined by 1H NMR analysis of 
the crude reaction mixture (90:10 dr). Purification by flash 
chromatography eluting with mixtures of PE/ethyl acetate 95/5 to 

















Major diast.: White solid, 90 mg. mp 
125.0-126.3 °C. [α]D
21
 = +45.4 (c 0.56, 
CHCl3), ee 86%. The ee was improved 
up to 99% by a single crystallization 
performed by slow evaporation of a n-hexane / ethanol solvent 
mixture at room temperature. FTIR max (KBr)/cm
-1 
2927, 1791, 
1733, 1590, 1493, 1399, 1265, 1174, 1136, 1094, 1032, 1011, 837, 
756, 699. 
1
H NMR (CDCl3, 400 MHz): δ 7.84 (d, 2H, J = 8.1 Hz), 
7.61 (d, 2H, J = 8.1 Hz), 7.34 and 7.28 (ABq, 4H, J = 8.3 Hz), 7.24-
7.20 (m, 5H), 6.37 (s, 1H), 4.54 and 4.47 (ABq, 2H, J = 10.0 Hz), 
3.10 and 2.86 (AX, 2H, J = 17.9 Hz), 1.77 (s, 3H), 1.73 (s, 3H). 
13
C 
NMR (CDCl3, 100 MHz): δ 173.6, 168.5, 164.0, 143.7, 135.5, 
133.2, 132.1, 131.2, 129.24, 129.18, 128.4, 128.3, 127.7, 127.6, 
124.2, 84.6, 76.4, 69.8, 55.5, 34.0, 28.2, 27.7. MS (ESI m/z) 571.4 
[MH
+
, 4%], 595.0 [MNa
+
, 10%], 610.2 [MK
+
, 6%]. Elemental 
analysis calcd (%) for C28H24BrClO6: C, 58.81; H, 4.23; found C, 
59.08; H, 4.02. HPLC analysis with Chiralpak IC column, 90:10 n-
hexane:2-propanol, 1.0 mL/min, 254 nm, major diastereoisomer:  










Synthesis of compound 147f 
The title compound was synthesized according to the literature.
164b
 
Alcohol 146f was obtained after reduction of enantioenriched 
compound 143f (90:10 dr, 84% ee). Under a positive pressure of 
nitrogen, a flamed round bottom two necked flask was charged with 
anhydrous DCM (600 μL), alcohol 146f (42.2 mg, 0.12 mmol) and 
2,6-lutidine (28 μL, 0.24 mmol). The solution was cooled at 0 °C 
and tert-butyldimethylsilyl trifluoromethanesulfonate TBDMSOTf 
(41 μL, 0.18 mmol) was added. The reaction mixture was allowed 
to slowly warm up to room temperature under stirring, until the 
complete consumption of the starting material (19 h, TLC eluent: 
PE/ethyl acetate 8:2). The reaction mixture was then diluted with 
DCM and sat. aq. NaHCO3 solution was added. The organic 
solution was separated, washed with brine, dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. The residue was 
purified by flash chromatography (eluting with mixtures of 
PE/ethyl acetate 100/1 to 95/5) to give colourless gummy 
compound 147f in 60% yield (33.7 mg) as an inseparable mixture 
of diastereomers (85:15 dr). The diastereisomeric ratio was 
determined by 
1















Colourless liquid gum, 33.7 mg, 60% yield. 
FTIR max (KBr)/cm
-1 
2927, 2856, 1796, 1734, 
1497, 1464, 1385, 1366, 1255, 1179, 1137, 
1105, 1023, 839, 764, 699. 
1
H NMR (CDCl3, 
600 MHz): δ 7.42-7.22 (m, 10H), 5.79 (s, 1H) [minor 5.49 (s, 
0.20H)], 3.56 and 3.34 (AX, 2H, J = 10.0 Hz) [minor 4.00 and 3.98 
(ABq, 0.40H, J= 10.0 Hz)], 3.28 and 2.85 (AX, 2H, J= 17.3 Hz) 
[minor 3.17 and 2.98 (AX, 0.40H, J= 17.5 Hz)], 1.90 (s, 3H), 1.85 
(s, 3H), 0.85 (s, 9H), -0.07 (s, 3H), -0.11 (s, 3H). 
13
C NMR (CDCl3, 
100 MHz): δ 174.4 [minor 174.9], 169.8 [minor 168.3], 144.4 
[minor 144.7], 134.3 [minor 135.6], 128.5, 128.4, 128.2, 127.5, 
126.1, 124.3, 84.1 [minor 82.9], 83.9 [minor 83.7], 63.5 [minor 
64.3], 56.4 [minor 57.9], 36.6 [minor 34.6], 28.7, 27.8 [minor 27.6, 
27.2], 25.7 [minor 25.8], 18.1 [minor 22.7], -6.0 [minor -5.5, -5.6]. 
MS (ESI m/z) 491.7 [MNa
+
, 62%], 507.8 [MK
+
, 100%]. Elemental 
analysis calcd (%) for C27H36O5Si: C, 69.20; H, 7.74; found C, 
69.38; H, 7.64. HPLC analysis with Chiralpak AD-H column, 100:1 
n-hexane : ethanol, 1.0 mL/min, 220 nm, major diastereoisomer: 































Confirmation of the relative configuration of compound 147f by 
NOESY  













X-ray data for the relative and absolute configuration 
assignment of compound 148j 
 
X-ray diffraction quality single crystals of major diastereoisomer of 
compound 148j were obtained by slow evaporation of a solution of 
148j in n-hexane / ethanol solvent mixture at room temperature. 
A suitable crystal of 148j was selected and mounted on a cryo-loop 
with Paratone oil and measured at 100 K room temperature with a 
Rigaku AFC7S diffractometer equipped with a Mercury2 CCD 
detector using MoK radiation. Data reduction was performed with 
the crystallographic package CrystalClear.
264
 Data have been 
corrected for Lorentz, polarization and absorption. The structures 
were solved by direct methods using the program SIR2011
265
 and 
refined by means of full matrix least-squares based on F
2




All non-hydrogen atoms were refined anisotropically, hydrogen 
atoms were positioned geometrically and included in structure 
factors calculations but not refined.  
A total of 325 refinable parameters were finally considered, final 





wR2= 0.1902 (all 6047 independent. reflections).  
Flack parameter is -0.010(14). 
ORTEP plot is obtained by means of the program Mercury.
267
 
Crystal data:  
C28H24BrClO6, FW= 571.83, monoclinic, space group P21, Z= 2, a= 
14.053(2) Å, b= 6.2308(9) Å, c=14.438(2)  Å,  = 95.626(3) °, 






, Dx = 1.509 gcm
-3




Molecular structure of 148j. Thermal ellipsoids are drawn at 30% 


























6.4 Organocatalytic enantioselective synthesis of α-
nitroepoxides via kinetic resolution 
Experimental procedures and compounds characterization 
Catalyst 187 was prepared according to the literature.
268 
 
General procedure for the epoxidation of nitroalkenes 
The (E)-α,β- disubstituted nitroalkenes were synthesized according 
to the literature.
269 
α-Nitroepoxides were prepared according to published 
procedures.
187,188c,191 
To a stirred ice-bath cold suspension of (E)-
α,β-disubstituted nitroalkene (6 mmol) in methanol (12 mL) and 
hydrogen peroxide 50% aqueous solution (450 μL, 7.8 mmol), 
aqueous NaOH 2M (1.5 mL, 3 mmol) was added rapidly (ca. 5 
minutes) with stirring. The reaction was stirred at 0 ºC for 1 h (5 h 
for compound 184h). Then, water was added (30 mL), extracted 
with diethyl ether (3 x 30 mL) and the combined ethereal extracts 
were washed with brine (40 mL), dried with Na2SO4 and 
concentrated under vacuum. The residue was purified by flash 
chromatography (PE/ diethyl ether 100:5) to give compounds 184a, 
184e-m (13-72% yields). 
 
General procedure for the aminolytic kinetic resolution (AKR) 
of racemic α-nitro epoxides 
 
A sample vial was charged with nitroepoxide 184 (0.20 mmol) and 
catalyst 78c (22.5 mg, 0.04 mmol) in anhydrous toluene (2 mL). 
Aniline (55 μL, 0.60 mmol) was added and the reaction stirred at 
room temperature for 84-115 h, monitored by TLC (eluent PE/ 




diethyl ether 95:5 or 90:10 and PE/ ethyl acetate 90:10 only for 
compounds 184, 185g and 184, 185k). The enantioenriched α-
nitroepoxides 184a, 184e-m and products 185a-185e-m were 
isolated by flash chromatography (eluting from PE/ diethyl ether 
100:2 to 100:5 and to 80:20 only for compound 185m. In particular, 
aniline and -amino ketone 185m have the same polarity. To 
remove aniline from the mixture of the two products, recovered 
after silica gel chromatography, the mixture was diluted with Et2O 
and washed with water. 
 
General procedure for the kinetic resolution of 184a with thiol 
190 
A sample vial was charged with nitroepoxide 184a-(±) (17.9 mg, 
0.10 mmol), K2CO3 (2.8 mg, 0.02 mmol) and catalyst 783c (8.5 mg, 
0.015 mmol) in anhydrous toluene (1 mL). Then, 2-
naphthalenethiol (19.2 mg, 0.12 mmol) was added and the reaction 
stirred at room temperature for 70 h, monitored by TLC (eluent PE/ 
diethyl ether 95:5).  
The enantioenriched α-nitroepoxide 184a (4.5 mg, 25% yield) and 
product 192 (21.3 mg, 73% yield) were isolated by flash 
chromatography (eluting from PE/ diethyl ether 100:1 to 80:20). 
 
General procedure for the kinetic resolution of 184a with 
diamine 191 
A sample vial was charged with nitroepoxide 184a-(±) (26.9 mg, 
0.15 mmol) and catalyst 78c (12.7 mg, 0.022 mmol) in anhydrous 
toluene (1.5 mL). Then o-phenylenediamine 191 (19.5 mg, 0.18 




mmol) was added and the reaction was stirred at room temperature 
for 47 h, monitored by TLC (eluent PE/ diethyl ether 95:5). The 
enantioenriched α-nitroepoxide 184a (8.6 mg, 32% yield) and 
product 193 (18.5 mg, 56% yield) were isolated by flash 
chromatography (eluting from PE/ diethyl ether 100:2 to 90:10). 
 
General procedure for one-pot stereoselective ring-
opening/reduction sequence to amino alcohol 189 
To a solution of nitroepoxide 184a-(±) (22.6 mg, 0.126 mmol) in 
dry CHCl3 (315 μL), pyrrolidine (21 μL, 0.252 mmol) was added at 
0 °C. The resulting mixture was stirred for 6 hours at 0 °C (TLC 
eluent PE/ diethyl ether 95:5). After completion, dry MeOH (105 
μL) was added at 0 °C, followed by dry CeCl3 (31.1 mg, 0.126 
mmol, finely ground CeCl3•7H2O dried at 100 °C under vacuum 
overnight). The reaction mixture was stirred for 10 min at the same 
temperature and then NaBH4 (4.8 mg, 0.126 mmol) was added. 
After stirring at 0 °C for 2.5 h, a second portion of NaBH4 (4.8 mg, 
0.126 mmol) and CeCl3 (31.1 mg, 0.126 mmol) was added, and 
stirring continued for additional 3 h. After complete conversion of 
the ketone to the alcohol (TLC eluent ethyl acetate/ MeOH 10 mL : 
1 mL with 6 drops of NH4OH, stained with permanganate) the 
reaction was quenched by diluting with brine (20 mL) and 
extracting with ethyl acetate (3x20 mL). The combined organic 
layers were washed with brine, dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. Purification by flash 
chromatography eluting with CH2Cl2 and then with diethyl ether 
afforded anti-1,2-amino alcohol 189 in 78% yield (20.2 mg). 




Absolute configuration of (1R,2S)-1-phenyl-1-(pyrrolidin-1-
yl)propan-2-ol 189 was determined by comparison of optical 
rotation with the literature.
207
 The absolute configuration of -
nitroepoxide 184a was assigned to be (2R,3S) and the absolute 
configuration of -nitroepoxides 184 was assigned to be (2R,3S) by 
analogy. 
 
(2R, 3S)-2-Methyl-2-nitro-3-phenyloxirane (184a) 
Data for this compound were consistent with those 
reported in the literature.
188c 
 
Yellow oil, 10 mg, 28 % yield. [α]D
17
 = -36.7 (c 0.48, CHCl3), ee 
72%. FTIR max (KBr)/cm
-1
 3066, 3035, 2947, 1558, 1451, 1357, 
1159, 1107, 901, 770, 754, 703, 602. 
1
H NMR (CDCl3, 400 MHz): 
δ 7.46-7.40 (m, 3H), 7.32-7.29 (m, 2H), 4.54 (s, 1H), 1.80 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 130.9, 129.4, 128.7, 126.4, 88.9, 
62.6, 12.4. HPLC analysis with Chiralpak AS-H column, 95:5 n-
hexane:2-propanol, 1 mL/min, 254 nm; minor enantiomer tR = 6.1 
min, major enantiomer tR = 6.8 min. 
 
(2R, 3S)-2-Methyl-2-nitro-3-p-tolyloxirane (184e) 
Data for this compound were consistent with 
those reported in the literature.
188c
 
Yellow oil, 6.6 mg, 17% yield. [α]D
24
 = -33.5 (c 0.50, CHCl3), ee 
84%. FTIR max (KBr)/cm
-1
 3028, 2925, 1559, 1452, 1346, 1159, 
1106, 903, 848, 817, 772.  
1
H NMR (CDCl3, 300 MHz): δ 7.25-
7.16 (m, 4H), 4.50 (s, 1H), 2.38 (s, 3H), 1.80 (d, 3H, J= 1.3 Hz). 





C NMR (CDCl3, 100 MHz): δ 139.5, 129.4, 127.9, 126.3, 89.0, 
62.8, 21.3, 12.4. MS (ESI m/z) 216.5 [MNa
+
, 12%]. HPLC analysis 
with Chiralpak IE-3 column, 98:2 n-hexane:2-propanol, 0.7 
mL/min, 220 nm; minor enantiomer tR = 16.2 min, major 
enantiomer tR = 14.2 min. 
 
(2R, 3S)-3-(4-Chlorophenyl)-2-methyl-2-nitrooxirane (184f) 
White solid, 12.4 mg, 29% yield. mp 55.9-
57.9 °C. [α]D
22
 = -53.8 (c 0.65, CHCl3), ee 
86%. FTIR max (KBr)/cm
-1
 1561, 1495, 1436, 1352, 1159, 1091, 
1015, 900, 763. 
1
H NMR (CDCl3, 400 MHz): δ 7.41 (d, 2H, J= 8.2 
Hz), 7.25 (d, 2H, J= 8.2 Hz), 4.52 (s, 1H), 1.79 (s, 3H). 
13
C NMR 
(CDCl3, 100 MHz): δ 135.6, 129.4, 129.1, 127.8, 88.6, 62.0, 12.4. 
Elemental analysis calcd (%) for C9H8ClNO3: C, 50.60; H, 3.77; N, 
6.56; found C, 50.89; H, 3.97; N, 6.60. HPLC analysis with 
Chiralpak AS-H column, 90:10 n-hexane:2-propanol, 1 mL/min, 





Yellow solid, 18 mg, 36% yield. mp 58.2-
62.6 °C. [α]D
23
 = -30.9 (c 0.53, CHCl3), ee 
77%. FTIR max (KBr)/cm
-1
 1561, 1325, 
1167, 1127, 1067, 1019, 857, 832. 
1
H NMR (CDCl3, 250 MHz): δ 
7.69 (d, 2H, J= 8.1 Hz), 7.45 (d, 2H, J= 8.1 Hz), 4.61 (s, 1H), 1.78 
(s, 3H). 
13
C NMR (CDCl3, 75 MHz): δ 134.9, 131.7 (q, 
2
J(C-C-F)= 




32.8 Hz), 126.9, 125.9, 125.8, 123.6 (q, 
1
J(C-F)= 271.0 Hz), 88.5, 
61.8, 12.4. MS (ESI m/z) 285.6 [MK
+
, 20%]. Elemental analysis 
calcd (%) for C10H8F3NO3: C, 48.59; H, 3.26; N, 5.67; found C, 
48.94; H, 3.48; N, 5.40. HPLC analysis with Chiralpak IE-3 
column, 98:2 n-hexane:2-propanol, 0.7 mL/min, 220 nm; minor 
enantiomer tR = 18.4 min, major enantiomer tR = 13.2 min. 
 
(2R, 3S)-2-Methyl-3-(naphthalen-2-yl)-2-nitrooxirane (184h) 
Pale yellow solid, 11.9 mg, 26% yield. mp 
63.8-65.7 °C. [α]D
20
 = -72.2 (c 0.67, CHCl3), 
ee 95%. FTIR max (KBr)/cm
-1
 3057, 2925, 1559, 1343, 1105, 893, 
861, 821, 756.  
1
H NMR (CDCl3, 300 MHz): δ 7.92-7.85 (m, 3H), 
7.79 (s, 1H), 7.58-7.53 (m, 2H), 7.39 (dd, 1H, J1= 8.4 Hz, J2= 1.5 
Hz), 4.71 (s, 1H), 1.83 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 
133.6, 132.8, 128.8, 128.3, 128.0, 127.9, 126.9, 126.1, 123.2, 80.0, 
62.9, 12.5. MS (ESI m/z) 230.0 [MH
+
, 6%], 248.6 [M+H3O
+
, 38%]. 
Elemental analysis calcd (%) for C13H11NO3: C, 68.11; H, 4.84; N, 
6.11; found C, 68.44; H, 5.10; N, 6.24. HPLC analysis with 
Chiralpak IE-3 column, 98:2 n-hexane:2-propanol, 0.7 mL/min, 254 
nm; minor enantiomer tR = 24.7 min, major enantiomer tR = 20.3 
min. 
 
(2R, 3S)-2-Ethyl-2-nitro-3-phenyloxirane (184i)  
Yellow oil, 8 mg, 21% yield. [α]D
22
 = -25.1 (c 
0.67, CHCl3), ee 92%. FTIR max (KBr)/cm
-1
 
2918, 1557, 1458, 1435, 1351, 938, 813, 768. 
1
H NMR (CDCl3, 
300 MHz): δ 7.44-7.38 (m, 3H), 7.33-7.29 (m, 2H), 4.52 (s, 1H), 




2.55-2.41 (m, 1H), 1.69 (dq, 1H, J1= 15.1 Hz, J2= 7.3 Hz), 1.07 (t, 
3H, J1= 7.4 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 131.1, 129.4, 





, 15%]. Elemental analysis calcd (%) for C10H11NO3: 
C, 62.17; H, 5.74; N, 7.25; found C, 62.46; H, 5.50; N, 7.48. HPLC 
analysis with Chiralpak IE-3 column, 98:2 n-hexane:2-propanol, 
0.7 mL/min, 220 nm; minor enantiomer tR = 13.7 min, major 
enantiomer tR = 11.9 min. 
 
(2R, 3S)-2-Ethyl-2-nitro-3-m-tolyloxirane (184j) 
Yellow oil, 12.8 mg, 31% yield. [α]D
23
 = -30.6 (c 
0.57, CHCl3), ee 92%. FTIR max (KBr)/cm
-1
 
2984, 2945, 1559, 1462, 1435, 1351, 1152, 1083, 
969, 815, 790. 
1
H NMR (CDCl3, 400 MHz): δ 7.30 (t, 1H, J= 7.5 
Hz), 7.23-7.18 (m, 1H), 7.12-7.07 (m, 2H), 4.47 (s, 1H), 2.48 (dq, 
1H, J1= 15.1 Hz, J2= 7.4 Hz), 2.38 (s, 3H), 1.69 (dq, 1H, J1= 15.1 
Hz, J2= 7.4 Hz), 1.08 (t, 3H, J= 7.4 Hz). 
13
C NMR (CDCl3, 75 
MHz): δ 138.6, 131.0, 130.1, 128.6, 126.9, 123.3, 92.6, 63.3, 21.4, 
19.5, 7.6. MS (ESI m/z) 207.9 [MH
+
, 8%], 230.5 [MNa
 +
, 10%]. 
Elemental analysis calcd (%) for C11H13NO3: C, 63.76; H, 6.32; N, 
6.76; found C, 64.07; H, 6.53; N, 6.63. HPLC analysis with 
Chiralpak IE-3 column, 98:2 n-hexane:2-propanol, 0.7 mL/min, 254 










(2R, 3S)-3-(4-Bromophenyl)-2-ethyl-2-nitrooxirane (184k) 
White solid, 18.2 mg, 33% yield. Mp 59.6-
60.3 °C. [α]D
21
 = -29.0 (c 0.53, CHCl3), ee 
90%. FTIR max (KBr)/cm
-1
 2984, 1557, 1489, 1463, 1434, 1346, 
1071, 1011, 936, 808. 
1
H NMR (CDCl3, 300 MHz): δ 7.56 (d, 2H, 
J= 8.4 Hz), 7.19 (d, 2H, J= 8.4 Hz), 4.48 (s, 1H), 2.46 (dq, 1H, J1= 
15.1 Hz, J2= 7.4 Hz), 1.66 (dq, 1H, J1= 15.1 Hz, J2= 7.4 Hz), 1.07 
(t, 3H, J= 7.4 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 132.0, 130.1, 





-NO2+2H2O, 20%]. Elemental analysis calcd (%) 
for C10H10BrNO3: C, 44.14; H, 3.70; N, 5.15; found C, 43.87; H, 
3.88; N, 5.37. HPLC analysis with Chiralpak IE-3 column, 98:2 n-
hexane:2-propanol, 0.7 mL/min, 220 nm; minor enantiomer tR = 
17.4 min, major enantiomer tR = 14.6 min. 
 
(2R, 3S)-3-(3,4-Dichlorophenyl)-2-ethyl-2-nitrooxirane (184l) 
Yellow oil, 18.1 mg, 35% yield. [α]D
25
 = -18.3 
(c 0.76, CHCl3), ee 61%. FTIR max (KBr)/cm
-
1
 2984, 2944, 1561, 1474, 1435, 1350, 1133, 
1033, 944, 811. 
1
H NMR (CDCl3, 400 MHz): δ 7.51 (d, 1H, J= 8.3 
Hz), 7.40 (d, 1H, J= 1.9 Hz), 7.16 (dd, 1H, J1= 8.3 Hz, J2= 1.9 Hz), 
4.48 (s, 1H), 2.46 (dq, 1H, J1= 15.1 Hz, J2= 7.4 Hz), 1.65 (dq, 1H, 
J1= 15.1 Hz, J2= 7.4 Hz), 1.09 (t, 3H, J= 7.4 Hz). 
13
C NMR 
(CDCl3, 75 MHz): δ 133.8, 133.3, 131.3, 130.9, 128.2, 125.6, 92.0, 
61.8, 19.5, 7.6. MS (ESI m/z) 251.6 [M
+
-NO2+2H2O, 100%]. 
Elemental analysis calcd (%) for C10H9Cl2NO3: C, 45.83; H, 3.46; 
N, 5.34; found C, 46.16; H, 3.24; N, 5.55. HPLC analysis with 




Chiralpak IE-3 column, 98:2 n-hexane:2-propanol, 0.7 mL/min, 254 




Yellow oil, 14.5 mg, 35% yield. [α]D
25
 = -4.6 
(c 0.88, CHCl3), ee 16%. FTIR max 
(KBr)/cm
-1
 3027, 2924, 1557, 1496, 1455, 1388, 1357, 1112, 1083, 
751, 699. 
1
H NMR (CDCl3, 400 MHz): δ 7.35-7.24 (m, 3H), 7.21-
7.16 (m, 2H), 3.48 (t, 1H, J= 6.3 Hz), 2.95-2.87 (m, 1H), 2.83-2.74 
(m, 1H), 2.06-1.95 (m, 1H), 1.93-1.83 (m, 1H), 1.74 (s, 3H). 
13
C 
NMR (CDCl3, 100 MHz): δ 139.6, 128.8, 128.3, 126.7, 62.4, 31.9, 
29.8, 13.5. Elemental analysis calcd (%) for C11H13NO3: C, 63.76; 
H, 6.32; N, 6.76; found C, 64.11; H, 6.58; N, 6.65. HPLC analysis 
with Chiralpak AS-H column, 99:1 n-hexane:2-propanol, 0.8 
mL/min, 220 nm; minor enantiomer tR = 12.7 min, major 
enantiomer tR = 11.5 min. 
 
1-Phenyl-1-(phenylamino)propan-2-one (185a) 
Data for this compound were consistent with those 
reported in the literature.
270
 
Wax, 29.3 mg, 65% yield. [α]D
27
 = +27.9 (c 0.50, 
CHCl3), ee 16%. FTIR max (KBr)/cm
-1
 3393, 2863, 
1714, 1600, 1505, 1312, 1230, 1165, 745, 692. 1H NMR (CDCl3, 
400 MHz): δ 7.55-7.32 (m, 5H), 7.13-7.06 (m, 2H), 6.73-6.66 (m, 
1H), 6.63-6.57 (m, 2H), 5.01 (brd, 1H), 2.14 (s, 3H). 
13
C NMR 
(CDCl3, 75 MHz): δ 203.8, 145.4, 137.6, 129.7, 129.2, 129.1, 




128.8, 127.8, 118.0, 113.7, 68.4, 26.7. MS (ESI m/z) 248.5 [MNa
+
, 
10%]. HPLC analysis with Chiralpak IE-3 column, 95:5 n-
hexane:2-propanol, 0.7 mL/min, 254 nm; minor enantiomer tR = 
18.8 min, major enantiomer tR = 15.6 min. 
 
1-(naphthalen-1-ylamino)-1-phenylpropan-2-one (185b) 
Red solid, 12.4 mg, 30% yield. mp 81 °C 
(Decomp.). FTIR max (KBr)/cm
-1
 3415, 3064, 
1715, 1625, 1582, 1526, 1476, 1165, 769, 701. 
1
H 
NMR (CDCl3, 400 MHz): δ 8.09 (d, 1H, J= 8.2 
Hz), 7.76 (d, 1H, J= 8.0 Hz), 7.58-7.44 (m, 3H), 
7.41-7.29 (m, 3H), 7.20-7.13 (m, 2H), 6.36-6.30 (m, 2H), 5.15 (d, 
1H, J= 2.7 Hz), 2.20 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 
204.0, 140.9, 137.8, 134.3, 129.3, 128.6, 128.5, 127.8, 126.3, 125.8, 
124.9, 123.4, 120.2, 117.6, 105.3, 68.2, 26.6. MS (ESI m/z) 276.7 
[MH
+
, 28%], 298.6 [MNa
+
, 100%]. Elemental analysis calcd (%) 




Red solid, 12.8 mg, 31% yield. mp 83 °C 
(Decomp.). FTIR max (KBr)/cm
-1
 3398, 3057, 
1714, 1629, 1519, 1482, 1358, 1190, 827, 748, 
701. 
1
H NMR (CDCl3, 400 MHz): δ 7.64-7.58 
(m, 2H), 7.54-7.45 (m, 3H), 7.42-7.37 (m, 2H), 7.34-7.28 (m, 1H), 
7.18-7.13 (m, 1H), 6.96 (dd, 1H, J1= 8.8 Hz, J2= 2.5 Hz), 6.63-6.60 
(m, 2H), 5.61 (brs, 1H), 5.13 (d, 1H, J= 4.3 Hz), 2.18 (s, 3H). 
13
C 




NMR (CDCl3, 100 MHz): δ 203.9, 143.5, 137.8, 134.8, 129.3, 
129.0, 128.5, 127.8, 127.6, 126.2, 125.9, 122.1, 118.1, 105.4, 68.1, 
26.7. MS (ESI m/z) 276.7 [MH
+
, 26%], 298.6 [MNa
+
, 100%]. 
Elemental analysis calcd (%) for C19H17NO: C, 82.88; H, 6.22; N, 
5.09; found C, 83.22; H, 6.50; N, 4.84. 
 
1-(4-methoxyphenylamino)-1-phenylpropan-2-one (185d) 
Ochre wax, 14.6 mg, 38% yield. FTIR max 
(KBr)/cm
-1
 3404, 1719, 1654, 1513, 1239, 
1178, 1035, 820, 762, 701. 
1
H NMR (CDCl3, 
300 MHz): δ 7.48-7.30 (m, 5H), 6.69 (d, 2H, 
J= 8.8 Hz), 6.50 (d, 2H, J= 8.8 Hz), 5.15 (brs, 1H), 4.93 (s, 1H), 
3.68 (s, 3H), 2.12 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 204.4, 
152.1, 140.3, 138.3, 129.2, 128.3, 127.8, 114.8, 114.5, 69.1, 55.7, 
26.7. MS (ESI m/z) 255.7 [MH
+
, 13%], 278.0 [MNa
+
, 16%]. 
Elemental analysis calcd (%) for C16H17NO2: C, 75.27; H, 6.71; N, 
5.49; found C, 75.58; H, 7.00; N, 5.72. 
 
1-(phenylamino)-1-p-tolylpropan-2-one (185e) 
Red wax, 37.8 mg, 79% yield. FTIR max 
(KBr)/cm
-1
 3422, 2921, 1707, 1668, 1601, 1496, 
1444, 1314, 1159, 1113, 1030, 901, 823, 744. 
1
H 
NMR (CDCl3, 400 MHz): δ 7.32 (d, 2H, J= 7.7 
Hz), 7.17 (d, 2H, J= 7.7 Hz), 7.13-7.06 (m, 2H), 6.72-6.66 (m, 1H), 
6.64-6.58 (m, 2H), 4.99 (brs, 1H), 2.33 (s, 3H), 2.13 (s, 3H). 
13
C 
NMR (CDCl3, 75 MHz): δ 204.2, 145.8, 138.2, 134.8, 130.4, 129.9, 
129.5, 129.1, 127.6, 117.6, 113.3, 67.8, 26.6, 21.1. MS (ESI m/z) 






, 10%], 262.8 [MNa
+
, 14%]. Elemental analysis calcd 
(%) for C16H17NO: C, 80.30; H, 7.16; N, 5.85; found C, 79.98; H, 
7.41; N, 6.06. 
 
1-(4-chlorophenyl)-1-(phenylamino)propan-2-one (185f) 
Red wax, 34.9 mg, 67% yield. FTIR max 
(KBr)/cm
-1
 3449, 1715, 1670, 1601, 1542, 1500, 
1489, 1441, 1315, 1162, 1091, 836, 752, 693. 
1
H 
NMR (CDCl3, 400 MHz): δ 7.46-7.33 (m, 4H), 
7.14-7.07 (m, 2H), 6.70-6.66 (m, 1H), 6.55-6.50 (m, 2H), 4.98 (brs, 
1H), 2.14 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 203.2, 145.5, 
136.6, 131.7, 129.4, 129.2, 129.1, 117.9, 113.3, 67.4, 26.6. MS 
(ESI m/z) 260.5 [MH
+
, 37%], 282.5 [MNa
+
, 10%]. Elemental 
analysis calcd (%) for C15H14ClNO: C, 69.36; H, 5.43; N, 5.39; 




Yellow wax, 28.1 mg, 48% yield. FTIR max 
(KBr)/cm
-1
 3392, 3052, 2926, 1721, 1603, 
1505, 1417, 1325, 1279, 1166, 1125, 1066, 
1017, 845, 751, 692. 
1
H NMR (CDCl3, 400 
MHz): δ 7.67-7.58 (m, 4H), 7.12-7.07(m, 2H), 6.70-6.66 (m, 1H), 
6.53-6.48 (m, 2H), 5.47 (brs, 1H), 5.06 (brs, 1H), 2.16 (s, 3H). 
13
C 
NMR (CDCl3, 100 MHz): δ 202.7, 145.5, 142.3, 130.7 (q, 
2
J(C-C-F) = 
32.3 Hz), 129.3, 128.2, 126.2 (q, 
3
J(C-C-C-F) = 3.6 Hz), 123.9 (q, 
1
J(C-F) 
= 270.5 Hz), 118.1, 113.3., 67.8, 26.8. MS (ESI m/z) 293.6 [MH
+
, 






, 21%]. Elemental analysis calcd (%) for C16H14 
F3NO: C, 65.52; H, 4.81; N, 4.78; found C,65.79; H, 4.97; N, 4.63. 
 
1-(naphthalen-2-yl)-1-(phenylamino)propan-2-one (185h) 
Red wax, 39.6 mg, 72% yield. FTIR max 
(KBr)/cm
-1
 3056, 1711, 1667, 1598, 1544, 
1496, 1444, 1313, 1232, 1155, 1028, 821, 753, 
693. 
1
H NMR (CDCl3, 300 MHz): δ 7.99 (s, 
1H), 7.93-7.80 (m, 2H), 7.58-7.35 (m, 5H), 7.17-7.05 (m, 2H), 
6.70-6.58 (m, 2H), 5.17 (s, 1H), 2.16 (s, 3H). 
13
C NMR (CDCl3, 75 
MHz): δ 203.9, 145.9, 135.5, 133.4, 133.2, 129.2, 129.1, 128.3, 
127.8, 127.7, 127.3, 126.5, 126.3, 124.9, 117.7, 113.3, 68.3, 26.8. 
MS (ESI m/z) 276.6 [MH
+
, 39%], 298.6 [MNa
+
, 77%]. Elemental 
analysis calcd (%) for C19H17NO: C, 82.88; H, 6.22; N, 5.09; found 
C, 82.58; H, 6.38; N, 5.37. 
 
1-phenyl-1-(phenylamino)butan-2-one (185i) 
Ochre solid, 28.2 mg, 59% yield. mp 84.2-86.7 °C. 
FTIR max (KBr)/cm
-1
 3395, 2923, 1716, 1603, 
1504, 1454, 1428, 1317, 1260, 1111, 1034, 749. 
1
H 
NMR (CDCl3, 400 MHz): δ 7.47-7.42 (m, 2H), 
7.39-7.34 (m, 3H), 7.30 (d, 1H, J= 7.2 Hz), 7.12-7.05 (m, 2H), 6.65 
(t, 1H, J= 7.3 Hz), 6.57-6.53 (m, 2H), 5.50 (brs, 1H), 5.00 (s, 1H), 
2.53-2.40 (m, 2H), 0.99 (t, 3H, J= 7.3 Hz). 
13
C NMR (CDCl3, 100 
MHz): δ 206.9, 146.0, 138.3, 129.14, 129.12, 128.3, 127.8, 117.6, 
113.3., 67.4, 32.5, 7.86. MS (ESI m/z) 240.7 [MH
+
, 18%], 262.6 
[MNa
+
, 43%]. Elemental analysis calcd (%) for C16H17NO: C, 




80.30; H, 7.16; N, 5.85; found C, 80.57; H, 7.41; N, 6.12. 
 
1-(phenylamino)-1-m-tolylbutan-2-one (185j) 
Orange wax, 33.4 mg, 66% yield. FTIR max 
(KBr)/cm
-1
 3386, 1716, 1603, 1505, 1428, 1321, 
1111, 1035, 749, 692. 
1
H NMR (CDCl3, 300 
MHz): δ 7.31-7.23 (m, 3H), 7.16-7.08 (m, 3H), 
6.68 (t, 1H, J= 7.3 Hz), 6.61-6.56 (m, 2H), 5.48 (brs, 1H), 4.98 (s, 
1H), 2.48 (q, 2H, J= 7.3 Hz), 2.36 (s, 3H), 1.01 (t, 3H, J= 7.3 Hz). 
13
C NMR (CDCl3, 75 MHz): δ 207.1, 146.2, 138.9, 138.3, 129.13, 
129.09, 128.95, 128.21, 125.0, 117.5, 113.3, 67.4, 32.4, 21.4, 7.9. 
MS (ESI m/z) 276.5 [MNa
+
, 100%]. Elemental analysis calcd (%) 




Red wax, 40.7 mg, 64% yield. FTIR max 
(KBr)/cm
-1
 3066, 1719, 1602, 1505, 1428, 
1404, 1316, 1140, 1111, 1071, 1010, 833, 750, 
692. 
1
H NMR (CDCl3, 300 MHz): δ 7.50 (d, 
2H, J= 8.3 Hz), 7.34 (d, 2H, J= 8.3 Hz), 7.13-7.05 (m, 2H), 6.67 (t, 
1H, J= 7.2 Hz), 6.54-6.49 (m, 2H), 4.96 (s, 1H), 2.50-2.40 (m, 2H), 
1.00 (t, 3H, J= 7.3 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 206.1, 
145.6, 137.4, 132.3, 129.3, 129.1, 122.2, 117.8, 113.3, 66.7, 32.4, 
7.8. MS (ESI m/z) 318.5 [MH
+
, 45%]. Elemental analysis calcd (%) 
for C16H16BrNO: C, 60.39; H, 5.07; N, 4.40; found C, 60.13; H, 
5.28; N, 4.63. 





Red wax, 29 mg, 47% yield. FTIR max 
(KBr)/cm
-1
 3390, 1720, 1604, 1505, 1467, 
1429, 1394, 1318, 1135, 1031, 752, 740, 692. 
1
H NMR (CDCl3, 300 MHz): δ 7.56 (s, 1H), 
7.48-7.42 (m, 1H), 7.35-7.28 (m, 1H), 7.16-7.07 (m, 2H), 6.70 (t, 
1H, J= 7.3 Hz), 6.55-6.48 (m, 2H), 5.55 (brs, 1H), 4.95 (s, 1H), 
2.53-2.41 (m, 2H), 1.02 (t, 3H, J= 7.3 Hz). 
13
C NMR (CDCl3, 75 
MHz): δ 205.5, 145.4, 138.9, 133.4, 132.5, 131.1, 129.5, 129.2, 





, 12%]. Elemental analysis calcd (%) for 




Yellow oil, 14.2 mg, 28% yield. Aniline and α-
amino ketone 185m have the same polarity. To 
remove aniline from the mixture of the two 
products, recovered after silica gel 
chromatography, the mixture was diluted with Et2O and washed 
with water. FTIR max (KBr)/cm
-1
 3441, 2918, 2850, 1705, 1635, 
1602, 1506, 1454, 1260, 1093, 799, 748, 693. 
1
H NMR (CDCl3, 
400 MHz): δ 7.33-7.15 (m, 7H), 6.77-6.72 (m, 1H), 6.59-6.52 (m, 
2H), 4.32 (brs, 1H), 4.07-4.02 (m, 1H), 2.94-2.84 (m, 1H), 2.80-
2.65 (m, 2H), 2.19 (s, 3H), 2.03-1.93 (m, 1H). 
13
C NMR (CDCl3, 
100 MHz): δ 210.0, 146.8, 140.8, 129.4, 128.5, 128.4, 126.2, 118.1, 
113.2, 62.8, 33.4, 31.5, 26.4. Elemental analysis calcd (%) for 




C17H19NO: C, 80.60; H, 7.56; N, 5.53; found C, 82.32; H, 7.72; N, 
5.70. 
(1R,2S)-1-phenyl-1-(pyrrolidin-1-yl)propan-2-ol (189) 
Data for this compound were consistent with those 
reported in the literature.
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White solid, 20.2 mg, 78% yield. [α]D
24
 = -53.0 (c 
0.82, CH2Cl2), ee 67%. 
1
H NMR (CDCl3, 400 MHz): δ 7.32-7.27 
(m, 5H), 4.27-4.21 (m, 1H), 2.99 (d, 1H, J= 3.3 Hz), 2.69-2.60 (m, 
2H), 2.47-2.40 (m, 2H), 1.79-1.74 (m, 4H), 0.83 (d, 3H, J= 6.4 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 138.4, 129.4, 127.8, 127.4, 75.7, 
66.9, 52.8, 23.3, 19.1. HPLC analysis with Chiralcel OD-H column, 
99:1 n-hexane: ethanol, 1 mL/min, 220 nm; minor enantiomer tR = 
7.5 min, major enantiomer tR = 8.4 min, ee 67 %. 
 
1-(Naphthalen-2-ylthio)-1-phenylpropan-2-one (192) 
Pink solid, 21.3 mg, 73% yield. mp 70.8-
74.3 °C. FTIR max (KBr)/cm
-1
 2923, 1712, 
1585, 1493, 1454, 1355, 1067, 815, 744, 699, 
569. 
1
H NMR (CDCl3, 300 MHz): δ 7.81-7.68 
(m, 4H), 7.48-7.44 (m, 2H), 7.41-7.31 (m, 6H), 5.10 (s, 1H), 2.21 
(s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 203.1, 135.4, 133.5, 132.5, 
131.3, 131.0, 129.3, 128.9, 128.6, 128.5, 128.3, 127.6, 127.5, 126.5, 
126.4, 64.4, 27.3. MS (ESI m/z) 293.4 [MH
+
, 14%]. Elemental 
analysis calcd (%) for C19H16OS: C, 78.05; H, 5.52; S, 10.97; found 
C, 78.27; H, 5.34; S, 11.12. 
 
 





Data for this compound were consistent with those 
reported in the literature.
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White wax, 18.5 mg, 56% yield. FTIR max (KBr)/cm
-1
 3060, 2924, 
1562, 1483, 1445, 1396, 1374, 1343, 1191, 1132, 1006, 996, 766, 
699. 
1
H NMR (CDCl3, 400 MHz): δ 8.13-8.10 (m, 1H), 8.07-8.05 
(m, 1H), 7.76-7.68 (m, 2H), 7.68-7.63 (m, 2H), 7.56-7.47 (m, 3H), 
2.77 (s, 3H). 
13
C NMR (CDCl3, 100 MHz): δ 154.9, 152.5, 141.1, 



























6.5 Enantioselective α-hydroxylation of β-ketoamides 
Experimental procedures and compounds characterization 
General procedure for the synthesis of β-ketoamides 
1-Isocyanato-4-(pentyloxy)benzene was synthesized according to 




METHOD A: β-ketoamides 216a-j, m were prepared following a 
general procedure reported in the literature.
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In a two necked round bottom flask under a positive pressure of 
nitrogen, NaH (60% w/w dispersion in mineral oil, 10 mmol) was 
suspended in dry THF (10 mL) for 10 minutes under stirring. The 
suspension was allowed to settle and after removal of the 
supernatant, fresh THF (10 mL) was added. A solution of the 
appropriate indanone or α-tetralone (4 mmol) and isocyanate (4.8 
mmol) in dry THF (1.5 mL) was added dropwise over 10 minutes to 
the refluxing suspension. After completion, monitored by TLC 
(eluent: PE/ AcOEt 8:2) the mixture was cooled to 0 °C and 1 N 




HCl was added cautiously until the solid completely dissolved (≈ 
15 mL). The solution was extracted with ethyl acetate (2 x 20 mL) 
and the organic phase was washed with saturated NaHCO3 (20 mL), 
brine (20 mL), dried (Na2SO4) and concentrated. The residue was 
triturated with Et2O to give the desired compound as yellow/white 
solid.  
METHOD B: β-ketoamides 216k and 216l were prepared by using 
a general procedure reported in the literature.
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The β-ketoester (4 mmol) and appropriate benzylamine (8 mmol) in 
dry toluene (40 mL) were heated to reflux or to 70 °C under 
nitrogen over molecular sieves for the necessary time (monitoring 
by TLC, PE/AcOEt 8:2 as eluent). Then molecular sieves were 
filtered off, and the mixture was purified by flash 
chromatography, using PE/AcOEt 9:1 to 7:3 as eluent, to give 
compounds 216k, 216l. 
 
General procedure for the racemic hydroxylation of compounds 
216  
In a sample vial, the appropriate β-ketoamide 216 (0.10 mmol), 
TBHP (0.12 mmol), and 2-piperidinemethanol (3.5 mg, 0.03 mmol) 
were dissolved in dry CHCl3 or anhydrous toluene (0.5 mL). The 
reaction was stirred at room temperature for 17-41 h until 
completion, monitored by TLC (PE/AcOEt 8:2 or 7:3). After 
removing the solvent under vacuum, the mixture was directly 
purified by flash chromatography (PE/AcOEt 9:1 to 7:3) to give 
products 220 in 34-97%. 
 




General procedure for the asymmetric hydroxylation of 
compounds 216a-n 
 
To a sample vial charged with the appropriate β-ketoamide 216 
(0.10 mmol) and the hydroquinine (6.5 mg, 0.02 mmol) in 
anhydrous chloroform (2.0 mL), TBHP (0.12 mmol) was added and 
the reaction was stirred at –20 °C for 64-144 h until completion 
(monitored by TLC, PE/AcOEt 8:2 or 7:3). The solvent was 
removed under vacuum and the product 220 was isolated by flash 
chromatography (PE/AcOEt 9:1 to 7:3). The absolute configuration 
of compounds 220 was assigned to be (S) by analogy to the 
structure determined by single-crystal X-ray analysis performed on 
compound 220b (see the X-ray analysis section). Crystallization 
using n-hexane/CHCl3 or n-pentane/CHCl3 mixtures performed at 














White solid (83% yield, 66% after 
crystallization), mp 149.9-151.3 °C. [α]D
25
 = 
+6.4 (c 0.6, CHCl3), ee 87%. FTIR max 
(KBr)/cm
-1





(CDCl3, 400 MHz): δ 8.83 (bs, 1H), 7.77 (d, 1H, J= 7.7 Hz), 7.67 (t, 
1H, J= 7.2 Hz), 7.52-7.50 (m, 3H), 7.42 (t, 1H, J= 7.2 Hz ), 7.29 (t, 
2H, J= 7.5 Hz), 7.11 (t, 1H, J= 7.1 Hz), 4.36 (bs, 1H), 3.87 (d, 1H, 
J= 16.8 Hz), 3.18 (d, 1H, J= 16.8 Hz). 
13
C NMR (CDCl3, 100 
MHz): δ 203.2, 168.4, 153.1, 136.9, 136.5, 133.7, 129.0, 128.1, 





, 85%]. HPLC analysis with Chiralcel ODH 
column, 70:30 n-hexane:2-propanol, 1 mL/min, detection at 254 




White solid (88% yield, 66% after 
crystallization), mp 171.9-173.6 °C. [α]D
25
 = 
+50.0 (c 0.6, CHCl3), ee 96%. FTIR max 
(KBr)/cm
-1
 3339, 1728, 1657, 1598, 1533, 1445, 1267, 1120, 943, 
753, 692. 
1
H NMR (CDCl3, 400 MHz): δ 8.70 (bs, 1H), 7.84 (d, 
1H, J= 7.8 Hz), 7.76 (d, 1H, J= 7.6 Hz), 7.53 (d, 2H, J = 8.4 Hz), 
7.36-7.29 (m, 3H), 7.15-7.11 (m, 1H), 3.84 (d, 1H, J= 17.3 Hz), 
3.72 (bs, 1H), 3.12 (d, 1H, J= 17.3 Hz) 
13
C NMR (CDCl3, 100 
MHz): δ 202.6, 168.0, 152.7, 139.1, 136.7, 135.7, 129.8, 129.0, 









, 25%]. HPLC analysis with Chiralcel ODH 
column, 80:20 n-hexane:2-propanol, 1 mL/min, detection at 254 




Pale yellow solid (85% yield), mp 182.7-
183.1 °C. [α]D
23
 = +48.9 (c 0.6, CHCl3), 
ee 79%. FTIR  max (KBr)/cm
-1
 3307, 
1732, 1646, 1449, 1081, 759. 
1
H NMR (CDCl3, 400 MHz): δ 8.70 
(bs, 1H), 7.73 (d, 1H, J= 8.2 Hz), 7.53-7.51 (m, 3H), 7.41 (d, 1H, 
J= 7.9 Hz), 7.33-7.29 (m, 2H), 7.13 (t, 1H, J= 7.4 Hz), 3.84 (d, 1H, 
J= 16.9 Hz), 3.80 (bs, 1H), 3.17 (d, 1H, J= 16.9 Hz) 
13
C NMR 
(CDCl3, 100 MHz): δ 201.6, 167.8, 154.3, 143.3, 136.7, 132.1, 
129.1, 126.7, 126.2, 124.9, 119.7, 82.8, 40.6. MS (ESI m/z) 301.97 
[MH
+
, 8%], 324.02 [MNa
+
, 100%]. HPLC analysis with Chiralcel 
ODH column, 70:30 n-hexane:2-propanol, 1 mL/min, detection at 





White solid (87% yield), mp 187.1-188.3 
°C. [α]D
26
=+45.1 (c 0.9, CHCl3), ee 78%. 
FTIR max (KBr)/cm
-1
 3355, 1723, 1659, 
1595, 1532, 1445, 1219, 772. 
1
H NMR (CDCl3, 400 MHz): δ 8.70 




(bs, 1H), 7.71 (s, 1H), 7.66 (d, 1H, J= 8.2 Hz), 7.58 (d, 1H, J= 8.0 
Hz), 7.52 (d, 2H, J= 8.6 Hz), 7.33-7.30 (m, 2H), 7.15-7.11 (m, 1H), 
3.84 (d, 1 H, J= 17.1 Hz), 3.75 (bs, 1H), 3.18 (d, 1H, J= 17.1 Hz) 
13
C NMR (CDCl3, 100 MHz): δ 201.8, 167.8, 154.3, 136.8, 132.5, 
132.2, 131.9, 129.7, 129.1, 126.2, 124.9, 119.7, 82.8, 40.5 MS (ESI 
m/z) 367.91 [MNa
+
, 100%]. HPLC analysis with Chiralcel ODH 
column, 70:30 n-hexane:2-propanol, 1 mL/min, detection at 254 




White solid (84% yield, 60% after 
crystallization), mp 146.0-147.2 °C. 
[α]D
20
= -31.3 (c 0.9, CHCl3), ee 98%. 
FTIR max (KBr)/cm
-1
 3343, 1717, 1661, 1600, 1532, 1494, 1445, 
1281, 1241, 1026, 754. 
1
H NMR (CDCl3, 400 MHz): δ 8.79 (bs, 
1H), 7.48 (d, 2H, J= 7.7 Hz), 7.36 (d, 1H, J= 8.4 Hz), 7.29-7.27 (m, 
1H), 7.25-7.23 (m, 2H) 7.15 (d, 1H, J= 2.5 Hz), 7.09 (t, 1H, J= 7.4 
Hz), 4.40 (bs, 1H), 3.80 (s, 3H), 3.75 (d, 1H, J= 16.6 Hz), 3.08 (d, 
1H, J= 16.5 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 203.1, 168.5, 
159.7, 146.1, 136.9, 134.8, 128.9, 127.1, 125.9, 124.7, 119.7, 106.1, 
83.2, 55.6, 40.2, MS (ESI m/z) 297.95 [MH
+





, 8%]. HPLC analysis with Chiralcel ODH 
column, 70:30 n-hexane:2-propanol, 1 mL/min, detection at 254 
nm; minor enantiomer tR = 10.9 min, major enantiomer tR = 7.5 
min. 
 






Pale yellow solid (82% yield), mp 166.2-
167.5 °C. [α]D
21
=+28.9 (c 0.6, CHCl3), ee 
74%. FTIR max (KBr)/cm
-1
 3368, 1722, 
1661, 1538, 1532, 1500, 1219, 772. 
1
H NMR (CDCl3, 400 MHz): δ 
9.23 (bs, 1H), 7.98 (d, 1H, J= 7.5 Hz), 7.89-7.81 (m, 3H), 7.68-7.66 
(m, 2H), 7.57-7.48 (m, 3H), 7.44-7.40 (m, 2H), 4.09 (bs, 1H), 3.94 
(d, 1H, J= 16.7 Hz), 3.26 (d, 1H, J= 16.7 Hz) 
13
C NMR (CDCl3, 
100 MHz): δ 203.0, 168.6, 153.0, 136.5, 134.0, 133.7, 131.3, 128.7, 
128.2, 126.53, 126.48, 126.42, 126.0, 125.8, 125.6, 125.3, 120.2, 
119.6, 83.1, 40.8 MS (ESI m/z) 318.10 [MH
+





, 25%]. HPLC analysis with Chiralpak ASH 
column, 70:30 n-hexane:2-propanol, 0.8 mL/min, detection at 254 





White solid (76% yield, 48% after 
crystallization), mp 90.3-93.0 °C. [α]D
21
 = 
+22.8 (c 0.6, CHCl3), ee 99%. FTIR max 
(KBr)/cm
-1
 3352, 1723, 1685, 1594, 1529, 1443, 1304, 1214, 751. 
1
H NMR (CDCl3, 400 MHz): δ 9.31 (bs, 1H), 8.31 (dd, 1H, J1= 8.2, 
J2=1.3 Hz), 7.84 (d, 1H, J= 7.8 Hz), 7.73-7.69 (m, 1H), 7.54 (d, 1H, 
J= 7.8 Hz), 7.48-7.44 (m, 1H), 7.38 (dd, 1H, J1= 8.1, J2=1.3 Hz), 
7.23-7.21 (m, 1H), 7.08-7.03 (m, 1H), 3.86 (d, 1H, J= 16.8 Hz), 




3.78 (bs, 1H), 3.27 (d, 1H, J= 16.8 Hz) 
13
C NMR (CDCl3, 100 
MHz): δ 202.6, 168.6, 152.7, 136.5, 133.7, 129.1, 128.2, 127.7, 
126.4, 125.3, 125.1, 123.2, 121.0, 82.9, 40.8 MS (ESI m/z) 302.10 
[MH
+
, 13%], 324.02 [MNa
+
, 100%], 340.03 [MK
+
, 5%]. HPLC 
analysis with Chiralcel ODH column, 80:20 n-hexane:2-propanol, 1 
mL/min, detection at 254 nm; minor enantiomer tR = 6.4 min, major 




Pale yellow solid (88% yield), mp 
138.4-139.8 °C. [α]D
26
=+9.7 (c 0.5, 
CHCl3), ee 56%. FTIR max (KBr)/cm
-1
 
3333, 1719, 1682, 1603, 1542, 1449, 1333, 1167, 1125, 772, 698. 
1
H NMR (CDCl3, 400 MHz): δ 8.93 (bs, 1H), 7.93 (s, 1H), 7.80 (d, 
1H, J= 7.7 Hz), 7.72-7.68 (m, 1H), 7.64 (d, 1H, J= 7.9 Hz), 7.52 (d, 
1H, J= 7.7 Hz), 7.46-7.41 (m, 1H), 7.39-7.35 (m, 2H), 3.95 (bs, 
1H), 3.88 (d, 1H, J= 16.7 Hz), 3.21 (d, 1H, J= 16.7 Hz) 
13
C NMR 
(CDCl3, 100 MHz): δ 202.8, 168.6, 152.9, 137.4, 136.7, 133.5, 
131.5 (q, J=32 Hz), 129.5, 128.3, 126.4, 125.3, 122.6, 121.3 (d, 
J=36 Hz), 116.5 (d, J=36 Hz), 82.9, 40.8 MS (ESI m/z) 336.06 
[MH
+
, 5%], 358.04 [MNa
+
, 100%]. HPLC analysis with Chiralpak 
ASH column, 70:30 n-hexane:2-propanol, 0.8 mL/min, detection at 














0.6, CHCl3), ee 76%. FTIR max 
(KBr)/cm
-1
 3325, 2930, 1721, 
1645, 1512, 1220, 828, 772. 
1
H NMR (CDCl3, 400 MHz): δ 8.70 
(bs, 1H), 7.74 (d, 1H, J= 7.7 Hz), 7.66-7.62 (m, 1H), 7.46 (d, 1H, 
J= 7.7 Hz), 7.40-7.35 (m, 3H), 6.77 (d, 2H, J= 9.0 Hz), 4.35 (bs, 
1H), 3.88 (t, 2H, J= 6.6 Hz), 3.82 (d, 1H, J= 16.8 Hz), 3.13 (d, 1H, 
J= 16.8 Hz), 1.79-1.73 (m, 2H), 1.44-1.34 (m, 4H), 0.92 (t, 3H, J= 
7.0 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 203.4, 168.1, 156.2, 
153.2, 136.4, 133.7, 129.9, 128.0, 126.4, 125.1, 121.3, 114.7, 82.5, 





, 10%]. HPLC analysis with Chiralcel ODH 
column, 70:30 n-hexane:2-propanol, 1 mL/min, detection at 254 




White wax (37% yield). [α]D
30
= -7.2 (c 0.7, 
CHCl3), ee 40%. FTIR max (KBr)/cm
-1
 3353, 
2930, 2855, 1723, 1646, 1530, 1465, 1215, 
752. 
1
H NMR (CDCl3, 400 MHz): δ 7.76 (d, 1H, J= 7.7 Hz), 7.64 
(t, 1H, J= 7.0 Hz), 7.47 (d, 1H, J= 7.7 Hz), 7.40 (t, 1H, J= 7.5 Hz), 
6.69 (d, 1H, J= 6.6 Hz), 3.79 (bs, 1H), 3.72 (d, 1H, J= 16.8 Hz), 
3.68-3.63 (m, 1H), 3.10 (d, 1H, J= 16.8 Hz), 1.89-1.86 (m, 2H), 




1.70-1.57 (m, 4H), 1.36-1.14 (m, 4H). 
13
C NMR (CDCl3, 100 
MHz): δ 203.4, 169.2, 152.9, 136.2, 133.9, 128.0, 126.3, 125.1, 
82.1, 48.4, 40.7, 32.83, 32.77, 29.7, 25.4, 24.7. MS (ESI m/z) 
274.13 [MH
+
, 97%], 296.06 [MNa
+
, 100%]. HPLC analysis with 
Chiralcel ODH column, 80:20 n-hexane:2-propanol, 1 mL/min, 
detection at 254 nm; minor enantiomer tR = 5.3 min, major 




Yellow wax (50% yield). [α]D
23
= -4.1 (c 
0.6, CHCl3), ee 29%. FTIR max (KBr)/cm
-
1
 3394, 2924, 1722, 1653, 1608, 1528, 
1455, 1218, 928, 772, 699. 
1
H NMR (CDCl3, 400 MHz): δ 7.77 (d, 
1H, J= 7.6 Hz), 7.65 (t, 1H, J= 7.5 Hz), 7.47 (d, 1H, J= 7.6 Hz), 
7.40 (t, 1H, J= 7.5 Hz), 7.35-7.29 (m, 2H), 7.27-7.25 (m, 3H), 7.18 
(bs, 1H), 4.41 (d, 2H, J= 5.9Hz), 3.83 (bs, 1H), 3.77 (d, 1H, J= 16.8 
Hz), 3.13 (d, 1H, J= 16.8 Hz). 
13
C NMR (CDCl3, 100 MHz): δ 
203.2, 170.3, 153.0, 137.6, 136.3, 133.8, 128.7, 128.1, 127.7, 127.6, 





, 100%]. HPLC analysis with Chiralcel ODH column, 
80:20 n-hexane:2-propanol, 1 mL/min, detection at 254 nm; minor 









X-Ray Data for the Absolute Configuration Assignment of 
Compound 220b 
X-ray diffraction quality single crystals of 220b were obtained by 
slow evaporation of a solution of 220b in n-pentane/CHCl3 mixture 
performed at room temperature. 
A suitable crystal of 220b was selected and glued on a glass fiber 
and measured at room temperature with a Rigaku AFC7S 
diffractometer equipped with a Mercury CCD detector using 
MoK radiation. Data reduction was performed with the 
crystallographic package CrystalClear.
264
 Data have been corrected 
for Lorentz, polarization and absorption. The structures were solved 
by direct methods using the program SIR2002
275
 and refined by 
means of full matrix least-squares based on F
2
 using the program 
SHELXL97.
266 
All non-hydrogen atoms were refined anisotropically, hydrogen 
atoms were positioned geometrically and included in structure 
factors calculations but not refined.  
A total of 190 refinable parameters were finally considered, final 





wR2= 0.199 (all 3466 independent. reflections).  
Flack parameter is 0.018(19). 











Crystal data:  
C16H12BrNO3, orthorhombic, space group P212121, Z= 4, a = 
9.801(3)Å, b = 10.969(3) Å, c = 14.070(4) Å, V=1512.6(8)Å
3
, Dx = 
1.520 g cm
-3
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